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Report Date: September 1989
TR-365 Toxicology and Carcinogenesis
Studies ofPentaerythritol Tetranitrate
(CAS No. 78-11-5) with 80% D-Lactose
Monohydrate (PETN, NF) in F344/N Rats
andB6C3F1 Mice (Feed Studies)
Pentaerythritol tetranitrate (PETN, NF) is a drug
used to preventanginapectoris. PETNwithout alactose
stabilizerisused as anexplosive. Toxicologyandcarcino-
genesisstudieswereconductedbyadministeringPETN,
NF, to groups ofF344/N rats and B6C3F1 mice ofeach
sexoncebygavageorinfeedfor14days,13 or14weeks,or
2 years. The PETN component was greater than 99%
pure. Genetic toxicology studies were conducted with
Salmanella typhimurium and Chinese hamster ovary
(CHO) cells.
Fourteen-Day and Thirteen-Week Studies: All rats
and mice lived to the end of the 14-day studies (dietary
concentrations up to 50,000 ppm). Final mean body
weights ofdosed and control rats were comparable. The
final mean body weight of female mice that received
50,000 ppm was 13% lower than that of controls. No
clinical signs or toxic lesions were attributed to PETN,
NF, administration.
All rats andmicelived totheend ofthe13-week (mice)
and 14-week (rats) studies (dietary concentrations up to
50,000 ppm). Final mean body weights of dosed and
controlrats andmiceweresimilar,althoughweightgains
offemale rats at 25,000 and 50,000 ppm were less than
that of controls. The nitrite level in urine of rats and
methemoglobin levels in whole blood of rats and mice
were not affected by administration of PETN, NF. An
adenoma of the Zymbal gland was seen in a female rat
thatreceived 50,000 ppm. Ahepatocellular adenomawas
seen in a female mouse that received 50,000 ppm.
Based on these results and the NTP convention of
limiting concentrations in 2-year feed studies to 5% of
the diet, the 2-year studies were conducted by admin-
istering 0, 25,000 or 50,000 ppm PETN, NF, in feed for
104weeks to groups of50male rats and for 103weeks to
groups of49 or 50 mice ofeach sex. Groups of50 female
rats were given feed containing 0, 6,200, or 12,500 ppm
PETN, NF, for 104 weeks.
Body Weight and Survival in the Two-Year Studies:
Mean bodyweights ofhigh dose male rats were 2%-9%
lower than those ofcontrols throughout the study; body
weights of all groups of female rats were similar. No
significant differences in survival were observed
between any groups ofrats ofeither sex (male: control,
23/50; low dose, 29/50; high dose, 29/50; female: 33/50;
33/50; 31150). Mean body weights of dosed and control
mice were similar. The survival ofboth groups of dosed
male mice was significantly greater than that of the
controls (26/49; 38/50; 38/50). No significant differences
in survivalwere observed between any groups offemale
mice (38/50; 30/50; 38/50).
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: No nonneoplastic lesions were attributed to
PETN, NF, administration inrats ormice. Neoplasms of
the Zymbal gland occurred in dosed male (control, 0/49;
low dose, 3/45; high dose, 2/41) and dosed female (0/36;
1/37; 3/35) rats. The historical incidence of these neo-
plasmsis 1% ± 2%inuntreatedmales and 0.6% ± 1% in
females.
At no site was a significantly increased incidence of
neoplasms observed in dosed male or female mice.
Genetic Toxicology: PETN, NF, was not mutagenic in
S. typhimurium strains TA98, TA100, TA1535, or
TA1537whentestedwith orwithoutexogenous metabolic
activation (S9). When tested for cytogenetic effects in
culturedCHOcells,PETN,NF,inducedsisterchromatid
exchanges (SCEs) in the presence and absence of
metabolic activation; no induction of chromosomal
aberrations was observed in CHO cells with or without
activation.
Audit: The data, documents, and pathology materials
fromthe2-yearstudies ofPETN, NF,havebeenaudited.
The auditfindings showthatthe conductofthe studiesis
documentedadequatelyand supportthedataandresults
given in this Technical Report.
Conclusions: Underthe conditions ofthese2-yearfeed
studies, there was equivocal evidence ofcarcinogenic
activity ofPETN, NF, formale andfemale F344/N rats,
basedonamarginalincreaseinneoplasms oftheZymbal
gland. Female rats might have tolerated a higher dose.
There was no evidence of carcinogenic activity of
PETN, NF, for male or female B6C3F1 mice fed diets
containing 25,000, or 50,000 ppm for 2 years. No non-
neoplastic lesions were attributed to PETN, NF, admin-
istration.
Synonyms for PETN: 2,2-bis((nitrooxy)methyl)-1,3-
propanediol dinitrate (ester); 2,2-bisdihydroxy-
methyl-1,3-propanediol tetranitrate; niperyt; nitropen-
taerythritol; pentaerythrityl tetranitrate; penthrit
Trade Names for PETN, NF: Angitet; Cardiacap;
Dilcoran-80; Dipentrate; Hasethrol; Lentrat; Metranil;
Myeardol; Neo-Corovas; Nitropenta; Nitropenton; Pen-ABSTRACTSFROMLONG-TERM CANCER STUDIES, 1976-1992
tafin;Pentanitrine;Pentitrate;Pentral80;Pentrite; Pen-
tritol; Pentryate; Peridex; Pergitral; Peritrate; Perityl;
Prevangor; Quintrate; Subicard; Terpate; Vasodiatol
Report Date: August 1989
TR-366 Toxicology and Carcinogenesis
Studies ofHydroquinone (CAS No.
123-31-9) in F344/N Rats and B6C3F1 Mice
(GavageStudies)
Hydroquinone is used an antioxidant in the rubber
industry and as a developing agent in photography. It is
also an intermediate in the manufacture of rubber and
food antioxidants and monomer inhibitors. Hydro-
quinone and products containing hydroquinone are used
as depigmenting agents to lighten skin. Toxicology and
carcinogenesis studies were conductedbyadministering
hydroquinone (greater than 99% pure) in corn oil or
water by gavage to groups of F344/N rats and B6C3F1
mice of each sex for 14 days, 13 weeks, or 2 years.
Additionally, genetic toxicology studies were conducted
in Salmonella typhimurium, mouse lymphoma cells,
Chinese hamster ovary (CHO) cells, and Drosophila
melanogaster.
Preliminary3-daydermalstudieswereconductedwith
rats and mice using sufficient hydroquinone in 95%
ethanol tocrystallize ontheskin(4or40mgperanimal);
conjugatedmetabolites ofhydroquinoneweredetectedin
the urine. Fourteen-day dermal studies were conducted
at doses up to 3,840 mg/kg for rats and 4,800 mg/kg for
mice. Notoxiceffectswereseeninthe3-or14-daydermal
studies. Therefore, in further evaluations of hydro-
quinone, the gavage route ofadministration was used.
Results ofFourteen-Day and Thirteen-Week Studies:
Fourteen-day gavage studies were conducted by admin-
isteringhydroquinone incornoiltorats atdosesranging
from 63 to 1,000 mg/kgbodyweight and to mice atdoses
ranging from 31 to 500 mg/kg. All rats receiving 1,000
mg/kgand1/5maleand4/5femaleratsreceiving500mg/
kg died before the end ofthe 14 days. Compound-related
clinical signs in rats included tremors lasting up to 30
minutes aftereach dosing at500 and 1,000mg/kg. In the
14-day gavage studies with mice, 4/5 male mice and 5/5
femalemicereceiving500mg/kgand3/5malesreceiving
250 mg/kg died before the end of the studies. Tremors
followed byconvulsions were seen at250 and 500mg/kg.
Inthe13-week studies, dosesforrats andmiceranged
from 25 to 400 mg/kg. All rats receiving 400 mg/kg and
3/10 female rats receiving 200 mg/kg died before the end
ofthestudies. Themeanbodyweightatnecropsyofmale
rats administered 100 or 200 mg/kg was about 8%-9%
lowerthanthatofvehicle controls. Meanbodyweights of
vehicle control and dosed female rats at necropsy were
similar. Tremors and convulsions were observed after
dosing in most rats receiving 400 mg/kg and in several
female rats receiving 200 mg/kg. Inflammation and/or
epithelial hyperplasia (acanthosis) of the forestomach
were seen in4/10malerats and1/10femaleratsreceiving
200 mg/kg. Toxic nephropathy, characterized by tubular
cell degeneration in the renal cortex, was seen in 7/10
maleand6/10femaleratsreceiving200mg/kgandin1/10
females receiving 100 mg/kg.
In the 13-week studies in mice, 8/10 males and 8/10
females receiving 400 mg/kg and 2/10 male mice receiv-
ing 200 mg/kg died early. Mean body weights of dosed
and vehicle control mice at necropsy were similar. Liver
weight to body weight ratios for dosed male mice were
significantly greater than for vehicle controls. Ulcera-
tion, inflammation, or epithelial hyperplasia ofthe fore-
stomach was found in 3/10 male and 2/10 female mice
receiving 400 mg/kg and /10 females receiving 200 mg/
kg.
Based on these collective results, 2-year studies were
conducted by administering 0, 25, or 50 mg/kg hydro-
quinoneindeionizedwaterbygavagetogroupsof65rats
ofeach sex, 5 days per week. Groups of65 mice ofeach
sex were administered 0, 50, or 100 mg/kg on the same
schedule. Ten rats and 10 mice from each group were
killed after 15 months for an interim evaluation.
Observations atFifteenMonths: Intheratskilledat15
months, the relative kidney weight for high dose male
rats was greater than that for vehicle controls. The
hematocrit value, hemoglobin concentration, and
erythrocyte count for high dose female rats were
decreased. Compound-related increased severity of
nephropathywas observed in male rats. Inmice killed at
15 months, the relative liver weights for high dose male
andfemalemiceweresignificantlygreaterthanthosefor
vehicle controls. Lesions seen in the liver of male mice
included increased syncytial cells and diffuse
cytomegaly.
Body Weights, Organ Weights, and Survival in the
Two-Year Studies: Meanbodyweights ofhigh dosemale
rats were 5%-13% lower than those of vehicle controls
after week 73, and those of low dose male rats were
5%-9%lowerthanthoseofvehiclecontrolsafterweek89.
Meanbodyweights ofdosed female rats were similar to
those ofvehicle controls throughout the study. The rela-
tivekidneyandliverweightsforhighdosemaleratswere
higher than those for vehicle controls. Mean body
weights ofhigh dose male mice were 5%-8% lower than
those ofvehicle controls afterweek 93, and those ofhigh
dose female mice were 5%-14% lower after week 20.
Relative liverweightswereincreasedfordosedmale and
high dose female mice. No significant differences in
survival were observed between any groups of rats or
miceofeithersexafter2years(malerats:vehiclecontrol,
27/55; low dose, 18/55; high dose, 18/55; female rats:
40/55;27/55; 32/55;malemice: 33/55;37/54;36/55;female
mice: 37/55; 39/55; 36/55).
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: Nearly all male rats and most female rats in all
vehicle control and dosed groups had nephropathy. The
severity ofthis disease wasjudged to be greater in high
dose male rats. Hyperplasia of the renal pelvic transi-
tional epithelium and renal cortical cysts, changes
obsei vedwith advancedrenaldisease, wereincreased in
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male rats. Renal tubular hyperplasia was seen in 2 high
dose male rats, and renal tubular adenomas were seen in
4/55lowdoseand8/55highdosemalerats; nonewas seen
in vehicle controls.
Mononuclear cell leukemia in female rats occurred
with a positive trend, and the incidences in the dosed
groups were greater than that in the vehicle controls
(vehicle control, 9/55; low dose, 15/55; high dose, 22/55).
The historical incidence of leukemia in water gavage
vehicle control female F344/N rats is 25% + 15% and in
untreated controls is 19% + 7%.
Compound-related lesions observedinthe liver ofhigh
dosemalemiceincluded anisokaryosis (0/55; 2/54; 12/55),
syncytial alteration (5/55; 3/54;25/55), andbasophilicfoci
(2/55; 5/54; 11/55). The incidences of hepatocellular ade-
nomas were increased in dosed male mice (9/55; 21/54;
20/55), but these increases were offset by decreases in
the incidences ofhepatocellular carcinomas (13/55; 11/54;
7/55). The incidences of hepatocellular neoplasms, pri-
marily adenomas, were increased in dosed female mice
(3/55; 16/55; 13/55).
Follicular cell hyperplasia of the thyroid gland was
increased in dosed mice (male: 5/55; 15/53; 19/54; female:
13/55;47/55;45/55). Follicularcelladenomas were seenin
2/55 vehicle control, 1/53 low dose, and 2/54 high dose
male mice and in 3/55 vehicle control, 5/55 low dose, and
6/55 high dose female mice, a follicular cell carcinoma
was seen in a seventh high dose female mouse. The
highest observed incidence offollicular cell adenomas or
carcinomas (combined) inhistoricalwater gavagevehicle
control female B6C3F1 mice is 3/48 (6%).
Genetic Toxicology: Hydroquinone was notmutagenic in
S. typhimurium strains TA98, TA100, TA1535, or TA1537
with orwithout exogenous metabolic activation. It induced
trifluorothyrnidine (Tft) resistance in mouse L5178Y/TK
lymphoma cells in the presence or absence of metabolic
activation. An equivocal response was obtained in tests for
induction ofsex-linked recessive lethal mutations in Dros-
ophila administered hydroquinone by feeding. Hydro-
quinone induced sister chromatid exchanges (SCEs) in
CHOcellsbothwith orwithoutexogenousmetabolicactiva-
tion and caused chromosomal aberrations in the presence
ofactivation.
Conclusions: Under the conditions of these 2-year
gavage studies, there was some evidence of carcino-
genic activity ofhydroquinone formale F344/N rats, as
shown by marked increases in tubular cell adenomas of
the kidney. There was some evidence ofcarcinogenic
activity of hydroquinone for female F344/N rats, as
shown by increases in mononuclear cell leukemia. There
was no evidence of carcinogenic activity of hydro-
quinone for male B6C3F1 mice administered 50 or 100
mg/kg in water by gavage. There was same evidence of
carcinogenic activity of hydroquinone for female
B6C3F1 mice, as shown by increases in hepatocellular
neoplasms, mainly adenomas.
Administration of hydroquinone was associated with
thyroidfollicularcellhyperplasiainbothmaleandfemale
mice and anisokaryosis, multinucleated hepatocytes, and
basophilic foci ofthe liver in male mice.
Synonyms: 1,4-benzenediol; p-benzenediol; benzohydro-
quinone; benzoquinol; 1,4-dihydroxybenzene; p-
dihydroxybenzene;p-dioxobenzene;p-dioxybenzene; hy-
droquinol; hydroquinole; a-hydroquinone; p-hydro-
quinone; p-hydroxyphenol; quinol; f3-quinol
Report Date: October 1989
TR-367 lTxicology and Carcinogenesis
Studies ofPhenylbutazone (CAS No.
50-33-9) in F344/N Rats and B6C3F1 Mice
(GavageStudies)
Phenylbutazone is a nonsteroidal anti-inflammatory
drug. Toxicology and carcinogenesis studies were con-
ducted by administering phenylbutazone (greater than
99%pure) in corn oilbygavage to groups ofF344/N rats
and B6C3F1 mice ofeach sex for 19 days, 13 weeks, or 2
years. Genetic toxicology studies were performed with
Salmnmella typhimurium, mouse L5178Y lymphoma
cells, and Chinese hamster ovary (CHO) cells.
Nineteen-Day Studies: The deaths of3/5 male and 4/5
female rats that received 600 mg/kg and of 2/5 females
thatreceived300mg/kgwereconsidered tobechemically
related. Thefinalmeanbodyweightofratsthatreceived
300 or600mg/kgwas 14%-15% or46%lowerthanthatof
vehiclecontrols. Nocompound-relateddeathsoccurredin
mice (doses up to 600 mg/kg). The final mean body
weights of dosed and vehicle control mice were similar.
Thirteen-Week Studies: Most rats that received 300
mg/kg and V10 male and 2/10 female rats that received
200mg/kgdiedearly.Thefinalmeanbodyweightofmale
rats at300 mg/kgwas 31% lower than that ofthe vehicle
controls. The liver weight to body weight ratios were
increased in the 200 and 300 mg/kg group of rats.
Compound-related lesions occurredmainlyin the kidney
and included papillary necrosis, papillary edema, and
multifocal mineralization.
Five of10malemiceand4/10femalemice thatreceived
600mg/kgdiedearly. No othercompound-related deaths
occurred in mice. Final meanbodyweights ofdosed and
vehiclecontrolmicewerecomparable.Theliverweightto
body weight ratios were increased for mice at 300 and
600 mg/kg. No compound-related histopathologic effects
were observed in mice.
Body Weight and Survival in the Two-Year Studies:
Two-year studieswereconductedbyadministering0,50,
or 100 mg/kg phenylbutazone in corn oil by gavage to
groups of 50 rats of each sex, 5 days per week for 103
weeks. The doses given groups of50 mice ofeach sex on
the same schedulewere 0,150, or300mg/kg. Meanbody
weights ofhigh dose rats were generally 6%-11% lower
thanthoseofvehiclecontrols.Meanbodyweightsofmice
were similar among all groups except for high dose
female mice, which weighed 4%-11% less than vehicle
controls. Thesurvivalofallgroupswas similarexceptfor
that of the low dose group of male rats, which was
significantlylowerthanthatofthevehiclecontrols atthe
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end ofthe studies; the survival ofthe top dose group of
female rats and the vehicle control group offemale mice
was low but not statistically reduced (final survival-
male rats: vehicle control, 33/50; low dose, 20/50; high
dose, 27/50; female rats: 31150; 35/50; 22/50; male mice:
36/50; 40/50; female mice: 22/50; 29/50; 32/50).
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: Mild pyelonephritis, renal papillary necrosis, and
mineralization of the renal papillae in dosed male and
female rats and hyperplasia ofthe renal pelvis epithelium,
dilatationoftherenalpelvis,andrenalcystsindosedfemale
ratswere observed atincreasedincidences comparedwith
thoseinvehiclecontrols.Arenaltubularcellcarcinomawas
observed in one low dose male rat, and renal tubular
adenomas were observed in three high dose male rats. A
carcinoma ofuncertain histogenesis was observed in one
low dose female rat. Carcinomas ofthe renal transitional
epithelium were seen in two high dose female rats. When
the kidneys were step-sectioned, additional tubular cell
adenomas were diagnosed in four low dose and one high
dose male rats and in three low dose and one high dose
female rats; none was observed in vehicle controls.
Papillomas of the transitional epithelium of the uri-
narybladderwereseenin2/43lowdosemaleand1/49low
dose female F344/N rats. The historical incidence of
urinarybladder transitional cell neoplasms in male corn
oil vehicle control F344/N rats is 5/2,034 (0.2%; highest
observed incidence, 2/50) and 4/2,026 (0.2%; highest
observed incidence, 1/45) in females.
Adrenal medullary hyperplasia was observed at an
increased incidence in high dose female rats (vehicle
control, 3/50; low dose, 6/50; high dose, 19/50).
Ulcers ofthe forestomach were observed atincreased
incidences in high dose rats (male: 0/50; 5/50; 6/50;
female: 2/49; 1/49; 12/49). In high dose female rats,
acanthosis (4/49; 0/49; 12/49), hyperkeratosis (3/49; 0/49;
12/49), and basal cellhyperplasia (4/49; 1/49; 12/49) ofthe
forestomach were observed at increased incidences.
No neoplasms were associated with these stomach
lesions.
Peliosis hepatis, centrilobular cytomegaly and
karyomegaly, fattychange, hepatocellular degeneration,
and coagulative necrosis of the liver were observed in
dosedmalemice; clearcellfociwereobservedinfivehigh
dose male mice. The incidences of hepatocellular ade-
nomas and adenomas or carcinomas (combined) in male
micewereincreasedinthehighdosegroup(adenomas or
carcinomas, combined: 16/50; 14/50; 31/50).
Genetic Toxicology: Phenylbutazone was not mutagenic
in S. typhimurium strains TA98, TA100, TA1535, or
TA1537 when tested with or without exogenous metabolic
activation. Phenylbutazoneproduced apositive responsein
the mouse lymphoma assay in both the presence and
absence of activation. Phenylbutazone induced chromoso-
mal aberrations in CHO cells in the presence, but not the
absence, ofexogenous metabolic activation; noinduction of
sister chromatid exchanges was observed in CHO cells in
the presence or absence ofactivation.
Conclusions: Under the conditions of these 2-year
gavage studies, there was equivocal evidence of car-
cinogenic activity of phenylbutazone for male F344/N
rats, as shown by the occurrence of small numbers of
renal tubular cell adenomas or carcinomas. There was
some evidence of carcinogenic activity for female
F344/N rats, as shown primarily by the occurrence of
two rare transitional cell carcinomas in the top dose
group; none has ever been seen in vehicle control or
untreatedcontrolfemalerats.Thbularcelladenomasmay
have been associated with the administration of phe-
nylbutazone to female rats. There was some evidence of
carcinogenic activity formale B6C3F1 mice, as shown
bytheincreasedincidence ofhepatocellularadenomas or
carcinomas (combined). There was no evidence ofcar-
cinogenicity forfemaleB6C3F1 miceadministeredphe-
nylbutazone in corn oil by gavage at doses of150 or 300
mg/kg.
Phenylbutazonewasalsonephrotoxic torats, as shown
bythedose-relatedincreaseintheseverityofage-related
nephropathy,necrosis oftherenalpapilla, andmineraliz-
ation ofthe collecting ducts in the papilla.
Synonyms: 4-butyl-1,2-diphenyl-3,5-pyrazolidinedione;
3,5-dioxo-1,2-diphenyl-4-n-butylpyrazolidine
Trade Names: Therehavebeen over100registeredtrade
names including: Anerval; Azobutil; Bizolin 200;
Butacote; Butadion; Butagesic; Butazolidin; Chem-
butazone; Equi Bute; Flexazone; Fenibutol; G 13,871;
Pyrazolidin; Reumazol; Robizon-V; Uzone
Report Date: March 1990
TR-368 Toxicology and Carcinogenesis
Studies ofNalidixic Acid (CAS No.
389-08-2) in F344/N Rats and B6C3F1 Mice
(FeedStudies)
Nalidixic acid is an antimicrobial agent to treat bac-
terial infections of the urinary tract. Toxicology and
carcinogenesis studies were conducted by feeding diets
containing nalidixic acid (approximately 99% pure) to
groups ofF344/N rats and B6C3F1 mice ofeach sex for
13 weeks or 2 years. Genetic toxicology studies were
conducted in Salmonella typhimurium, mouse lym-
phoma cells, and Chinese hamster ovary (CHO) cells.
Thirteen-Week Studies: Nalidixic acid was admin-
istered at dietary concentrations ranging from 1,000 to
16,000 ppm. One female rat that received 16,000 ppm
nalidixic acid died before the end ofthe studies; no other
compound-related deaths occurred in rats and mice. The
final mean body weights of rats that received 8,000 or
16,000ppmwere23% or49%lowerthanthoseofcontrols
for males and 11% or 31% lower for females. Feed con-
sumption by rats receiving 16,000 ppm was approx-
imatelytwo-thirdsthatbycontrols. Liverweighttobody
weight ratios for male rats that received 2,000 ppm or
more and female rats that received 8,000 ppm or more
were significantly greater than those for controls.
Degeneration of the germinal epithelium in the semi-
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niferous tubules ofthe testis was observed in 10/10 male
ratsthatreceived16,000ppm;noothercompound-related
histopathologic effects were observed in rats. The final
mean bodyweights ofmice thatreceived 8,000 or 16,000
ppm were 10%-20% lower than those of controls. Feed
consumption by dosed mice was similar to that by con-
trols. Liver weight to body weight ratios were signifi-
cantly greater for male mice receiving 2,000, 8,000, or
16,000 ppm andforfemale micereceiving4,000, 8,000, or
16,000 ppm than for the controls. No compound-related
histopathologic effects were observed in mice.
Based on these results, 2-year studies ofnalidixic acid
were conducted by feeding diets containing 0, 2,000, or
4,000 ppm nalidixic acid to groups of 50 male and 50
female F344/N rats and 50 male and 50 female B6C3Fj
mice.
Body Weight and Survival in the Two-Year Studies:
Meanbodyweights ofhighdoseratswere 7%-23%lower
than those of controls, and those of low dose male rats
were 6%-11% lower than those of controls. The average
dailyfeedconsumptionbydosedratsrangedfrom89%to
96% that by controls. The average amount of nalidixic
acid consumed per daywas approximately 80 or 175 mg/
kg for low dose orhigh dose rats. Mean bodyweights of
high dose male mice were 1%-8% lower than those of
controls throughout the study. Mean body weights of
dosed female mice were 5%-17% lower than those of
controls. Average daily feed consumption by dosed mice
waswithin3% ofthatbycontrols. Theestimated average
amount of nalidixic acid consumed per day was approx-
imately220 or475 mg/kgforlow dose orhigh dose mice.
No significant differences in survivalwere seen between
any groups of rats or mice of either sex after 2 years
(male rats: control, 27/50; low dose, 28/50; high dose,
27/50; female rats: 22/50; 31150; 29/50; male mice: 33/50;
34/50; 31V50; female mice: 40/50; 43/50; 32/50).
Nonneoplastic and Neoplastic Effects inthe Two-Year
Studies: The incidences ofpreputial gland neoplasms in
dosed male rats and ofclitoral gland neoplasms in dosed
female rats were significantly greater than those in
controls (male-preputial gland adenomas, papillomas,
or carcinomas, combined: control, 3/49; low dose, 19/49;
high dose, 20/47; female-clitoral gland adenomas,
papillomas, or carcinomas, combined: 5/46; 15/46; 16/47).
A squamous cell carcinoma ofthe tongue was seen in
two high dose male rats. The historical incidence oforal
cavity neoplasms in untreated control male F344/N rats
is 7/1,596 (0.4%).
There were decreased incidences of leukemia (20/50;
9/50; 7/50) and mammary gland neoplasms (10/50; 7/50;
2/50) in dosed female rats and of pituitary gland neo-
plasms (11149; 2/50; 2/50) in dosed male rats.
Retinal degeneration and cataracts ofthe eye were ob-
served at increased incidences in dosed rats (degenera-
tion-male: 4/48; 41148; 47/49; female: 2/47; 40/48; 46/50;
cataracts-male: 1148; 23/48; 38/49; female: 0/47; 18/48;
14/50). The cause ofthese cataracts and retinal degenera-
tion is uncertain because cages were not rotated and low
and high dose groups of rats may have been exposed to
greater light intensity than were the controls.
Subcutanous tissue fibrosarcomas and fibromas or
fibrosarcomas (combined) were increased in dosed male
mice (fibromas or fibrosarcomas, combined: 5/50; 9/50;
14/50). There were no increased incidences ofneoplasms
in dosed female mice.
Genetic Toxicology: Nalidixic acid was not mutagenic
in any of several in vitro short-term tests. No gene
reversion was observed in S. typhimurium strains
TA97,TA98,TA100, orTA1535afterexposuretonalidixic
acid in either the presence or absence of exogenous
metabolic activation. Results of tests for induction of
trifluorothymidine resistance in mouse L5178Y/TKlym-
phoma cells were negative with or without metabolic
activation. In CHO cells, nalidixic acid did not induce
sister chromatid exchanges or chromosomal aberrations
in either the presence or absence ofactivation.
Conclusions: Undertheconditions ofthese2-yearfeed
studies, there was clear evidence of carcinogenic
activity ofnalidixic acidforF344/N rats, asindicatedby
increased incidences of preputial gland neoplasms in
malesandclitoralglandneoplasmsinfemales.Therewas
equivocal evidence ofcarcinogenic activity for male
B6C3F1 mice fed diets containing nalidixic acid, as indi-
cated by marginally increased incidences of sub-
cutaneous tissue neoplasms. There was no evidence of
carcinogenic activity forfemale B6C3F1 micefed diets
containing 2,000 or 4,000 ppm nalidixic acid for 2 years.
Synonym: 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-na-
phthyridine-3-carboxylic acid
Trade Names: NegGram®; Dixiben®; Nalidixan®; Na-
lurin®; Nogram®; UroNeg®; Uralgin®; Urisal®
Report Date: October 1989
TR-369 Toxicology and Carcinogenesis
Studies ofa-Methylbenzyl Alcohol (CAS
No. 98-85-1) in F344/N Rats and B6C3F
Mice (Gavage Studies)
Toxicology and carcinogenesis studies of a-methylb-
enzyl alcohol (greater than 99% pure), a cosmetic ingre-
dient and food flavoring agent, were conducted by
administering the chemical in corn oil by gavage to
groups ofF344/N rats and B6C3F1 mice ofeach sex for
16 days, 13 weeks, or 2 years. Genetic toxicology studies
were conducted in Salmonella typhimurium, mouse
lymphomacells, and Chinesehamsterovary(CHO) cells.
cx-Methylbenzyl alcohol was nominated for study by the
National Cancer Institute because of the potential for
widespread human exposure.
Sixteen-Day and Thirteen-Week Studies: The doses
used in the 16-day studies for rats and mice ranged
between 125 and 2,000mg/kg. Six of10 rats and all mice
dosed at2,000mg/kg died. In addition, because 7/9 mice
dosed at 1,000 mg/kg died, the doses selected for the 13-
week studies for mice (47-750 mg/kg) were half those
used for rats (93-1,500 mg/kg).
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In the 13-week studies, deaths of 1/10 male and 3/10
femalerats dosed at1,500mg/kgwerecompoundrelated;
none ofthe mice died. Bodyweight gain was reduced in
rats at 1,500 mg/kg; there were no significant histo-
pathologic lesions in either rats or mice. The only
compound-related effectswereataxia,laboredbreathing,
andlethargyforupto30minutesafterdosinginratsand
mice given the two highest doses and increases in liver
weighttobodyweightratiosformaleratsgiventhethree
highest doses and for female rats at all doses.
Based on the pattern of mortality and the effects on
bodyweight gain in the short-term studies, doses of375
and 750 mg/kg oa-methylbenzyl alcohol were admin-
istered in corn oil by gavage, 5 days per week for 103
weeks, to groups of50 rats and 50 mice ofeach sex.
Two-Year Studies: Significant reduction in body
weightgaincommenced atweeks20-30inhighdosemale
and female rats, and bodyweights were 20%-30% below
those ofvehicle controls atstudy termination. In thelow
dose groups, body weight reduction occurred only in
male rats during the last 10weeks ofthe study. After80
weeks,60%ofthehighdoseratsand80%-100%ofthelow
dose and vehicle control rats were alive; thereafter, the
number of deaths in the chemically exposed groups
increased sharply so that, at the end of 2 years, final
survival forvehicle control, low dose, and high dose rats
was 35/50; 8/50; and 1/50 formales and 34/50, 25/50, and
11/50 for females. There were a large number ofgavage
accidents in these studies (1, 9, and 8 formale rats and 1,
4, and 14 for female rats), but these accidents did not
contribute to the increase in mortality afterweek 80, as
all but 4 ofthese occurred earlier.
Mortality in the last quarter ofthe studywas thought
to be due to the effects of cumulative toxicity of
a-methylbenzyl alcohol on a renal excretory system
already compromised by aging. Renal nephropathy that
commonlyoccurs duringagingwasfoundinallgroups of
rats, butthe severitywas greaterinmale rats dosedwith
a-methylbenzyl alcohol. In addition, a collection of non-
neoplastic lesions (parathyroid hyperplasia, calcification
of the heart and glandular stomach, and fibrous
osteodystrophy of bone) was found in the dosed male
rats; these lesions were probably secondary to mineral
imbalance arising from renal dysfunction.
Since survival was poor in low and high dose male and
high dose female rats, the sensitivity of the study for
detecting a carcinogenic effect in these groups was
reduced. Despite this limitation, there were dose-related
increasesintheincidencesofrenaltubularcelladenomasor
adenocarcinomas (combined) in male rats (vehicle control,
0/50; low dose, 2/50; high dose, 5/50). In addition, transi-
tionalcellpapillomas oftheurinarybladderwere observed
in one high dose male and two high dose female rats.
Inmice, areduction inbodyweightgainwas apparent
in the high dose groups of males and females. Final
survival rates in mice were similar among groups (male:
39/49; 40/50; 28/50; female: 41/50; 41/50; 38/50). No neo-
plastic or nonneoplastic lesions were attributed to
a-methylbenzyl alcohol administration in mice ofeither
sex.
Genetic Toxicology: a-Methylbenzyl alcohol was not
mutagenic in S. typhimurium strains TA98, TA100,
TA1535, or TA1537 when tested in the presence or
absence of exogenous metabolic activation. cx-Methylb-
enzyl alcohol produced a positive response without
activation in the mouse L5178Y/TK+/- lymphoma assay
forinduction oftrifluorothymidine resistance; itwas not
tested with activation. In cytogenetic tests with CHO
cells, a-methylbenzyl alcoholinduced chromosomal aber-
rations in the presence, butnotthe absence, ofmetabolic
activation; no induction of sister chromatid exchanges
was observed in CHO cells after exposure to a-methyl-
benzyl alcohol.
Conclusions: Under the conditions of these 2-year
gavage studies, there was some evidence of carcino-
genic activity ofa-methylbenzyl alcohol formale F344/
Nrats, as shownbyincreasedincidences ofrenaltubular
cell adenomas and adenomas or adenocarcinomas (com-
bined). Therewasno evidence ofcarcinogenic activity
for female F344/N rats administered 375 or 750 mg/kg.
Renal toxicity characterized by severe nephropathy and
relatedsecondarylesionswasobservedinthedosedrats,
andexcessivemortalityoccurredduringthelastquarter
ofthestudies.Poorsurvivalreducedthesensitivityofthe
studies for detecting the presence of a carcinogenic
responseboth in chemically exposed groups ofmale rats
and in the high dose group offemale rats. There was no
evidence of carcinogenic activity of a-methylbenzyl
alcohol for male or female B6C3F1 mice administered
375 or 750 mg/kg for 2 years.
Synonyms: styrallylalcohol; styralylalcohol; ac-methylb-
enzenemethanol; phenylmethylcarbinol; 1-phenethyl
alcohol
Report Date: January 1990
TR-370 Toxicology and Carcinogenesis
Studies ofBenzofuran (CAS No. 271-89-6)
in F344/N Rats and B6C3F1 Mice (Gavage
Studies)
Benzofuran is used as anintermediate in thepolymer-
ization of coumarone-indene resins found in various
corrosion-resistant coatings such as paints and var-
nishes, in water-resistant coatings for paper products
and fabrics, and in adhesives approved for use in food
containers. Toxicology and carcinogenesis studies were
conducted by administering benzofuran (approximately
99%pure) in corn oilbygavage to groups ofF344/N rats
and B6C3F1 mice ofeach sex for 14 days, 13 weeks, or 2
years. Genetictoxicologytestswere conductedinSalrno-
nella typhimurium, mouse lymphoma cells, and Chi-
nese hamster ovary (CHO) cells.
Fourteen-Day Studies: Benzofuran doses for groups
offive ratsranged from 63 to1,000mg/kg andfrom16 to
250 mg/kg for mice. All male and female rats that
received1,000mg/kgandonefemaleratthatreceived500
mg/kgdied before the end ofthe studies. Thefinal mean
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bodyweights ofmaleratsthatreceived250 or500mg/kg
were 13% or 21% lower than that of controls; the final
meanbodyweightoffemaleratsthatreceived500mg/kg
was 10% lower than that of controls. Final mean body
weights of chemically exposed and control mice were
similar. No compound-related histologic lesions were
found in rats or mice.
Thirteen-Week Studies: Doses for groups of 10 rats
and10micerangedfrom31to 500mg/kg. Onefemale rat
thatreceived500mg/kgand onethatreceived250mg/kg
diedbeforetheendofthestudy.Finalmeanbodyweights
of male rats that received 125, 250, or 500 mg/kg were
11%, 17%, or 27% lower than that ofvehicle controls; the
final mean bodyweight offemale rats that received 500
mg/kgwas 11%lowerthanthatofvehiclecontrols. Histo-
logic lesions observed in chemically exposed rats
included minimal hepatocellular necrosis, increased
severityofnephropathy, andcytoplasmicvacuolizationof
the adrenal cortex.
Seven male and three female mice that received 500
mg/kgand onemale mouse thatreceived 250mg/kgdied
before the end of the 13-week studies. The final mean
body weight of mice that received 500 mg/kg was 13%
lower than that of vehicle controls. Nephrosis was
observed in male mice that received 250 mg/kg.
Basedonreducedmeanbodyweights,increasedseverity
of nephropathy, and hepatocellular necrosis, benzofuran
doses selected for the 2-year studies in rats were 30 or 60
mg/kgformales and 60 or120mg/kgforfemale. Based on
increased mortality and nephrosis in male mice, doses
selectedforthe2-yearstudiesinmicewere60or120mg/kg
for males and 120 or 240 mg/kg for females.
Body Weights and Survival in the Two-Year Studies:
Mean body weights of high dose rats and dosed male
mice were 4%-11% lower than those ofvehicle controls.
Mean body weights of chemically exposed female mice
were 8%-35% lower than those ofvehicle controls. The
survival of chemically exposed male rats was reduced
afterweek 92 (survival atweek89:vehicle control, 47/50;
low dose, 39/50; high dose, 38/50; final survival: vehicle
control, 33/50; lowdose, 12/50; high dose,18/50). Survival
of chemically exposed female rats and male mice was
similar to that ofvehicle controls after 2 years (female
rats: 27/50; 23/50; 25/50; male mice: 33/50; 20/50; 28/50).
Deaths of 10 low dose male mice at weeks 20-21 were
caused by a dosing error; these animals were not
included in survival and tumor analyses. Survival of
chemically exposed female mice was reduced afterweek
89 (final survival: 37/50; 19/50; 21150).
Nonneoplastic and Neoplastic Effects in theTwo-Year
Studies: Nephropathy occurred with increased severity
in chemically exposed male rats. The incidences ofpara-
thyroid hyperplasia, fibrous osteodystrophy, mineraliza-
tion of the pulmonary artery, renal cortical cysts, and
hyperplasia of the pelvic epithelium were increased in
chemicallyexposedmalerats.Theincidenceofnephropa-
thy was increased in chemically exposed female rats
(vehicle control, 29/50; lowdose, 48/50; high dose, 39/50).
Renal atypical tubularcellhyperplasia andrenal tubular
cell adenocarcinomas occurred in chemically exposed
female rats (atypical tubular cell hyperplasia: 0/50; 1/50;
3/50; tubular cell adenocarcinomas: 0/50; 1/50; 4/50). No
renal tubular cell adenocarcinomas have been observed
in 2,094 female corn oil vehicle control F344/N rats in
National Toxicology Program studies.
Chronic inflammation, ulcers, and epithelial hyper-
plasia of the forestomach were observed at increased
incidences in chemically exposed male rats (chronic
inflammation: 1/50; 11/50; 6/49; ulcers: 1/50; 5/50; 8/49;
epithelial hyperplasia: 9/50; 15/50; 18/49).
Metaplastic hepatocytes arising within pancreatic
islets occurred at an increased incidence in high dose
female rats (0/50; 1/50; 11/49).
The incidences of neurilemomas were markedly
increased above the historical control incidences
(0.1%-0.4%)inallgroupsofrats(male:18/50;13/50;14/50;
female: 7/50; 9/50; 3/50).
Syncytial alteration ofthe liver occurred at increased
incidences in male mice exposed to benzofuran. The
incidences ofhepatocellular adenomas, hepatoblastomas
(high dose male mice) and hepatocellular adenomas,
hepatocellular carcinomas, or hepatoblastomas (com-
bined) were increased in chemically exposed mice
(male-adenomas: 4/49; 24/39; 34/48; hepatoblastomas:
0/49; 3/39; 18/48; carcinomas, adenomas, or
hepatoblastomas, combined: 12/49;31/39;40/48;female-
adenomas:1/50;22/48;21/47;hepatoblastomas: 0/50;1/48;
2/47; carcinomas, adenomas, or hepatoblastomas, com-
bined: 4/50; 25/48; 22/47).
Squamous cellpapillomas orcarcinomas (combined) of
the forestomach were increased in chemically exposed
mice (male: 2/49; 11/39; 13/48; female: 2/50; 9/50; 5/50).
The incidences of epithelial hyperplasia of the bron-
chioles were increased in chemically exposed mice. The
incidences of alveolar/bronchiolar adenomas or car-
cinomas (combined) in high dose males and chemically
exposed females were increased (adenomas or car-
cinomas, combined-male: 10/49; 9/39; 19/48; female:
2/50; 9/48; 14/47).
Genetic Toxicology: Benzofuran was not mutagenic in
S. typhimurium strains TA98, TA100, TA1535, or
TA1537 in the presence or absence of exogenous meta-
bolic activation. Benzofuran induced trifluorothymidine
resistance in mouse L5178Y lymphoma cells treated in
the absence of metabolic activation; this assay was not
conducted with activation. Benzofuran induced sister
chromatidexchangesbutnotchromosomalaberrationsin
CHO cells in the presence and absence ofactivation.
Conclusions: Under the conditions of these 2-year
gavage studies, there was no evidence ofcarcinogenic
activity of benzofuran for male F344/N rats receiving
doses of 30 or 60 mg/kg per day. There was same
evidence of carcinogenic activity of benzofuran for
female F344/N rats, based on increased incidences of
tubular cell adenocarcinomas of the kidney. There was
clear evidence ofcarcinogenic activity for male and
female B6C3F1 mice, based on increased incidences of
neoplasms ofthe liver, lung, and forestomach.
Exposure to benzofuran increased the severity of
nephropathy in male rats, increased the incidences of
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nephropathy in female rats, and induced hepatocellular
metaplasia in the pancreas infemale rats. Nonneoplastic
lesions observed inmice exposed to benzofuran included
syncytial alteration of the liver, bronchiolar epithelial
hyperplasia, and epithelial hyperplasia of the fore-
stomach.
Synonyms: coumarone; cumarone
Report Date: October 1989
TR-371 Toxicology and Carcinogenesis
Studies ofToluene (CAS No. 108-88-3) in
F344/N Rats and B6C3F1 Mice (Inhalation
Studies)
Toluene is used to back-blend gasoline, as a chemical
intermediate, and as a solvent; 920 million gallons were
producedinthe United States in1988.Toxicologystudies
were conducted by administering toluene (greater than
99%pure)incorn oilbygavage to groups ofF344/N rats
and B6C3F1 mice ofeach sex for 13 weeks or by whole-
body inhalation exposure for 14 or 15 weeks. Toxicology
and carcinogenesis studies were conducted by whole-
body inhalation exposure of F344/N rats and B6C3F1
mice of each sex for 15 months or 2 years. Genetic
toxicology studies were conducted in Salmonella
typhimurium, mouse L5178Ylymphoma cells, and Chi-
nese hamster ovary cells.
Thirteen-Week Gavage Studies: All rats thatreceived
the top dose of 5,000 mg/kg died during the first week,
and 8/10 male rats that received 2,500 mg/kg died early.
The final mean body weight of male rats that received
2,500 mg/kgwas 19% lowerthan that ofvehicle controls.
Relativeliver, kidney, andheart(female only)weightsfor
rats that received the higher doses were greater than
those for vehicle controls. Necrosis of the brain and
hemorrhage of the urinary bladder were seen at
increased incidences in dosed rats.
All mice that received the top dose of5,000 mg/kg died
duringthefirstweek, and40%ofthosethatreceived2,500
mg/kg died before the end ofthe 13-week gavage studies.
The final mean body weight ofmales at 2,500 mg/kg was
16%lowerthanthatofvehiclecontrols.Atthehigherdoses,
relative liverweights were increased for mice.
Fifteen-Week and Fourteen-Week Inhalation Studies:
Eight of 10 male rats exposed at the top exposure con-
centration of3,000 ppm died duringweek 2. Final mean
body weights ofrats exposed at concentrations of2,500
or 3,000 ppm were 14%-25% lower than that ofcontrols.
As in the gavage studies, the relative liver, kidney, and
heartweights forrats exposed atthe top two concentra-
tions were increased compared with those for controls.
No compound-related effects were seen on sperm; no
adverse effects on the estrous cycle were observed.
Five of 10 male mice and all female mice exposed at
3,000 ppm and 70% of female mice at 2,500 ppm died
during the first 2weeks. Final mean bodyweights ofall
exposed groups were 7%-13% lower than those of con-
trols. Relative liverweights formice exposed at 625 ppm
orhigher, relative lungweights formiceexposed at1,250
ppm or higher, and relative kidney weights for female
mice exposed at 1,250 ppm or higher were greater than
thoseforcontrols. Centrilobularhypertrophyoftheliver
was observed in all male mice exposed at 2,500 ppm and
70% of male mice exposed at 3,000 ppm. No effects on
sperm or the estrous cycle were observed.
Fifteen-Month and Two-Year Inhalation Studies:
Long-termstudieswereconductedbyexposinggroupsof
60 rats of each sex to 0, 600, or 1,200 ppm toluene by
inhalation, 6.5 hours per day, 5 days perweek. Groups of
60 mice ofeach sex were exposed at 0, 120, 600, or 1,200
ppmonthesameschedule.Tenanimalspergroup(except
malemice) were removed fortoxicologic evaluation after
being exposed for 15 months. All other animals were
exposed to toluene for 103 weeks.
In the 15-month inhalation studies, the incidences and
severity of nonneoplastic lesions of the nasal cavity
(degeneration of olfactory and respiratory epithelium
and goblet cell hyperplasia) were increased in exposed
rats. Minimal hyperplasia of the bronchial epithelium
was seenin4/10femalemiceat1,200ppm.The severityof
nephropathy was slightly increased in exposed female
rats. No chemical-induced neoplasms were observed.
Body Weight and Survival in the Two-Year Studies:
Mean body weights of rats and mice were generally
similar (yearly averages within 5%) among groups
throughoutthe2-yearstudies. No significant differences
in survival were observed among rats or mice of either
sex, although survival in all groups of male mice was
lower than usual (male rats: control, 30/50; 600 ppm,
28/50; 1,200 ppm, 22/50; female rats: 33/50; 35/50; 30/50;
malemice: control, 17/60; 120ppm,22/60; 600ppm,16/60;
1,200 ppm, 19/60; female mice: 30/50; 33/50; 24/50; 32/50).
Scrotal, preputial, and penile lesions observed in male
mice were associated with many ofthe early deaths and
with animals killed in a moribund condition.
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: Nephropathywas seeninalmostallrats,andthe
severitywas somewhatincreased inexposed rats. Arare
renal tubular cell carcinoma in a female rat and an
equally uncommon sarcoma of the kidney in another
female rat were seen in the 1,200-ppm exposure group.
Erosion ofthe olfactory epithelium and degeneration of
the respiratory epithelium were increased in exposed
rats. Inflammation ofthenasalmucosaandmetaplasiaof
the olfactory epithelium were increased in exposed
female rats. Arare squamous cell carcinoma ofthe nasal
mucosa was seen in one female rat at 1,200 ppm. A
squamous cell papilloma of the forestomach was
observed in one female rat at1,200 ppm, and a squamous
cell carcinoma was observed in a second female rat at
1,200 ppm. No chemically related neoplasms were found
in male rats, and the one nasal, two kidney, and two
forestomach neoplasms observed in female rats were
considered not to be associated with inhalation exposed
to toluene.
For mice, no biologically important increases were
observed for any nonneoplastic or neoplastic lesions.
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Genetic Toxicology: Toluene did notinduce gene muta-
tions inS. typhimurium strain TA98, TA100, TA1535, or
TA1537 with or without exogenous metabolic activation.
In the mouse lymphoma assay, toluene gave an equivocal
response with and without exogenous metabolic activa-
tion. Toluene did not induce sister chromatid exchanges
or chromosomal aberrations in Chinese hamster ovary
cells in the presence or absence of exogenous metabolic
activation.
Conclusions: Under the conditions of these 2-year
inhalation studies, there was no evidence of carcino-
genic activity formaleorfemale F344/Nratsexposedto
toluene atconcentrations of600 or1,200ppm. Therewas
no evidence ofcarcinogenic activity formale orfemale
B6C3F1 mice exposed by inhalation to toluene at con-
centrations of120, 600, or 1,200 ppm for 2 years.
Synonyms: monomethylbenzene; methylbenzene; toluol;
phenylmethane; tolueen (Dutch); toluen (Czech), tolueno
(Spanish); toluolo (Italian)
Trade Name: Methacide
Report Date: February 1990
TR-372 Toxicology and Carcinogenesis
Studies of3,3'-Dimethoxybenzidine
Dihydrochloride (CAS No. 20325-40-0) in
F344/N Rats (Drinking Water Studies)
3,3'-Dimethoxybenzidine dihydrochloride is an off-
white powder with a melting point of2740 C. 3,3'-Dime-
thoxybenzidine is used principally as an intermediate in
the production of commercial bisazobiphenyl dyes for
coloring textiles, paper, plastic, rubber, and leather. In
the synthesis of the bisazobiphenyl dyes, the amine
groups of3,3'-dimethoxybenzidine are chemically linked
with other aromatic amines. A small quantity of 3,3'-
dimethoxybenzidineisalsousedasanintermediateinthe
production ofo-dianisidine diisocyanate,which isusedin
isocyanate-based adhesive systems and as a component
ofpolyurethane elastomers.
3,3'-Dimethoxybenzidine dihydrochloride was evalu-
ated intoxicity and carcinogenicity studies aspartofthe
National ToxicologyProgram's Benzidine Dye Initiative.
This Initiative was designed to evaluate the representa-
tivebenzidine congeners andbenzidine congener-derived
and benzidine-derived dyes. 3,3'-Dimethoxybenzidine
dihydrochloride was nominated for study because ofthe
potential for human exposure during production of
bisazobiphenyl dyes and because benzidine, a struc-
turally related chemical, is a known human carcinogen.
Toxicology and carcinogenesis studieswere conducted
by administering 3,3'-dimethoxybenzidine dihydro-
chloride (greater than 97.5% pure) in drinking water to
groups ofF344/Nratsofeach sexfor14 days, 13weeks, 9
months, or 21-months. The 21-month studies were
intended to last 24 months but were terminated early
because of rapidly declining survival due to neoplasia.
Studies were performed only in rats because similar
studies are being performed in mice at the National
CenterforToxicologyResearch. Genetictoxicologystud-
ieswereconductedwithSalmanellatyphimurium, Chi-
nese hamster over (CHO) cells, and Drosophila
melanogaster.
Fourteen-Day Studies: All rats receiving drinking
water concentrations up to 4,500 ppm lived to the end of
the studies. Rats that received water containing 4,500
ppm 3,3'-dimethoxybenzidine dihydrochloride lost
weight. Water consumption decreased with increasing
concentration ofchemical and at4,500ppmwasless than
one-fourth that by the controls. Lymphoid depletion of
the thymus in males and hypocellularity of the bone
marrowinmalesandfemaleswere seen atthe4,500-ppm
concentration, but not at the nextlower concentration or
in controls.
Thirteen-Week Studies: All rats receiving concentra-
tionsupto2,500ppmlivedtotheendofthestudies. Final
meanbodyweights ofrats givendrinkingwatercontain-
ing 1,250 or 2,500 ppm 3,3'-dimethoxybenzidine
dihydrochloride were 5%-20% lower than those of con-
trols. Water consumption at these concentrations was
40%-60% that consumed by controls. Compound-related
effects in rats given water containing 2,500 ppm 3,3'-
dimethoxybenzidine dihydrochloride included a mind
exacerbation ofnaturallyoccurringnephropathyandthe
presence of a yellow-brown pigment (lipofuscin) in the
cytoplasm of thyroid follicular cells. Serum tri-
iodothyronine (T3) and thyroxin (T4) concentrations in
femalesreceiving330ppmormoreandT4concentrations
in males receiving 170 ppm or more were significantly
lower than in controls. Thyrotropin (TSH) concentra-
tions were comparable in controls and exposed rats.
Basedonthechemical-relatednephropathyandreduc-
tions in water consumption and body weight gain
observed in the 13-week studies, doses forthe long-term
studies in male and female rats were 0 or 330 ppm 3,3'-
dimethoxybenzidine dihydrochloride in drinking water
administered for 9 months and 0, 80, 170, or 330 ppm
administered for 21 months.
Nine-Month Studies: Ten rats of each sex in control
and 330-ppm groups were evaluated after 9 months.
Significant decreases in T3 and T4 concentrations were
seenin exposedmale and female rats. Otherlesions seen
in exposed rats included foci of alteration in the liver, a
carcinomaofthepreputialglandinonemale, acarcinoma
ofthe clitoral gland in one female, and carcinoma ofthe
Zymbal gland in two males.
BodyWeights and Survival in the Twenty-One-Month
Studies: The average amountof3,3'-dimethoxybenzidine
dihydrochloride consumed per daywas approximately 6,
12, or21mg/kgforlow,mid, orhigh dosemalerats and 7,
14, or 23 mg/kg for low, mid, or high dose female rats.
Mean body weights of male and female rats began to
decreaserelative tothoseofcontrols afterabout1yearof
exposure at 170 or 330 ppm and were 6%-22% lower for
males and 7%-17% lower for females. Survival of rats
exposed to3,3'-dimethoxybenzidine dihydrochloride was
reduced because animals were dying with neoplasms or
being killed in a moribund condition (survival at 21
250ABSTRACTS FROMLONG-TERM CANCER STUDIES, 1976-1992
months-male: control, 44/60, 73%; low dose, 8/45,18%;
mid dose, 0/75; high dose, 0/60; female: 45/60, 75%; 15/45,
33%; 6/75, 8%; 0/60). Because of these early compound-
related deaths, the studieswereterminated at21months.
Nonneoplastic and Neoplastic Effects in the Twenty-
One-Month Studies: Increasedincidences ofseveral non-
neoplastic lesions were observed in exposed rats, includ-
ing hematopoietic cell proliferation in the spleen and
cystic and centrilobular degeneration and necrosis ofthe
liver. Neoplasms attributed to 3,3'-dimethoxybenzidine
dihydrochloride exposure were observed in rats at many
tissue sites, including the skin, Zymbal gland, preputial
andclitoralglands, oralcavity, smallandlargeintestines,
liver, brain, mesothelium, mammary gland, and uterus/
cervix. The incidences of these neoplasms in male and
female rats are given in the abstract summarytable (see
page 5 ofthe Technical Report).
Genetic Toxicology: 3,3'-Dimethoxybenzidine was
mutagenic in S. typhimurium strain TA100 with
exogenous metabolic activation and in strain TA98 with-
out activation; a weakly positive response was observed
in strain TA1535 with metabolic activation. 3,3'-
Dimethoxybenzidine induced sisterchromatidexchanges
and chromosomal aberrations in CHO cells -vith and
without exogenous metabolic activation. 3,3'-
Dimethoxybenzidine did not induce sex-linked recessive
lethal mutations in adult male D. melanogaster exposed
via feeding or injection.Conclusions: Under the condi-
tions ofthese21-monthdrinkingwaterstudies,therewas
clear evidence of carcinogenic activity of 3,3'-
dimethoxybenzidine dihydrochloride for male F344/N
rats, as indicated bybenign and malignant neoplasms of
the skin, Zymbal gland, preputial gland, oral cavity,
intestine, liver, andmesothelium. Increased incidences of
astrocytomas of the brain may have been related to
chemical administration. There was clear evidence of
carcinogenic activity of 3,3'-dimethoxybenzidine
dihydrochloride for female F344/N rats, as indicated by
benign and malignant neoplasms of the Zymbal gland,
clitoral gland, and mammary gland. Increases in neo-
plasms ofthe skin, oral cavity, large intestine, liver, and
uterus/cervixwere also considered tobe related to chem-
ical administration of 3,3'-dimethoxybenzidine
dihydrochloride.
Synonyms: o-dianisidine dihydrochloride; 3,3'-
dimethoxy-1,1-biphenyl)-4,4'-diamine dihydrochloride;
3,3'-dimethoxy-4,4'-diaminobiphenyl dihydrochloride
Report Date: January 1990
TR-373 Toxicology and Carcinogenesis
Studies of Succinic Anhydride (CAS No.
108-30-5) in F344/N Rats and B6C3F1 Mice
(Gavage Studies)
Succinic anhydride, a food additive, is also used in the
manufacture of polymeric materials, pharmaceuticals,
andagricultural andindustrialchemicals.Toxicologyand
carcinogenesis studieswere conducted by administering
suspensions ofsuccinic anhydride (97% pure) in corn oil
bygavage to groups ofF344/N rats and B6C3F1 mice of
each sex for 16 or 20 days, 13 weeks, or 2 years. Genetic
toxicology studies were conducted in Salmonella
typhimurium and Chinese hamster ovary (CHO)
cells.
Twenty-Dayor Sixteen-Day and Thirteen-Week Stud-
ies: In the 20-day studies in rats, doses of succinic
anhydride given on 14 exposure days ranged from 47 to
750 mg/kg. Compound-related deaths occurred in the
groups ofmales thatreceived 375 mg/kg orhigher doses
and in females that received 187 mg/kg or higher doses.
Necrosis andinflammation oftheupperrespiratorytract
were seenin3/10male and3/10female rats given 750mg/
kg and 2/10 female rats given 375 mg/kg.
Inthe16-daystudiesinmice,dosesofsuccinicanhydride
given on12 exposure daysrangedfrom219 to3,500mg/kg.
All animals that received 875 mg/kg or higher doses of
succinic anhydride died before the end ofthe studies. No
compound-related lesionswere seeninmale orfemalemice
examined from the 438 mg/kg dose group.
In the 13-week studies in rats, doses of succinic
anhydriderangedfrom25to400mg/kgformalesandfrom
12.5to200mg/kgforfemales. Deaths of8/10maleratsthat
received 400 mg/kg and 4/10 males and 5/10 females that
received 200 mg/kg were compound related. At necropsy,
themeanbodyweightsofmaleratsthatreceived200or400
mg/kgwere 9% or 15% lower than that ofvehicle controls,
whereas the mean body weights of dosed and vehicle
control female rats were similar. No compound-related
gross or microscopic lesions were observed.
In the 13-week studies in mice, doses of succinic
anhydride ranged from 37 to 600 mg/kg. All 10 males and
8/10 females that received 600 mg/kg and 2/10 males and
2/10 femalesthatreceived300mg/kgdiedbeforethe end of
the studies. The final mean body weights of mice that
received 150 or300 mg/kgwere 13% or 9% lowerthan that
of vehicle controls for males and 8% or 7% lower for
females. Mildinflammation ofthe stomachwasobservedin
7/10malemice thatreceived 150mg/kgand5/10males that
received 300 mg/kg compared with 2/10 vehicle controls.
Based primarily on the effects of administration of
succinic anhydride on survival andmeanbodyweights of
rats and mice, doses for the 2-year studies were 0, 50, or
100mg/kgtogroupsof60ratsofeachsex; 0,38, or75mg/
kg to groups of50 male mice; and 0, 75, or 150 mg/kg to
groups of50femalemice. Succinicanhydridewas admin-
istered as a suspension in corn oil by gavage, 5 days per
week for 103 weeks.
Body Weights and Survival in the Two-Year Studies:
Meanbodyweights ofhigh dose rats were 5%-11% lower
than those ofvehicle controls during the second year of
the studies. No significant differences in survival after 2
yearswereobservedbetween anygroups ofrats ofeither
sex (male: vehicle control, 36/60; low dose, 33/60; high
dose, 32/60; female: 31/60; 27/60; 27/60). For mice, mean
bodyweights ofhigh dose males were generally 5%-12%
lowerthanthoseofvehiclecontrolsthroughoutthestudy.
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Mean body weights of high dose female mice were
10%-32%lowerthanthoseofvehiclecontrols;meanbody
weights of low dose female mice were 10%-20% lower
than those ofvehicle controls. The survival ofhigh dose
male mice was significantly greater than that ofvehicle
controls after week 77 (survival after 2 years-male:
27/50; 30/50; 42/50; female: 37/50; 38/50; 41150). No other
differences in survival were observed between any
groups ofmice ofeither sex.
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: At no site in rats or mice was there a chemical-
related increase in the incidence of nonneoplastic or
neoplastic lesions. Asufficientnumberofanimals in each
dose group lived long enough to allow evaluation of the
potential carcinogenicity ofsuccinic anhydride.
Genetic Toxicology: Succinic anhydride was not muta-
genic in S. typhimurium with or without exogenous
metabolic activation. The chemical did not induce sister
chromatid exchanges or chromosomal aberrations in
cultured CHO cells in the presence or absence of
exogenous metabolic activation.
Conclusions: Under the conditions of these 2-year
studies, therewasno evidence ofcarcinogenic activity
of succinic anhydride for male or female F344/N rats
given 50 or 100 mg/kg succinic anhydride. There was no
evidence of carcinogenic activity for male B6C3F1
mice given 38 or 75 mg/kg succinic anhydride or for
female B6C3F1 mice given 75 or 150 mg/kg.
Synonyms: butanedioic anhydride; dihydro-2,5-
furandione; 2,5-diketotetrahydrofuran; succinic acid
anhydride; succinyl anhydride; succinyl oxide;
tetrahydro-2,5-dioxofuran
Report Date: January 1990
TR-374 Toxicology and Carcinogenesis
Studies ofGlycidol (CAS No. 556-52-5) In
F344/N Rats and B6C3F1 Mice (Gavage
Studies)
Glycidol is aviscous liquidthatisused as astabilizerin
the manufacture ofvinyl polymers, as an additive for oil
and synthetic hydraulic fluids, and as a diluent in some
epoxyresins.Toxicologyandcarcinogenesis studieswere
conducted byadministering glycidol (94% pure, contain-
ing 1.2% 3-methoxy-1,2-propanediol, 0.4% 3-chloro-1,2-
propanediol, 2.8% diglycidyl ether, and 1.1% 2,6-
dimethanol-1,4-dioxane) in waterby gavage to groups of
F344/N rats and B6C3F1 mice ofeach sexfor16 days, 13
weeks, or 2 years. Genetic toxicology studies were con-
ducted in Salmonella typhimurium, Chinese hamster
ovary (CHO) cells, Drosophila melanogaster, and the
bone marrow ofmale B6C3F1 mice.
Sixteen-Day Studies: Glycidol doses for groups offive
rats orfive mice ofeach sexranged from 37.5 to 600 mg/
kg; vehicle controls received distilledwater. All rats that
received 600 mg/kg died between days 3 and 13. Edema
and degeneration of the epididymal stroma, atrophy of
the testis, and granulomatous inflammation of the epi-
didymis occurred in males that received 300 mg/kg.
All mice that received 600 mg/kg and two males and
two females thatreceived 300mg/kgdied byday4 ofthe
studies.Focaldemyelinationinthemedullaandthalamus
ofthebrain occurred in allfemalemice thatreceived300
mg/kg.
Thirteen-Week Studies: Doses for groups of 10 rats
ranged from 25 to 400mg/kg, and doses for groups of10
mice ranged from 19 to 300 mg/kg; vehicle controls
received distilledwater. All rats thatreceived 400 mg/kg
diedbyweek2; threemales and onefemalethatreceived
200 mg/kg died during weeks 11-12. Final mean body
weights ofmale rats that received 50, 100, or 200 mg/kg
were 96%-85% that ofvehicle controls; final mean body
weights of female rats receiving the same doses were
95%-89% that of vehicle controls. Sperm count and
sperm motility were reduced in male rats that received
100 or 200 mg/kg. Necrosis of the cerebellum,
demyelineation in the medulla of the brain, tubular
degeneration and/or necrosis of the kidney, lymphoid
necrosis of the thymus, and testicular atrophy and/or
degeneration occurred in rats that received 400 mg/kg.
All mice that received 300 mg/kg died by week 2;
deaths ofmice that received 150 mg/kg occurred during
weeks 4-8 for males and weeks 1-5 for females. Mean
bodyweightsofchemicallyexposedmicesurvivingtothe
end of the studies were generally 90%-94% those of
vehicle controls. Sperm count and sperm motility were
reduced in dosed male mice. Compound-related histo-
pathologic lesions included demyelination ofthe brain in
males and females that received 150 or 300 mg/kg, testi-
cularatrophyinmales atall doses, andrenal tubular cell
degeneration in male mice that received 300 mg/kg.
Based on reduced survival, reduced weight gain, and
histopathologic lesions in the brain and kidney in rats
that received 200 or 400 mg/kg and on reduced survival
and histopathologic lesions of the brain in mice that
received 150 or 300 mg/kg, doses selected for the 2-year
studies ofglycidolwere37.5and 75mg/kgforrats and25
and 50 mg/kg for mice.
Body Weights and Survival in the Two-Year Studies:
Mean body weights of chemically exposed male rats
generally ranged from 80% to 94% of those of vehicle
controls, and mean body weights ofchemically exposed
female rats were from 90% to 97% those of vehicle
controls. Meanbodyweights ofchemicallyexposed male
micewere similartothose ofvehiclecontrols; meanbody
weights of chemically exposed female mice were
79%-95% of those ofvehicle controls. Virtually all male
and female rats thatreceived glycidol died orwere killed
in amoribund condition as aresult ofthe earlyinduction
of neoplastic disease (final survival-male: vehicle con-
trol, 16/50; lowdose, 0/50; high dose, 0/50; female: 28/50;
4/50;0/50).Survivalofvehiclecontrolmaleratswaslower
than that usually observed; however, specific causes of
deaths could not be determined. The survival of male
mice and low dose female mice was similar to that of
vehicle controls; survival offemale mice thatreceived 50
mg/kgwas lowerthanthatofvehicle controls afterweek
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101 (final survival-male: 33/50; 25/50; 27/50; female:
29/50; 27/50; 17/50).
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: Chemical-related nonneoplastic lesions in both
rats and mice included hyperkeratosis and epithelial
dysplasia ofthe forestomach. Fibrosis ofthe spleen was
also presentinrats ofeach sex, and cysts ofthepreputial
gland and kidney were present in male mice.
Exposure to glycidolinduced dose-related increases in
the incidences ofneoplasms in numerous tissues in both
rats and mice (see summary table on page 5 of the
Technical Report). Inmalerats,mesotheliomas arisingin
the tunicavaginalis and frequently metastasizing to the
peritoneum were considered the major cause of early
death. Early deaths in female rats were associated with
the presence ofmammary gland neoplasms.
Genetic Toxicology: Glycidol was mutagenic in a vari-
ety of in vitro and in vivo short-term tests. Mutagenic
activity was observed in S. typhimurium strains TA97,
TA98, TA100, TA1535, and TA1537 exposed to glycidol
with and without exogenous metabolic activation.
Glycidol was positive in the absence of exogenous meta-
bolic activation in the mouse lymphoma assay for induc-
tion oftrifluorothymidine resistance in L5178Y/TK cells;
it was not tested with activation. In cytogenetic tests
with CHO cells, glycidol induced both sister chromatid
exchanges and chromosomal aberrations in the presence
and absence of exogenous metabolic activation. Glycidol
induced sex-linked recessive lethal mutations and
reciprocal translocations in the germ cells of male D.
melanogaster exposed by feeding. The incidence of
micronucleated polychromatic erythrocytes was
increased in the bone marrow of male B6C3F1 mice
administered glycidol by intraperitoneal injection.
Conclusions: Under the conditions of these 2-year
gavage studies, there was clearevidence ofcarcinogenic
activity of glycidol for male F344/N rats, based on
increased incidences ofmesotheliomas of the tunica vagi-
nalis;fibroadenomas ofthemammarygland;gliomasofthe
brain; and neoplasms of the forestomach, intestine, skin,
Zymbal gland, and thyroid gland. There was clear evi-
dence of carcinogenic activity for female F344/N rats,
based on increased incidences offibroadenomas and ade-
nocarcinomas ofthemammarygland; gliomasofthebrain;
neoplasms ofthe oral mucosa, forestomach, clitoral gland,
andthyroidgland;andleukemia.Therewasclearevidence
ofcarcinogenic activity for male B6C3F1 mice based on
increased incidences ofneoplasms ofthe harderian gland,
forestomach, skin, liver, and lung. There was clear evi-
dence ofcarcinogenic activity for female B6C3F1 mice,
based on increased incidences of neoplasms of the hard-
erian gland, mammary gland, uterus, subcutaneous tissue,
and skin. Other neoplasms that may have been related to
the administration of glycidol were fibrosarcomas of the
glandular stomach in female rats and carcinomas of the
urinary bladder and sarcomas of the epididymis in male
mice.
Synonym: 2,3-epoxy-1-propanol
Report Date: March 1990
TR-375 Toxicology and Carcinogenesis
Studies ofVinyl Toluene (Mixed Isomers)
(65%-71% meta-isomer and 32-35%para-
isomer) (CAS No. 25013-15-4) in F344/N
Rats and B6C3F1 Mice (Inhalation
Studies)
Vinyl Toluene is used as amonomerin the plastics and
surface-coating industries. Toxicology and carcino-
genesis studies were conducted by exposing groups of
F344/N rats and B6C3F1 mice of each sex to vinyl
toluene (mixed isomers: 65%-71% meta and 32%-35%
para) by inhalation 6 hours per day, 5 days per week,
for 15 days, 13 weeks, or 2 years. Genetic toxicology
studies were conducted in Salmanella typhimurium,
mouse L5178Y cells, and Chinese hamster ovary (CHO)
cells.
Fifteen-Day Studies: Rats were exposed to 0, 200, 400,
800, or1,300ppmvinyltoluene, andmicewereexposedto0,
10, 25, 50, 100, or 200 ppm. All rats lived to the end ofthe
studies. The mean body weights at necropsy of rats
exposed to400-1,300ppmwere13%-19% lowerthanthatof
controls for males and 9%-13% lower for females. Most
male rats exposed to 1,300 ppm had centrilobular necrosis
andfocalinflammatorycellinfiltration oftheliver,whereas
minimal centrilobularvacuolization ofthe liverwas seen in
all female rats exposed to 1,300 ppm. Dysplasia of the
bronchialepitheliallining, chronicbronchitis, andlymphoid
hyperplasiaofthelungwereobservedinallratsexposedto
1,300 ppm.
Three of five male mice exposed to 200 ppm vinyl
toluene died before the end of the studies. Four of five
male mice exposed to 200 ppm had moderate-to-severe
hepatocellular necrosis; all female mice exposed to 200
ppm had hyperplasia of the epithelium of the intra-
pulmonarybronchi and centrilobularnecrosis, vacuoliza-
tion, and inflammatory cell infiltrates in the liver.
Thirteen-WeekStudies: Ratswereexposedto0,25,60,
160, 400, or 1,000 ppm vinyl toluene. All rats lived to the
end ofthe studies. The final mean body weights of rats
exposed to 400-1,000 ppm were 8%-19% lower than that
of controls for males and 6%-12% lower for females.
Relative liver weights for rats at 1,000 ppm were signifi-
cantly greater than those for controls. The severity of
nephropathy was increased in male rats exposed to 160,
400, or 1,000 ppm. Compound-related lesions were not
observed in female rats.
Mice were exposed to 0, 10, 25, 60, or 160 ppm vinyl
toluene. The final mean bodyweights ofmice exposed to
25-160ppmwere 12%-20% lowerthanthatofcontrols for
males and 13%-16% lower for females. Inflammation of
the lung was observed in 5/10 male and 3/9 female mice
exposed to 160 ppm. Metaplasia of the nasal turbinates
was seen in all exposed groups.
Based on these results, 2-year studies were conducted
byexposinggroupsof49or50ratsofeach sexto0,100, or
300 ppm vinyl toluene by inhalation, 6 hours per day, 5
days per week for 103 weeks. Groups of 50 mice ofeach
sexwereexposedto0,10, or25ppmonthe sameschedule.
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Body Weights and Survival in the Two-Year Studies:
Meanbodyweightsofmaleratsexposedto300ppmvinyl
toluene and those offemale rats exposed to 100 and 300
ppmweregenerally4%-11% lowerthanthoseofcontrols.
No significant differences in survivalwere seenbetween
anygroups ofrats ofeither sex (male: control, 19/49; low
dose, 17/50; high dose, 19/50; female: 31150; 28/50; 26/50).
Mean body weights of mice exposed to 25 ppm were
10%-23% lower than those of controls after week 8,
whereas mice exposed to 10ppm showed aweightdecre-
ment that was generally less than 10%. The survival of
male mice exposed to 25 ppm was significantly greater
than that ofcontrols. No other significant differences in
survivalwere seen between anygroups ofmice ofeither
sex(male:33/50;30/50;41150;female:36/50;37/50;34/50).
Nonneoplastic and Neoplastic Effects intheTwo-Year
Studies: Degenerative and nonneoplastic proliferative
lesions ofthe nasal mucosa were observed at increased
incidencesinexposedrats. Theselesionsincluded diffuse
hyperplasia (goblet cell) of the respiratory epithelium
withintraepithelial mucouscysts andfocalerosionofthe
olfactory epithelium with cystic dilation (cysts) of the
Bowman's glands. Focal respiratory epithelial meta-
plasia of the olfactory epithelium was seen in some
exposed males, and cells with homogeneous eosinophilic
cytoplasm in the olfactory epithelium occurred at
increased incidences in exposed female rats. Neoplasms
ofthe nasalmucosawere notseeninmale orfemalerats.
There were no chemically related increases in neo-
plasm incidence in exposed male or female rats.
Degenerative and inflammatory lesions of the nasal
mucosawereobserved atincreasedincidencesinexposed
mice. These lesions included focal chronic active inflam-
mation and diffuse hyperplasia of the respiratory epi-
thelium. Chronic active inflammation ofthe bronchioles
occurred in many exposed mice but not in controls.
Neoplasms of the nasal passage were not observed in
mice.
There were no chemically related increases in neo-
plasm incidence in exposed male or female mice.
Exposure-related decreased incidences included
alveolar/bronchiolar neoplasms (control, 12/50; 10 ppm,
5/49;25ppm,2/49) andmalignantlymphomas (7/50;3/50;
0/50) in males and hepatocellular neoplasms (9/48; 5/16;
2/49) in females.
Genetic Toxicology: Vinyl toluene did not induce gene
mutations in S. typhimurium strains TA98, TA100,
TA1535, or TA1537 with orwithout exogenous metabolic
activation (S9). Vinyl toluene was positive in the mouse
lymphoma assay for induction of trifluorothymidine
resistanceinL5178Y/TKcellsintheabsence ofS9;itwas
not tested with S9. Vinyl toluene did not induce sister
chromatid exchanges or chromosomal aberrations in
CHO cells with orwithout S9.
Conclusions: Under the conditions of these 2-year
inhalation studies, there was no evidence of carcino-
genicactivity formaleorfemaleF344/Nratsexposedto
100or300ppmvinyltolueneandnoevidenceofcarcino-
genic activity for male orfemale B6C3F1 mice exposed
to 10 or 25 ppm.
There was evidence ofchemical-related toxicity to the
nasal passage in both rats and mice.
Synonyms: 3-vinyl toluene and 4-vinyl toluene (mixed
isomers)
Report Date: March 1990
TR-376 lTxicology and Carcinogenesis
Studies ofAllyl Glycidyl Ether (CAS No.
106-92-3) in Osborne-Mendel Rats and
B6C3F1 Mice (Inhalation Studies)
Allylglycidyletherisused as aresinintermediate and
asastabilizerofchlorinatedcompounds,vinylresins,and
rubber. Toxicology and carcinogenesis studies were con-
ducted by exposing groups ofOsborne-Mendel rats and
B6C3F1 ofeach sex to allyl gylcidyl ether (greater than
97% pure) by inhalation for 6 hours per day, 5 days per
weekfor2weeks,13weeks, or2years. Genetictoxicology
studies were conducted in Salmonella typhimurium,
Chinese hamster ovary (CHO) cells, and Drosophila
melanogaster. Studies ofreproductive effectswere con-
ductedinratsandmiceexposedtoallylglycidyletherfor
8 weeks.
Two-Week Studies: Exposure concentrations ranged
up to 500 ppm in rats and 100 ppm in mice. All rats that
were exposed to 500ppmdied; no deaths occurred atthe
next lower (200 ppm) exposure concentration. All male
miceand3/5femalemiceexposedto100ppmand2/5male
mice and 1/5 female mice exposed to 50 ppm died.
Compound-relatedlesionsinratsandmiceincludedacute
inflammation ofthe nasal passage and major airways.
Eight-Week Studies of Reproductive Effects: Rats
were exposed to 0-200ppm allyl glycidyl ether, and mice
were exposed to 0-30 ppm, 6 hours per day, 5 days per
week for 8 weeks. The mating performance of exposed
male rats was markedly reduced; however, sperm
motility and number were not affected. No deficiencies
were seen in the reproductive performance of exposed
female rats or male or female mice.
Thirteen-Week Studies: Exposure concentrations
ranged up to 200 ppm for rats and 30 ppm for mice. All
rats lived to the end ofthe studies. The final mean body
weightsofmaleratsexposedto10-200ppmwere7%-24%
lowerthan that ofcontrols. Clinical signs attributable to
irritation of the upper respiratory tract and eyes were
seen in exposed animals. Histologic lesions included
squamousmetaplasiaofthenasalpassageinallexposure
groups (4 ppm, lowest concentration) and involved both
the respiratory epithelium and the olfactory epithelium.
Thelesionsweremoresevereanteriorlyanddorsallyand
with increasing concentration. At 30 ppm and higher,
erosion was seen in the nasal passage and squamous
metaplasia was seen in the upper airways.
There were no compound-related deaths in mice. The
finalmeanbodyweights ofmice exposed to 30ppmwere
12% lower than those of controls for both males and
females. Miceexposedto10 or30ppmallylglycidylether
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had squamous metaplasia ofthe nasalpassage, involving
both the respiratory epithelium and the olfactory epi-
thelium, which tended to be more severe in the anterior
anddorsalportions ofthenasalpassage. Inmiceexposed
to 30 ppm, epithelial erosions were also found.
Body Weights and Survival in the Two-Year Studies:
Two-year studies were conducted by exposing groups of
50 Osborne-Mendel rats and B6C3F1 mice ofeach sexto
0, 5, or 10 ppm allyl glycidyl ether by inhalation for 6
hoursperday,5daysperweekfor102or103weeks. Mean
bodyweights oftheexposedratswerewithin8%ofthose
ofcontrolsthroughoutthestudies. Meanbodyweights of
mice exposed to 5 or 10 ppm were 5%-20% lower than
those ofcontrols. Deaths were seen in all groups ofmale
rats beginning at 1 year of age (final survival-control,
12/50; 5 ppm, 11/50; 10 ppm, 8/50). Survival offemale rats
was not exposure related (24/50; 30/50; 25/50). Exposed
mice had slightly increased survival (male mice: 38/50;
39/50; 46/50; female mice: 33/50; 42/50; 41/50).
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: In male rats exposed to 10 ppm allyl glycidyl
ether, three apparentlyunrelated neoplasms ofthe nasal
passagewerefound.Twoneoplasms, apapillaryadenoma
and a squamous cell carcinoma, appeared to arise from
different cell types in the respiratory epithelium. One
poorly differentiated adenocarcinoma in the olfactory
regionwas alsofound. Onepapillaryadenomaofrespira-
toryepithelial originwasfoundinafemaleratexposedto
5 ppm. Exposure-related nonneoplastic lesions of the
nasal passages in rats included inflammation, squamous
metaplasia, respiratorymetaplasia (replacementofolfac-
toryepitheliumbyciliatedepithelium), hyperplasia ofthe
respiratoryepithelium, anddegeneration oftheolfactory
epithelium. In male mice exposed to 10ppm allyl glycidyl
ether, ahemangioma andthreepapillaryadenomas were
present in the nasal passage. In female mice exposed to
10ppm, ahemangiomaand anadenomawerefoundinthe
nasal passage. Nonneoplastic lesions of the nasal pas-
sages in mice included inflammation, squamous meta-
plasia, hyperplasia, basal cell hyperplasia, dysplasia of
the respiratory epithelium, and metaplasia of the olfac-
tory epithelium. In male mice, there was an exposure-
related decrease in the incidences ofhepatocellular neo-
plasms; in female mice, there was a decrease in the
incidences ofpituitary gland adenomas.
GeneticToxicology:Allylglycidyletherwasmutagenicin
S. typhimurium strains TA100 and TA1535 with and
without exogenous metabolic activation; no mutagenic
activity was observed in strains TA98 or TA1537. Allyl
glycidyl ether induced sister chromatid exchanges and
chromosomalaberrationsinCHOcellsbothinthepresence
and the absence of metabolic activation. A significant
increase in sex-linked recessive lethal mutations was
recorded in the germ cells ofmale D. nelanogaster fed a
sucrose solution containing allyl glycidyl ether, but no
increaseinreciprocaltranslocations occurredinthesecells.
Conclusions: Under the conditions of these 2-year
inhalation studies, there was equivocal evidence ofcar-
cinogenic activity of allyl glycidyl ether for male
Osborne-Mendel rats, based on the presence of one
papillary adenoma of respiratory epithelial origin, one
squamous cell carcinoma ofrespiratory epithelial origin,
and one poorly differentiated adenocarcinoma of olfac-
tory epithelial origin, all occurring in the nasal passage
of males exposed to 10 ppm. There was no evidence of
carcinogenic activity of allyl glycidyl ether for female
rats. One papillary adenoma of the respiratory epi-
thelium was present in a female rat exposed to 5 ppm.
There was some evidence ofcarcinogenic activity of
allyl glycidyl ether for male B6C3F1 mice, based on the
presence of three adenomas of the respiratory epi-
thelium, dysplasia in four males, and focal basal cell
hyperplasia ofthe respiratory epithelium in seven males
in the nasal passage of mice exposed to 10 ppm. There
was equivocal evidence of carcinogenic activity of
allyl glycidyl ether for female mice, based on the pres-
ence of one adenoma of the respiratory epithelium and
focal basal cell hyperplasia ofthe respiratory epithelium
in sevenfemales exposedto10ppm.The sensitivity ofthe
assay to detect potential carcinogenicity may have been
reduced in male rats because of poor survival in all
groups.
In exposed mice, bodyweights were decreased 10% or
more, mortality was decreased, and there were lower
incidences ofliverneoplasms (males) andpituitarygland
adenomas (females) compared with controls.
Significant exposure-related nonneoplastic lesions
were restricted to the nasal passage in both rats and
mice and induced inflammation, metaplasia, respiratory
epithelial hyperplasia, and olfactory epithelial degenera-
tion. Basal cell hyperplasia and dysplasia ofthe respira-
tory epithelium ofthe nasal passage were found only in
the mice.
Synonyms: allyl 2,3-epoxypropyl ether; 1-allyloxy-2,3-
epoxypropane; 1,2-epoxy-3-allyloxypropane; glycidyl
allyl ether; ((2-propenyloxy)methyl)oxirane; 1-
(allyloxy)-2,3-epoxypropane
Report Date: January 1990
TR-377 Toxicology and Carcinogenesis
Studies ofCS2 (94% o-Chlorobenzal-
malononitrile, CAS No. 2698-41-1) in F344/
N Rats and B6C3F1 Mice (Inhalation
Studies)
CS2 (94% o-chlorobenzalmalononitrile [CS]; 5% Cab-
O-Sil® colloidal silica; 1% hexamethyldisilizane), an eye
and respiratory irritant, is used as an aerosol to control
riots. Toxicology and carcinogenesis studies were con-
ducted by exposing groups of F344/N rats and B6C3F1
mice ofeach sexfor6hoursperday, 5daysperweekfor2
weeks, 13 weeks, or 2 years, to a CS2 aerosol. Genetic
toxicology studies with CS2 were conducted in Salmo-
nella typhimurium, mouse lymphoma cells, and Chi-
nese hamster ovary (CHO) cells.
Fourteen-Day Studies: At exposure concentrations of
0,1, 3, 10, 30, or 100 mg/m3 CS2, all rats exposed to 30 or
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100 mg/m3 and all mice exposed to 10, 30, or 100 mg/m3
died before the end of the studies. Compound-related
clinical signs observed included erythema,
blepharospasm, listlessness, nasaldischarge, andmouse
breathing.
Thirteen-Week Studies:Atexposureconcentrations of
0,0.4,0.75,1.5,3, or6 mg/m3, 1/10male rats exposed to 6
mg/m3 died before the end of the studies. Final mean
bodyweights ofrats exposed to 1.5 mg/m3 or more were
17%-44% lower than that of controls for males and
10%-24% lower for females. The absolute and relative
thymus weights were reduced for exposed male and
female rats, particularly at 6 mg/m3. Compound-related
lesions ofthenasalpassage inratsincludedfocalerosion
with regenerative hyperplasia and squamous metaplasia
oftherespiratory epithelium and suppurative inflamma-
tion. Acute inflammation and hyperplasia ofthe respira-
tory epithelium were seen in the larynx and trachea of
some exposed rats.
All mice exposed to 6 mg/m3 and V10 males and 1/10
females exposed to 3 mg/m3 died before the end of the
studies. Final mean body weights of mice exposed to 3
mg/m3 were 13% lower than that of controls for males
and 9% lower for females. Compound-related lesions of
the nasal passage inmiceincluded squamous metaplasia
ofthe nasal respiratory epithelium and inflammation.
Basedontheseresults, CS2exposure concentrationsfor
the 2-year studies were 0, 0.075, 0.25, or 0.75 mg/m3 for 6
hoursperday, 5 days perweekfor105weeks forgroups of
50 rats of each sex. Groups of 50 mice of each sex were
exposed to 0, 0.75, or 1.5 mg/m3 on the same schedule.
Body Weights and Survival in the Two-Year Studies:
Final mean bodyweights ofrats exposed to 0.75 mg/m3
were 7%-11% lower than those of controls. Final mean
body weights of mice exposed to CS2 were lower than
those of controls (male: 5% and 9%; female: 10% and
17%). No compound-related clinical signswere observed.
No significant differences in survival were seen for any
group ofrats or mice ofeither sex.
Nonneoplastic and Neoplastic Effects intheTwo-Year
Studies: Compound-related nonneoplastic lesions
occurred in the nasal passage ofexposed rats and mice.
Inexposedrats, hyperplasiaandsquamousmetaplasiaof
therespiratoryepithelium and degeneration ofthe olfac-
tory epithelium with ciliated columnar and/or squamous
metaplasia were observed. Focal chronic inflammation
and proliferation of the periosteum of the turbinate
boneswereincreased slightlyin rats atthe topexposure
concentration. Suppurative inflammation with hyper-
plasia and squamous metaplasia of the respiratory epi-
thelium occurred in exposed mice.
Therewere no compound-related increased incidences
ofneoplasms in rats ormice exposed to CS2. In exposed
female mice, there were pronounced decreases in the
incidences of adenomas of the pituitary pars distalis
(control, 13/47; 0.75 mg/m3, 5/46; 1.5 mg/m3, 1/46) and
decreased incidences of malignant lymphomas (21/50;
12/50; 8/50).
Genetic Toxicology: The responses in Salmonella gene
mutationtestswithCS2wereequivocalin onelaboratory
for strain TA100 in the absence of exogenous metabolic
activation (S9) and equivocal in another laboratory for
TA97withS9;inallotherstrainstested, CS2wasclearly
negative with or without S9. CS2 induced tri-
fluorothymidine resistance in mouse L5178Y/TK lym-
phoma cells in the absence ofS9; it was not tested with
S9. CS2 induced both sister chromatid exchanges and
chromosomal aberrations in CHO cellswith andwithout
S9.
Conclusions: Under the conditions ofthese inhalation
studies, therewasno evidence ofcarcinogenic activity
ofCS2 formale orfemale F344/N rats exposed to 0.075,
0.25, or0.75 mg/m3 in airforup to 2years. Therewasno
evidence of carcinogenic activity for male or female
B6C3F1 miceexposedto0.75or1.5mg/m3inairforupto
2 years. Concentration-related decreases in the inci-
dencesofpituitaryglandadenomasandlymphomaswere
observed in female mice.
Exposure to CS2 caused degeneration and squamous
metaplasia of the olfactory epithelium, hyperplasia and
metaplasia of the respiratory epithelium, and prolifera-
tion of the periosteum of the nasal passage of rats. In
mice, exposure to this compound caused suppurative
inflammation and hyperplasia and squamous metaplasia
ofthe respiratory epithelium ofthe nasal passage.
Report Date: March 1990
TR-378 Toxicology and Carcinogenesis
Studies ofBenzaldehyde (CAS No.
100-52-7) in F344/N Rats and B6C3F1 Mice
(GavageStudies)
Benzaldehydeisanaromaticaldehydeusedinthefood,
beverage, pharmaceutical, perfume, soap, and dyestuff
industries. Toxicology and carcinogenesis studies were
conducted by administering benzaldehyde (99% pure) in
corn oilbygavage to groups ofF344/N rats and B6C3F1
mice ofeach sexfor16 days, 13weeks, or2years. Genetic
toxicology studies were conducted in Salmonella
typhimurium, mouselymphomacells, Chinese hamster
ovary (CHO) cells, andDrosophila melanogaster.
Sixteen-Day Studies: All rats that received 1,600 mg/
kg died by day 2, and 2/5 males and 2/5 females that
received 800 mg/kg died before the end of the studies.
Final mean body weights of dosed and vehicle control
rats were similar, with the exception of the 800 mg/kg
groups, in which males were 14% lighter and females
were 11% lighter than vehicle controls. All mice that
received 1,600 or 3,200 mg/kg died by day 3. Final mean
body weights of dosed and vehicle control mice were
similar. No gross lesions attributable to benzaldehyde
were detected upon necropsy.
Thirteen-Week Studies: Six of 10 male rats and 3/10
female rats thatreceived 800mg/kg and 1/10 female rats
thatreceived 400mg/kgdied nearthe end ofthe studies.
Final mean body weights of dosed and vehicle control
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rats were similar, with the exception ofmale rats receiv-
ing 800 mg/kg, which were 26% lighter than vehicle
controls. Compound-relatedlesionsseeninratsreceiving
800mg/kg,butnotinthosereceiving400mg/kg,included
degeneration and necrosis in the cerebellum, necrosis in
the hippocampus, hyperplasia and/or hyperkeratosis in
theforestomach,anddegenerationornecrosisoftheliver
and ofthe tubular epithelium in the kidney.
Nineof10malemiceand1/10femalemicethatreceived
1,200 mg/kg benzaldehyde died by the end of the first
week. Compound-related renal tubule degeneration and/
or necrosis and reduction in final body weight were
observed in the 600 mg/kg group of male mice. No
reductions in body weight or compound-related lesions
were seen in female mice.
Based on observations of compound-related lesions
involvingthebrain,forestomach,kidney,andliverofmale
and female rats and the kidney of male mice in the 13-
week studies, 2-year studies were conducted by admin-
istering 0, 200, or400mg/kgbenzaldehyde in corn oilby
gavage, 5 days per week for 103 weeks to groups of 50
maleand50femaleratsandfor104weekstogroups of50
male mice. Based on survival data from the 16-day and
13-week studies, groups of50 female mice were admin-
istered 0, 300, or600mg/kgbenzaldehyde for103weeks.
Body Weights and Survival in the Two-Year Studies:
Mean bodyweights ofdosed rats and mice were similar
to their respective vehicle controls throughout the stud-
ies. The survival ofthe high dose group ofmale ratswas
lower than that of the vehicle controls after 1 year; no
othersignificant differences were observed between any
groups of rats or mice (survival-male rats; vehicle
control, 37/50; low dose, 29/50; high dose, 21/50; female
rats: 33/50; 33/50; 29/50; male mice: 32/50; 33/50; 31/50,
female mice: 30/50; 27/50; 35/50).
Nonneoplastic and Neoplastic Effects in the Two-year
Studies: The only effects of benzaldehyde were those
seen in the forestomach of mice. The incidences of
uncommonly occurring squamous cell papillomas ofthe
forestomach in both exposure groups were significantly
greater than those in vehicle controls (male: vehicle
control,1/50; lowdose,2/50;highdose,5/50; female: 0/50;
5/50; 6/50). The increased incidences ofpapillomas were
accompanied by dose-related increases in the incidences
in forestomach hyperplasia (male: 7/50; 8/50; 16/50;
female: 12/50; 23/50; 39/50).
Genetic Toxicology: Benzaldehyde was not mutagenic
in six strains of S. typhimurium and did not induce
chromosomal aberrations in CHO cells, with or without
exogenous metabolic activation. Benzaldehyde induced
increases in trifluorothymidine-resistant mouse lym-
phoma cells in the absence exogenous metabolic activa-
tion and increased sister chromatid exchanges in CHO
cells in both the presence and absence of metabolic
activation. Sex-linkedrecessivelethalmutationswerenot
induced in the germ cells ofadultmaleD. melanogaster
administered benzaldehyde by feeding or by injection.
Conclusions: Under the conditions of these 2-year
gavage studies, there was no evidence ofcarcinogenic
activity ofbenzaldehyde formale orfemale F344/N rats
receiving 200 or 400 mg/kg per day. There was scme
evidence ofcarcinogenic activity ofbenzaldehyde for
male or female B6C3F1 mice, as indicated by increased
incidences of squamous cell papillomas and hyperplasia
of the forestomach. Female rats and male and female
mice might have been able to tolerate higher doses.
Synonyms: artificial almond oil; artificial essential oil of
almond; benzenecarbonal; benzene carbaldehyde; ben-
zoic aldehyde; phenylmethanal
Report Date: March 1990
TR-379 Toxicology and Carcinogenesis
Studies of2-Chloroacetophenone (CAS No.
532-27-4) in F344/N Rats and B6C3F1 Mice
(InhalationStudies)
2-Chloroacetophenone is a potent lacrimator that has
beenusedas ariotcontrolagentandinteargasformula-
tions for personal protection devices. Toxicology and
carcinogenesis studies were conducted by exposing
groups of F344/N rats and B6C3F1 mice ofeach sex to
aircontaining2-chloroacetophenonevaporfor14days,13
weeks, 15 months, or 2 years. Genetic toxicology studies
were conducted in Salmonella typhimurium and Chi-
nese hamster ovary (CHO) cells.
Fourteen-Day Studies: In 14-day studies, exposure
concentrations of2-chloroacetophenone ranged from 4.8
to 64mg/m3. All rats exposed to 19,43, or64mg/m3 died
during the first week of the studies and 1/5 male rats
exposed to 10 mg/m3 died duringthe secondweek ofthe
study. Rats exposed to 10 mg/m3 lost weight; the final
meanbodyweights ofmale orfemale rats exposed to 4.8
mg/m3, the lowest concentration used, were 23% or 15%
lower than that of controls. During the exposure, rats
showed partial closure ofthe eyelids, excessive lacrima-
tion (dacryorrhea), dyspnea, and erythema. All mice
exposed to 10 mg/m3 or higher concentrations of2-chlo-
roacetophenone died duringthefirstweekofthe studies.
The final mean bodyweights ofmice exposed to 4.8 mg/
m3 were sirmiilar to those of controls. Dacryorrhea was
observed in exposed mice.
Thirteen-Week Studies: The exposure concentrations
of2-chloroacetophenone rangedfrom0.25to4mg/m3for
ratsandmice.Allratslivedtotheendofthestudies. The
finalmeanbodyweightsofratsexposedto4mg/m3were
9% lower than those of controls. Eye irritation during
exposure was evident in rats exposed to 0.5 mg/m3 or
higherconcentrations of2-chloroacetophenone. Oneof10
female mice exposed to 4 mmg/3 and 1/10 female mice
exposed to 0.5 mg/n3 died before the end of the study.
The final mean body weights of exposed mice were
7%-12% lower than that of controls for males and
12%-15% lowerforfemales. No chemical-related gross or
microscopic lesions were observed in rats or mice.
In the 2-year studies, groups of 60 rats of each sex
wereexposedtoavaporof0(chambercontrol),1, or2mg/
m3(0,0.15, or0.3ppm)2-chloroacetophenone,6hoursper
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day, 5 days perweek. Groups of60mice ofeach sexwere
exposed to 0 (chamber control), 2, or 4 mg/m3 (0, 0.3, or
0.6 ppm) on the same schedule. Ten animals from each
group were killed and examined at 15 months; the
remaining animals continued on study for 2 years.
Fifteen-Month Studies: In the 15-month studies, mini-
mal-to-mild focal squamous metaplasia and hyperplasia of
the respiratory epithelium were seen at increased inci-
dences in rats exposed to 2 mg/m3. No exposure-related
lesions were observed in mice ofeither sex.
Body Weight and Survival in the Two-Year Studies:
Meanbodyweightsandsurvivalofexposedandchamber
control ratswere similar throughout most ofthe studies
(survival-male: control, 14/50; 1 mg/m3, 22/50; 2 mg/m3,
17/50; female: 23/50; 20/50; 24/50). Meanbodyweights of
male mice exposed to 4 mg/n3were about 5%-12% lower
than those of controls after week 30; small differences
between mean body weights of exposed and control
female mice were not clearly exposure related. The sur-
vivaloffemalemiceexposedto2mg/m3wassignificantly
lower than that of chamber controls after week 98. No
otherdifferences in survivalwere observed between any
groups of mice (male: control, 34/50; 2 mg/m3, 36/50; 4
mg/m3, 33/50; female: 40/50; 28/50; 32/50).
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: Fibroadenomas of the mammary gland
occurred in female rats with positive trends, and the
incidence in the 2 mg/m3 groupwas greater than that in
chamber controls (control, 12/50; 1 mg/m3, 19/50; 2 mg/
mi3, 23/50). The incidences of adenomas or adenocar-
cinomas ofthemammaryglandwerenotincreasedinthe
exposed groups.
Minimal-to-mild suppurative inflammation of the
nasal mucosa was observed at increased incidences in
exposed male rats. Hyperplasia and squamous meta-
plasia ofthe nasal respiratoryepithelium were observed
at increased incidences in exposed male and female rats.
In mice, squamous metaplasia of the respiratory epi-
theliumofthenasalpassagewasseeninfourfemalesand
two males exposed to 4 mg/m3 2-chloroacetophenone.
Inflammation,ulcers, andsquamoushyperplasiaofthe
forestomach were observed at increased incidences in
exposed female rats.
Genetic Toxicology: 2-Chloroacetophenone was not
mutagenic in S. typhimurium strains TA98, TA100,
TA1535, or TA1537 with orwithout exogenous metabolic
activation. In cytogenetic tests with CHO cells, 2-chlo-
roacetophenone did not induce sister chromatid
exchangeswith orwithoutactivation, butaweakpositive
increaseinchromosomalaberrationswasobservedinthe
absence ofmetabolic activation.
Conclusions: Under the conditions of these 2-year
inhalation studies, there was no evidence of carcino-
genic activity of 2-chloroacetophenone for male rats
exposed to 1 or 2 mg/m3. There was equivocal evidence
ofcarcinogenic activity for female F344/N rats, based
on a marginal increase in fibroadenomas ofthe mamm-
ary gland. There was no evidence of carcinogenic
activity formale orfemaleB6C3F1 mice exposed to 2 or
4 mg/m3 2-chloroacetophenone.
Synonyms: a-chloroacetophenone; 2-chloro-1-
phenylethanone; CN; phenacyl chloride; phe-
nylchloromethylketone
Trade Names: Mace®; Chemical Mace®
Report Date: March 1990
TR-380 Tbxicology and Carcinogenesis
Studies ofl-Epinephrine Hydrochloride
(CAS No. 55-31-2) in F344/N Rats and
B6C3F1 Mice (Inhalation Studies)
I-Epinephrine, an endogenous neurotransmitter hor-
mone, is widely used for the treatment of allergic and
respiratory disorders. Toxicology and carcinogenesis
studies ofepinephrine hydrochloride were conducted by
exposing groups of F344/N rats and B6C3F1 mice of
each sex to an aerosol containing epinephrine hydro-
chloride for 14 days, 13 weeks, 15 months, or 2 years.
During the 14-day and 13-week studies, control animals
were exposed to dilute aerosols ofhydrochloric acid (pH
2.8), whereas during the 15-month and 2-year studies,
controls were exposed to aerosols ofwater. Genetic tox-
icology studies ofepinephrinewere conducted inSalmo-
nella typhimurium and Chinese hamster ovary (CHO)
cells.
Fourteen-DayStudies: Ratsandmicewereexposedto
0 or 12.5-200 mg/m3 epinephrine hydrochloride. Deaths
occurredinmalerats exposed to12.5mg/m3 ormore and
in females exposed to 25 mg/m3 ormore. Deaths ofmice
occurred at concentrations of 50 mg/m3 or higher.
Compound-related clinical signs included an increased
respiratory rate in all groups of epinephrine-exposed
rats andmice.Athigherconcentrations (100and200mg/
m3), excessive lacrimation and dyspneain rats and exag-
gerated visual and auditory reflexes in mice were
observed.
Thirteen-Week Studies: Rats and mice were exposed
to 0 or 2.5-40 mg/m3 epinephrine hydrochloride. Deaths
in rats and mice were not concentration related. Final
mean body weights of chemically exposed and hydro-
chloric acid aerosol control rats and micewere generally
similar. Increased respiratory rates were noted in rats
and mice exposed to 40 mg/m3. Heart and adrenal gland
weights of rats and mice and liver weights of mice
exposed to 40 mg/m3 were greater than those ofaerosol
controls. Squamous metaplasia occurred in the respira-
tory epithelium of the nasal mucosa of rats and mice
exposed to 40 mg/m3. Degenerative lesions of the
laryngeal muscle were seen in male and female rats
exposedto20or40mg/m3.Inflammationintheglandular
stomachwas seeninmale andfemalemiceexposedto10,
20, and 40 mg/m3, and uterine atrophy was seen in 7/10
female mice exposed to 40 mg/m3.
Two-year studies were conducted by exposing groups
of 60 rats or each sex to 0, 1.5, or 5 mg/m3 epinephrine
hydrochloride, 5 days perweek for 103weeks. Groups of
60 mice of each sex were exposed to 0, 1.5, or 3 mg/m3
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epinephrine hydrochloride, 5 days per week for 104
weeks. Use of these exposure concentrations repre-
sented a departure from the usual practice of utilizing
dosesequivalenttoone-halfthemaximumtolerateddose
(MTD) and the MTD for 2-year carcinogenicity studies.
Thus, although the dose levels exceeded maximum
humantherapeutic uselevels (normalized tobodyweight
and surface area), they were less than one-half the
MTD.
Fifteen-Month Studies: Results ofhematologic analy-
ses did not show compound-related changes. Absolute
liverweights for exposed mice (3 mg/m3) and rats (5mg/
m3) andrelativeliverweights forexposed rats (5mg/m3)
were significantly lower than those for controls. The
absolutekidneyweights formiceexposed to3mg/m3and
the kidney weight to body weight ratio for male mice
exposed to 3 mg/mi3 were significantly lower than those
for controls. No compound-related lesions were seen in
rats or mice.
Body Weights and Survival in the Two-Year Studies:
Mean bodyweights and survival ofexposed and control
ratsandmice weresimilar(survival, rats -male: control,
33/50; 1.5 mg/m3, 27/50; 5 mg/m3, 32/50; female: 3Z/50;
29/50; 30/50; mice-male: control, 33/50; 1.5 mg/m3,
34/50; 3 mg/M3, 36/50; female: 32/50; 35/50; 34/50).
Nonneoplastic and Neoplastic Effects intheTwo-Year
Studies: Suppurative inflammation ofthe nasal mucosa,
dilatation ofthenasal glands (Bowman's andseptal), and
hyperplasia of the respiratory epithelium were seen at
increasedincidencesinmaleratsexposedto5mg/m3and
in female rats exposed to 1.5 or 5 mg/m3.
Hyaline degeneration of the olfactory epithelium in
male mice and suppurative inflammation of the nasal
passage and hyaline degeneration of the respiratory
epithelium infemalemice wereincreased in the 1.5 and 3
mg/m3 groups compared with controls. No neoplasms
seeninthese studies wereconsideredrelatedtochemical
exposure.
Genetic Toxicology: Salmonella gene mutation tests
with l-epinephrine yielded negative results in strain
TA100 in the presence of exogenous metabolic activation
(S9) and equivocal results in the absence of S9. No
mutagenic activity was observed in strains TA98,
TA1535, or TA1537 with or without S9. The responses
observed in the CHO cell assay for induction of sister
chromatid exchanges were considered tobe negative and
equivocal in the presence and absence of S9 activation,
respectively. t-Epinephrine did not induce chromosomal
aberrations in CHO cells with or without S9.
Conclusions: Under the conditions of these 2-year
studies, no carcinogenic effects were observed inmale or
female F344/N rats exposed to aerosols containing 1.5 or
5 mg/m3 1-epinephrine hydrochloride for 2 years or in
B6C3F1 mice exposed to 1.5 or 3 mg/m3 1-epinephrine
hydrochloride for 2 years. However, these studies were
considered to be inadequate studies of carcinogenic
activity because the concentrations used, which were
chosen to represent multiples oftherapeutic doses, were
considered too low for the animals to have received an
adequate systemic challenge from the compound.
Synonyms: adrenaline hydrochloride; 4-(1-hydroxy-
2-(methylamino)ethyl)-1,2-benzenediol; (-)3,4-dihy-
droxy-ox-((methylamino)methyl)benzyl alcohol hydro-
chloride; methylaminoethanol catechol hydrochloride
Trade names for epinephrine formulations: Primatene®
Mist; Sus-Phrine®; Epipen®; Supravenin Hydro-
chloride®; Bronkaid®
Report Date: March 1990
TR-381 Toxicology and Carcinogenesis
Studies ofd-Carvone (CAS No. 2244-16-8)
in B6C3F1 Mice (Gavage Studies)
d-Carvone occurs naturally in caraway and dill seeds
andinmanyessentialoils;ithasbeenusedas acarmina-
tive and in perfumes and soaps. Toxicity and carcino-
genesis studies were conducted by administering
d-carvone (approximately 96% pure) in corn oil by
gavage togroups ofmale andfemale B6C3F1 micefor16
days, 13 weeks, or 2 years. Genetic toxicology studies
were conducted in Salmonella typhimurium and Chi-
nese hamster ovary (CHO) cells.
Sixteen-Day Studies: All mice that received 1,600 or
3,500 mg/kg died within 7 days. Relative liver weights
wereincreased for dosed malemice, andrelative thymus
weights were decreased for dosed female mice. No
compound-related lesions were observed.
Thirteen-Week Studies: Allmale mice and 9/10 female
micethatreceivedthetopdoseof1,500mg/kgdiedbefore
the end of the studies. No compound-related histo-
pathologic changes were observed.
Based on survival at the high doses in the 13-week
studies, 2-year toxicology and carcinogenesis studies
wereconductedbyadministeringd-carvoneincornoilby
gavage to groups of50 male and 50 femalemice at doses
of375 or 750 mg/kg, 5 days per week for 103 weeks.
Two-Year Studies: Mean body weights of dosed and
vehicle control micewere similarthroughout the studies.
Survival ofdosedmalemicewas similartothatofvehicle
controls (vehicle control, 37/50; low dose, 42/50; high
dose, 36/50); survival of dosed female mice was greater
than that of vehicle control female mice (14/50; 29/50;
38/50). Apparently, abscesses in the urogenital system
caused the early deaths of many vehicle control female
mice.
No neoplastic lesions attributed to d-carvone dosing
were observed in mice.
GeneticToxicology:d-CarvonewasnotmutagenicinS.
typhimurium but induced sister chromatid exchanges
and chromosomal aberrations in CHO cells.
Conclusions: Under the conditions of these 2-year
gavage studies, there was no evidence ofcarcinogenic
activity of d-carvone for male or female B6C3F1 mice
administered 375 or 750 mg/kg, 5 days per week for 2
years.
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Synonyms for d-carvone: (+)-carvone; d(+)-carvone;
(S)-carvone; (S)-( +)carvone; (S)-2-methyl-5-(1-methyle-
thenyl)-2-cyclohexen-1-one; (S)-d-p-mentha-6-8,(9)-
dien-2-one; (S)-( + )-p-mentha-6,8-dien-2-one; d-1-
methyl-4-isopropenyl-6-cyclohexen-2-one. Carvol is a
synonym for carvone (d, I not specified)
Report Date: February 1990
TR-382 Toxicology and Carcinogenesis
Studies ofFurfural (CAS No. 98-01-1) in
F344/N Rats and B6C3F1 Mice (Gavage
Studies)
Furfural isused as aprecursorforthemanufacture of
furan, furfuryl alcohol, tetrahydrofuran, andtheirderiv-
atives and as an industrial solvent. Furfural is also
present in numerous processed food and beverage prod-
ucts. Toxicology and carcinogenesis studies were con-
ducted by administering furfural (99% pure) in corn oil
bygavage to groups ofF344/N rats and B6C3F1 mice of
each sex for 16 days, 13 weeks, or 2 years. Genetic
toxicology studies were conducted in Salmonella
typhimurium, mouse lymphoma cells, Chinese hamster
ovary (CHO) cells, Drosophila melanogaster, and
mouse bone marrow cells.
Sixteen-Day Studies: Rats received doses ranging
from15 to240mg/kg, andmicereceived dosesfrom25to
400mg/kg. Eight of10 rats thatreceived 240mg/kgdied
within 3 days. Final mean body weights of chemically
exposedanimalsweresimilartothoseofvehiclecontrols;
no compound-related histologic lesions were observed in
any dosed groups.
Thirteen-Week Studies: Rats received doses ranging
from 11 to 180 mg/kg, and mice received doses from 75 to
1,200mg/kg. Mostratsthatreceived180mg/kgdied;mean
body weights of chemically exposed rats were similar to
those ofvehicle controls. Mean relative and absolute liver
and kidney weights were increased in male rats that
received 90 mg/kg, and cytoplasmic vacuolization of
hepatocyteswasincreasedinchemicallyexposedmalerats.
Almost all mice thatreceived doses of600 or1,200mg/
kg died within the first 3 weeks. Mean body weights of
chemically exposed mice were similar to those ofvehicle
controls throughout the studies. Mean absolute liver
weights and liver weight to body weight ratios were
increased in females that received 300 mg/kg. Cen-
trilobular coagulative necrosis and/or multifocal sub-
chronic inflammation of the liver were present in
chemically exposed mice but not in vehicle control mice.
Based on these results, doses selected for the 2-year
studies were 0, 30, and 60 mg/kg for rats and 0, 50, 100,
and 175 mg/kg for mice.
Body Weight and Survival in the Two-Year Studies:
Mean body weights of chemically exposed and vehicle
control animals were similar throughout the studies for
rats and mice. Two-year survival ofmale rats; low dose
female rats, and mice was unaffected by chemical expo-
sure (male rats: vehicle control, 31/50; low dose, 28/50;
high dose, 24/50; female rats: 28/50; 32/50; 18/50; male
mice: vehicle control, 35/50; low dose, 28/50; mid dose,
24/50; high dose, 27/50; female mice: 33/50; 28/50; 29/50;
32/50). Survival ofhigh dose female rats was reduced by
deaths associated with gavage administration; the
administration of furfural was considered
to be a contributing factor in these gavage-related
deaths.
Nonneoplastic and Neoplastic Effects in the Two-Year
Studies: Centrilobular necrosis of the liver occurred at
increased incidences in chemically exposed male rats
(vehicle control, 3/50; low dose, 9/50; high dose, 12/50).
Two high dose male rats had bile duct dysplasia with
fibrosis, andtwohadcholangiocarcinomas; neitherlesion
was seen in the other dose groups. The historical inci-
dence of bile duct neoplasms in corn oil vehicle control
male rats is 3/2,145 (0.1%).
Multifocal pigmentation and chronic inflammation of
the subserosaoftheliveroccurredinchemicallyexposed
mice(pigmentation-male: 0/50;0/50;8/49;18/50;female:
0/50; 0/50; 0/50; 11/50; chronicinflammation-male: 0/50;
0/50; 8/49; 18/50; female: 0/50; 0/50; 1/50; 8/50). The
incidences of hepatocellular adenomas and hepatocellu-
lar carcinomas in male mice and hepatocellular ade-
nomas in female mice were significantlyincreased in the
high dose group compared with those in the vehicle
controls (male-adenomas: 9/50; 13/50; 11/49; 19/50; car-
cinomas: 7/50; 12/50; 6/49; 21/50; female- adenomas:
1/50;3/50;5/50;8/50;adenomas orcarcinomas,combined:
5/50; 3/50; 7/50; 12/50).
Threerenalcorticaladenomas orcarcinomasoccurred
in chemically exposed male mice (0/50; 1/50; 1/49; 1/50),
and arenalcortical adenomawaspresentin onelowdose
female mouse; the historical incidence of renal cortical
neoplasms in National Toxicology Program 2-year corn
oil gavage studies in male B6C3F1 mice is 8/2,183.
Forestomach hyperplasia occurred in chemically
exposed female mice, and squamous cellpapillomaswere
increased in high dose female mice (hyperplasia: 0/50;
5/50; 5/50; 3/50; papillomas: 1/50; 0/50; 1/50; 6/50).
Genetic Toxicology: In gene mutation tests with four
strains of Salmonella (TA98, TA100, TA1535, and
TA1537), no mutagenic activity was observed in the
presence or absence of exogenous metabolic activation
(S9) in one laboratory and an equivocal response was
observed in TA100 in the absence of S9 in a second
laboratory. Exposure to furfural induced tri-
fluorothymidine resistance in mouse L5178Y lymphoma
cells in the absence ofS9 (no evaluation was made in the
presence ofS9), sister chromatid exchanges (SCEs) and
chromosomal aberrationsinCHOcellsinthepresence or
absence of S9, and an increase in sex-linked recessive
lethal mutationsbutnoreciprocaltranslocations in germ
cellsofD. melanogaster; furfuraldidnotinduceSCEs or
chromosomal aberrations inthebone marrowofB6C3Fj
mice.
Conclusions: Under the conditions of these 2-year
gavage studies, there was some evidence of carcino-
genic activity offurfuralformale F344/N ratsbased on
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theoccurrenceofuncommoncholangiocarcinomasintwo
animals andbileductdysplasiawithfibrosisintwoother
animals. There was no evidence of carcinogenic
activity forfemale F344/N rats thatreceived doses of0,
30, or 60 mg/kg furfural. There was clear evidence of
carcinogenic activity for male B6C3F1 mice, based on
increased incidences of hepatocellular adenomas and
hepatocellular carcinomas. There was some evidence of
carcinogenic activity infemale B6C3F1 mice, based on
increased incidences of hepatocellular adenomas. Renal
cortical adenomas or carcinomas in male mice and
squamous cell papillomas of the forestomach in female
mice may have been related to exposure to furfural.
Synonyms: 2-furancarboxaldehyde; 2-furaldehyde;
pyromucic aldehyde
Common Name: Artificial oil of ants
Report Date: March 1990
TR-383 Toxicology and Carcinogenesis
Studies of1-Amino-2,4-Dibromoan-
thraquinone (CAS: 81-49-2) in F344 Rats
and B6C3F1 Mice (Feed Studies)
ThisTechnical Reportwasnotafinalpublication atthe
time this "Compendium" was prepared.
TR-384 Toxicology and Carcinogenesis
Studies of1,2,3-frichloropropane (CAS No.
96-18-4) in F344 Rats and B6C3F1 Mice
(Gavage Studies)
ThisTechnical Reportwasnotafinalpublication atthe
time this "Compendium" was prepared.
TR-385 Toxicology and Carcinogenesis
Studies ofMethyl Bromide (CAS: 74-83-9)
in B6C3F1 Mice (Inhalation Studies)
Methyl bromide is widely used as a fumigant and
pesticide. Toxicology and carcinogenesis studies were
conducted by exposing groups of male and female
B6C3F1 mice to methyl bromide (99.8% pure) byinhala-
tion6hoursperday, 5daysperweek,for14days, 6weeks,
13 weeks, or 2 years. Six-week and 13-week inhalation
toxicity studies in F344/N rats were conducted concur-
rently with the mouse studies. Hematology parameters
were measured during the 6-week, 13-wveek, and 2-year
studies. Quantitative neurobehavioral testing was per-
formed during the 14-day, 13-week and 2-year studies.
Genetictoxicologystudieswereconductedforgenemuta-
tion induction in Salmonella typhimurium and for
induction of sister chromatid exchanges in mouse bone
marrow cells and of micronuclei from peripheral blood
erythrocytes.
14-Day Studies: Groups offive B6C3F1 mice ofeach
sexwere exposed to 0, 12, 25, 50, 100, or 200 ppmmethyl
bromidebyinhalation6hoursperday,5daysperweekfor
2 weeks. Only four female mice and one male mouse
survived10exposures at200ppm. No deaths occurred at
thelowerdoses. Neurobehavioral effectsincludingtrem-
bling and paralysis were noted in all groups, but were
most pronounced in the three highest dose groups. Red
urine was noted in the mice exposed to 200 ppm.
13-Week Studies: Groups of10 mice ofeach sex were
exposedto0,10, 20,40,80, or120ppmmethylbromideby
inhalation 6 hours per day, 5 days perweek for 13weeks.
Additional groups ofeight to 17 mice were concurrently
exposedforneurobehavioral andgenetictoxicologystud-
ies. The final mean bodyweight ofmales exposed to 120
ppm was significantly (12%) lower than that ofthe con-
trols. Four of24 males exposed to 120 ppm died during
the study.
Groups of10rats ofeach sexwere exposed to 0,30, 60,
or120ppmmethylbromidebyinhalation 6hoursperday,
5 days perweek for 13 weeks. Additional groups ofeight
rats were concurrently exposed for neurobehavioral
studies. Final mean bodyweights ofrats exposed to 120
ppmwere 12% lowerthan those ofthe controls formales
and 13% lower for females. No rats died as a result of
methyl bromide exposure during the studies.
Special 6-Week Target Organ Toxicity Studies: Nei-
ther the 14-day nor the 13-week studies provided strong
evidence for specific organ toxicity. Six-week studies
were therefore conducted to identify target organs for
the2-yearstudies. Groupsof20rats andmiceofeach sex
wereexposedtomethylbromidebyinhalationfor6hours
perday, 5daysperweekfor6weeks atadoseof160ppm.
Mortality rates exceeded 50% in the male mice after
eight exposures, in female mice after six exposures, and
inmaleratsafter14exposures.Onlythefemaleratgroup
survived 30 exposureswith less than 50%mortality. The
study identified the brain, kidney, nasal cavity, heart,
adrenal gland, liver, and testis as the primary organs to
examinefortoxicityinthe2-yearmethylbromideinhala-
tion studies.
2-YearStudies: Groups of70B6C3F1 mice ofeach sex
wereexposedtomethylbromidebyinhalationat0,10,33,
or 100 ppmfor 6 hours perday, 5 days perweek forup to
103weeks.Additional groups of16micewereincludedfor
neurobehavioral evaluations throughout the 2-year stud-
ies. By 20 weeks (139 days), 27 males and 7 females
exposed to 100 ppm had died and methyl bromide expo-
surewasdiscontinued fortheremainingmiceinthisdose
group. Tenfemalemicefromthe100ppmgrouppredesig-
nated for the 15-month interim evaluation were killed on
scheduleand allotherhigh-dose animalswereallowed to
live to term (24months) forevaluation ofchronic toxicity
andcarcinogenicity. Clinicalsignsindicative ofneurotox-
icity, including tremors, abnormal posture, tachypnea,
and hind legparalysis, persisted in these high-dose mice
until the end ofthe studies.
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Final mean bodyweights of surviving 100 ppm males
and females were markedly lower (33% and 31%) than
those ofthe controls. Neurobehavioral changes occurred
in male and female mice initially exposed to 100 ppm
methyl bromide, with more pronounced changes
observed in males. In general, these animals were less
active and manifested a heightened sensitivity in the
startle response than mice in other dose groups.
Exposure to methyl bromide was not carcinogenic
undertheconditionsofthesestudies. However,therewas
an increase in the incidence of several nonneoplastic
lesions in the brain, heart, bone (sternum), and nose.
Degenerative changes in the cerebellum and cerebrum
occurred in males and females exposed to 100 ppm.
Myocardial degeneration and cardiomyopathy were
observed in the hearts ofmice exposed to 100 ppm. An
increased incidence of sternal dysplasia was seen in
treated animals, particularly in those exposed to 100
ppm.Anincreasedincidenceofolfactoryepithelialnecro-
sisandmetaplasiawithinthenasalcavitywasseeninthe
mice exposed to 100 ppm, particularly males.
Genetic Toxicology: Methyl bromide was positive for
induction of gene mutations in Salmonella
typhimurium strainTA100,withandwithoutexogenous
metabolic activation; negativeresultswereobtainedwith
TA98 in this assay. In vivo, methyl bromide induced
sister chromatid exchanges in bone marrow cells and
micronuclei in peripheral erythrocytes of female mice
exposedbyinhalationfor14days. Nosignificantincrease
in either sister chromatid exchanges or micronuclei was
observed in male or female mice exposed to methyl
bromide by inhalation for 4, 8, or 12 weeks.
Conclusions: Under the conditions of these 2-year
inhalation studies, methyl bromide caused degenerative
changes in the cerebellum and cerebrum, myocardial
degenerationandcardiomyopathy, sternaldysplasia,and
olfactoryepithelial necrosis andmetaplasia. Toxic effects
persistedalthoughexposuretomethylbromideinthe100
ppm group terminated after 20 weeks. There was no
evidence ofcarcinogenic activity ofmethyl bromide in
male or female B6C3F1 mice exposed to 10, 33, or 100
ppm.
Synonym: Bromomethane
Report Date: March 1992
TR-386 Toxicology and Carcinogenesis
Studies ofTetranitromethane (CAS No.
509-14-8) in F344/N Rats and B6C3F1 Mice
(InhalationStudies)
Tetranitromethane is a volatile contaminant formed
during the manufacture ofTNT and has been used as a
rocket fuel and biochemical reagent. Toxicology and car-
cinogenesis studies were conducted in F344/N rats and
B6C3F1 mice of each sex by whole body exposure to
tetranitromethane vapor (greater than 99% pure), 6
hours per day, 5 daysperweekfor14 days, 13weeks, or2
years. Additional groups of male mice were exposed to
tetranitromethane for evaluation at 1 year. Genetic tox-
icology studies were performed in Salmonella
typhimurium and Chinese hamster ovary (CHO) cells.
Fourteen-Day Studies: Exposure concentrations
rangedfrom2to25ppmforratsandfrom2to50ppmfor
mice. All rats exposed to 25 ppm and all mice exposed at
the top concentration of 50 ppm died by day 2; reduced
survivalwas seen in mice exposed to 25 ppm and in rats
exposedto10ppm. Pulmonaryedemainrats andinflam-
mation ofthe lungin micewere seen in those animals in
the 25- and 50-ppm exposure groups examined micro-
scopically.
Thirteen-Week Studies: Exposure concentrations
ranged from 0.2 to 10 ppm for rats and mice. No
exposure-related deaths occurredinrats. Thefinalmean
body weight of rats exposed to 10 ppm was 16% lower
than thatofcontrols formales and 6% lowerforfemales.
Exposure-related histologic effects included squamous
metaplasia of the respiratory epithelium of the nasal
mucosa and chronic inflammation ofthe lung.
No deaths ofmice could be clearlyrelated to exposure
to tetranitromethane. The final mean body weights of
mice exposed to 5 or 10 ppmwere 5% or 12% lower than
that of controls for males and 9% or 12% lower for
females. Exposure-related histologic effects in mice
included inflammation and squamous metaplasia of the
respiratory epithelium of the nasal mucosa and hyper-
plasia ofthe bronchiolar epithelium.
Based on the incidences and severity oflesions in the
respiratory at the higher concentrations used in the 13-
week studies, exposure concentrations chosen for the
2-year studies were 0, 2, and 5ppmfor groups of50 rats
ofeach sexand 0, 0.5, and 2 ppmforgroups of50mice of
each sex. Additional groups of 6 or 10 male mice were
exposed at concentrations of 0, 0.5, or 2 ppm for 1 year.
Body Weights and Survival in the Two-Year Studies:
Meanbodyweights ofmale and female rats exposed to 5
ppm were approximately 5%-15% lower than those of
controls afterweek 70. Survival ofrats at104weekswas
asfollows: male: control, 18/50; 2ppm,17/50; 5ppm,4/50;
female: 25/50; 34/50; 15/50; survival of rats at the top
concentration was reduced due to neoplasia.
Mean body weights ofexposed mice were variable and
ranged asmuch as 10% belowthose ofcontrols duringthe
secondyearofthestudies.Survivalofexposedmalemiceat
104weekswassignificantlylowerthanthatofcontrolsdue
to neoplasia (control, 37/50; 0.5 ppm, 26/50; 2 ppm, 15/50).
Survival of female mice was not significantly affected by
exposure to tetranitromethane (31150; 28/50; 24/50).
Neoplastic and Nonneoplastic Effects inthe Two-Year
Studies: Effects ofexposure to tetranitromethane were
limitedtotherespiratorytract.Hyperplasiaofthealveo-
larandbronchiolarepitheliumwasobserved atincreased
incidences in exposed rats. The incidence of alveolar/
bronchiolar adenomas and carcinomas were markedly
increased in exposed male and female rats, with car-
cinomas (many of which metastasized to other sites)
occurringinnearlyallratsexposed tothetopconcentra-
tion of 5 ppm (adenomas or carcinomas-male: control,
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1/50; 2 ppm, 33/50; 5 ppm, 46/50; female: 0/50; 22/50;
50/50). Many of the rats exposed to 5 ppm also had
squamous cell carcinomas of the lung (male: 0/50; 1/50;
19/50; female: 0/50; 1/50; 1/50).
Hyperplasia oftherespiratoryepithelium and chronic
inflammation of the nasal mucosa were observed at
increased incidences in exposed male and female rats.
Squamous metaplasia ofthe respiratory epithelium was
increased in exposed male rats. No neoplasms of the
nasal passage were seen.
In exposed mice, hyperplasia ofthe alveolar and bron-
chiolar epitheliumwas observed atincreased incidences.
Alveolar/bronchiolar neoplasms, primarily carcinomas
(many of which metastasized to other sites), were
increased in exposed male and female mice (male: con-
trol, 12/50; 0.5 ppm, 27/50; 2 ppm, 47/50; female: 4/49;
24/50; 49/50).
Chronic inflammation ofthe nasal mucosa and hyper-
plasia and squamous metaplasia of the respiratory epi-
thelium of the nasal cavity occurred at increased
incidences in female mice exposed to 2 ppm. No primary
neoplasms ofthe nasal passage were observed in mice.
OncogeneAnalysis: DNAfrom14/19ratand4/4mouse
lung neoplasms caused morphologic transformation
after transfection into cultured NIH/3T3 fibroblasts.
The transforming gene from both rat and mouse lung
neoplasms was determined by Southern blot analysis to
be an activated K-ras oncogene.
GeneticToxicology: Tetranitromethanewasmutagenic
in S. typhimurium strains TA98, TA100, and TA1535
with andwithoutexogenous metabolic activation (S9); no
mutagenic activitywas observedinTA1537with orwith-
outS9. Chromosomal aberrationswere observed inCHO
cells treated invitrowithtetranitromethane inthepres-
ence ofS9. Sister chromatid exchanges were induced in
CHO cells in the absence ofS9.
Conclusions: Undertheconditionsofthese2-yearinhala-
tion studies, there was clear evidence of carcinogenic
activity oftetranitromethane formale andfemale F344/N
ratsandmaleandfemaleB6C3F1mice,basedonincreased
incidences of alveolar/bronchiolar neoplasms in both spe-
cies and squamous cell carcinomas ofthe lung in rats.
Chronic inflammation ofthe nasal mucosawas related
to exposureinrats andfemalemice, andhyperplasiaand
squamous metaplasia ofthe respiratory epithelium were
increased in exposed male rate.
Synonym: TNM
Report Date: March 1990
TR-387 Toxicology and Carcinogenesis
Studies ofdl-Amphetamine Sulfate (CAS
No. 60-13-9) in F344/N Rats and B6C3F
Mice (FeedStudies)
dl-Amphetamine sulfate is used for the treatment of
narcolepsy in adults and behavioral syndromes in chil-
dren. Toxicology and carcinogenesis studies were con-
ducted by administering dl-amphetamine sulfate (USP
grade)infeedtogroupsofF344/NratsandB6C3F1 mice
of each sex for 14 days, 13 weeks, or 2 years. Genetic
toxicology studies were conducted in Salmonella
typhimurium and Chinese hamster ovary (CHO) cells.
14-Day Studies: The chemical was administered at
dietary concentrations of0, 47, 94, 188, 375, or 750 ppm
forrats and 0,125, 250, 500,1,000, or2,000ppmformice.
Decreased body weight gain was seen at the higher
concentrations, but no chemical-related deaths or toxic
lesions were observed.
13-Week Studies: The chemical was administered at
dietary concentrations of0, 47, 94, 188, 375, or 750 ppm
forrats and 0,125, 250, 500,1,000, or2,000ppmformice.
None ofthe rats died, but6/10male mice and 7/10 female
mice that received 2,000 ppm, 3/10 male mice that
received 1,000ppm, and 8/10male mice thatreceived 500
ppm died before the end ofthe studies. Decreased body
weight gain and hyperactivity were seen in dosed rats
andmice.Finalbodyweightsofratsreceiving188ppmor
more were 62% to 89% those ofcontrols, and final body
weights ofmice receiving 250 ppm ormore were 70% to
86% those of controls. There were no lesions that were
considered to be a primary effect ofthe chemical.
Based on decreased body weight gain and hyperac-
tivity in the 13-week studies, 2-year studies were con-
ducted by feeding diets containing 0, 20 or 100 ppm dl-
amphetamine sulfate to groups of 50 rats or 50 mice of
each sex.
BodyWeights and Survival in the 2-Year Studies: No
significant differences in survival were observed
between any groups ofrats or mice (male rats: control,
30/50; low dose, 31/50; high dose, 33/50; female rats:
33/50; 42/50;37/50;malemice:48/50; 48/50;49/50; female
mice: 35/50; 36/50; 44/50).
Final body weights of dosed rats and mice were
decreased relative to those of controls. Final body
weightswere 92% and 86%those ofcontrols forlow- and
high-dose male rats, 89% and 70% those ofcontrols for
low- and high-dose female rats, 85% and 72% those of
controls for low- and high-dose male mice, and 81% and
66%thoseofcontrolsforlow-andhigh-dosefemalemice.
Hyperactivity was observed in all dosed groups.
Feed consumption was similar among control and
exposed groups with the exception of high-dose female
rats (84%ofcontrols)andhigh-dosemalemice,forwhich
hyperactivity resulted in scattering of feed and over-
estimation offeed consumption. The average amount of
dl-amphetamine sulfate consumed per day was esti-
mated tobe 1 or5mg/kgforlow- and high-dose rats,4 or
30mg/kgforlow-orhigh-dosemalemice,and3 or19mg/
kg for low- or high-dose female mice.
Nonneoplastic and Neoplastic Effects in the 2-Year
Studies: Myelofibrosis, cataracts, and retinal atrophy in
femalerats, andovarianatrophyinfemalemiceoccurred
in a larger proportion of high-dose animals than in
controls.
Dose-related increases in neoplasms did not occur in
rats ormice receiving amphetamine. The administration
of dl-amphetamine sulfate was associated with
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decreases in the incidence oftotal neoplasms and in the
incidences of certain site-specific neoplasms, including
pheochromocytomas of the adrenal gland in male rats
(23/49, 15/44, 7/50), fibroadenomas of the mammary
gland in female rats (21150, 11150, 2/50), adenomas ofthe
anterior pituitary gland in male and female rats and
female mice (male rats: 15/49, 15/48, 9/49; female rats:
31/50, 24/48, 19/50; female mice: 12/49, 6/49, 1146),
endometrial stromal polyps ofthe uterus offemale rats
(10/50,6/50,3/50), adenomas orcarcinomas (combined) of
theliverinmaleandfemalemice(male:14/50,12/50,2/50;
female:5/50,1/50,1147), adenomas oftheharderian gland
in male and female mice (male: 4/50, 2/50, 0/50; female:
5/50,2/50,0/47), andadenomas orcarcinomas (combined)
ofthelunginmaleandfemalemice(male:8/50,3/50,4/50;
female: 8/50, 6/50, 1147).
Genetic Toxicology: dl-Amphetamine sulfate was
tested for induction of gene mutations in Salmrnnella
typhimurium strainsTA98,TA100,TA1535, andTA1537
withandwithoutexogenousmetabolicactivation(S9);the
only response observed was in strain TA98 in the pres-
ence ofS9, and it wasjudged to be equivocal. No induc-
tion of sister chromatid exchanges or chromosomal
aberrations occurred in Chinese hamster ovary cells
treated with amphetamine sulfate in either the presence
or the absence ofS9.
Conclusions: Undertheconditions ofthese2-yearfeed
studies, therewasno evidence ofcarcinogenic activity
of dl-amphetamine sulfate for male or female F344/N
rats or male or female B6C3F1 mice fed 20 or 100 ppm.
The administration ofdl-amphetamine sulfatewas asso-
ciated with decreased body weight. There were
decreased incidences of total neoplasms in dosed rats
andmice, ofadrenal pheochromocytomas inmalerats, of
mammary gland fibroadenomas and uterine polyps in
female rats, of pituitary gland adenomas in male and
female rats and female mice, and of harderian gland
adenomas, liver neoplasms, and lung neoplasms in male
and female mice.
Synonyms: (± )-amphetamine sulfate; (± )-2-amino-1-
phenylpropane sulfate; amphetamine sulfate; deox-
ynorephedrine; desoxynorephedrine; (± )-a-
methylphenethylamine sulfate; (±)-phenisopropylamine
sulfate; ,B-phenyl isopropylamine
Trade Names: Acedron; Adipan; Adiparthrol; Aketdrin;
Aktedrin; Alentol; Amfetamina; Amphaetamin;
Amphamed; Amphatamin; Amphate; Amphedrine;
Amphetaminum; Amphezamin; Amphoids-S; Anara;
Anfetamina; Anorexine; Astedin; Benzafinyl; Ben-
zamphetamine; Benzebar; Benzedrina; Benzedryna;
Benzolone; Benzpropamine; Betafen; Betaphen;
Bluzedrin; Centramina; Didrex; Dietamine; Durophet;
Elastonin; Elastonon; Euphobine; Euphodine; Eupho-
dyn; Fabedrine; Fenamin; Fenara; Fenedrin;
Fenopromin; Halloo-Wach; Ibiozedrine; Isamin; Iso-
amin; Isoamyne; Isomyn; Leodrin; Levonor;
Linampheta; Mecodrin; Mimetina; Monetamine; Noclon;
Norephedrane; Norphedrane; Novydrine; Oktedrin;
Oraldrina; Ortenal; Orthedrin; Percomon; Phar-
mamedrine; Pharmedrine; Phenamine; Phenedrine;
Phenopromin; Phenpromin; Profamina; Profetamine;
Propenyl;Propisamine; Psychedrine; Psychedryna; Psy-
chedrinum; Psychoton; Racephen; Rhinalator; Sedolin;
Simpamina; Simpamine; Simpatedrin; Stimulan; Sym-
pametin; Sympamine; Sympatedrine; Synsatedrine;
Theptine;Vapedrine; Weckamine; Zedrine
Slang for Amphetamines: bennies; benzies; cartwheels;
hearts; peaches; roses
TR-388 Toxicology and Carcinogenesis
Studies ofEthylene Thiourea (CAS:
96-45-7) in F344 Rats and B6C3F1 Mice
(Feed Studies)
Ethylene thiourea is a white crystalline solid used
extensivelyintherubberindustryasanacceleratorinthe
vulcanizationofelastomers. Itisalsoatracecontaminant
andmetabolicdegradationproductofawidelyused class
of ethylene bisdithiocarbamate fungicides. Ethylene
thiourea is known to produce thyroid neoplasms in rats
and liver neoplasms in mice following long-term admin-
istration; thus, it was chosen by the National Toxicology
Program in an investigation of the potential value of
perinatal exposures in assessing chemical carcino-
genicity.
Chronic toxicity and carcinogenicity studies of eth-
ylenethiourea, 99% pure,wereconductedinF344/N rats
andB6C3F1 miceofeach sex.The studiesweredesigned
to determine 1) the effects of ethylene thiourea in rats
andmicereceivingadultexposureonly(atypicalcarcino-
genicity study), 2) the toxic and carcinogenic effects of
ethylene thiourea on rats and mice receiving perinatal
exposure only (dietary exposure ofdams prior to breed-
ing and throughout gestation and lactation), and 3) the
effects of combined perinatal and adult exposure to
ethylene thiourea.
Studies in F344/N Rats: In a preliminary study to
determine the perinatal dietary concentrations for the
2-year studies, female F344/N rats were fed 0, 8, 25, 83,
or 250 ppm ethylene thiourea in the feed beginning 2
weeks prior to breeding and continuing throughout ges-
tation and lactation, and the pupswere fed atthese same
concentrations up to 9 weeks postweaning. Based on
decreased survival ofrat pups between postnatal days 0
to 4andreduction inbodyweightgainsinmaleweanling
ratsreceiving250ppm, dietaryconcentrations of0,9,30,
and 90ppmwere selectedfortheperinatal(FO) exposure
levels in the 2-year studies. Groups of 10 male and 10
femalerats,8to 9weeks ofage,werefeddietscontaining
0, 60, 125, 250, 500, or 750 ppm ethylene thiourea for 13
weeks to determine the adult dietary concentrations.
Because of reduced weight gains and decreased feed
consumption in rats receiving 500 or 750 ppm ethylene
thiourea, dietaryconcentrations of0,25,83, and250ppm
were selected for the adult (F1) exposure during the
2-year studies.
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Inthe2-year studies, perinatal and adult exposures to
ethylene thiourea were applied separately and together
togroupsofmaleorfemalerats asshowninthefollowing
table.
The principal toxic effects ofethylene thiourea involved
the thyroid gland. Serum levels of thyroxine (T4) and/or
triiodothyronine (T3) were significantly decreased in rats
receiving adult concentrations of83 or 250 ppm, and thy-
rotropin (thyroid-stimulating hormone, TSH) was signifi-
cantly increased at these concentrations. In male and
femaleratsreceivingadult-onlyexposureof83 or250ppm,
the incidences offollicular cell hyperplasia orfollicular cell
adenoma ofthe thyroid gland were significantlyincreased
relative to the controls. The incidences of follicular cell
carcinoma were significantly increased in the 250 ppm
groups, andcarcinomas occurredmorefrequentlyinmales
than in females.
Perinatal-only exposure to 90ppmhad noeffectonthe
incidence ofthyroid neoplasms inthese studies, although
there was a marginal increase in follicular cell hyper-
plasiarelativetothecontrols. However, forgroups ofrats
receivingcombinedperinatal andadultexposure(Fo:F1),
males and females receiving concentrations of 90:250
ppm ethylene thiourea had significantly increased inci-
dences of thyroid follicular cell neoplasms relative to
thosereceivingadult-onlyexposure to250ppm. Further,
groupsofmale ratsreceiving90:83ppmshowed asignifi-
cantly increased incidence of follicular cell hyperplasia.
Final mean bodyweights ofmales and survival ofmales
and females receiving combined perinatal (90 ppm) and
adult (250 ppm) exposure were lower than those receiv-
ing adult-only exposure of250 ppm.
Thus, in rats, combined perinatal and adult exposure
slightlyenhanced thetoxicityandproliferative effects on
the thyroid gland observed with adult-only exposure to
ethylene thiourea.
Neoplasms of the Zymbal's gland were marginally
increased in rats receiving 90:250 ppm (males - 0:0,150;
90:250, 5/50; females - 0:0, 1150; 90:250, 4/50). Mono-
nuclearcellleukemiaoccurredwith asignificanttrendin
groups ofmale and female rats receiving perinatal expo-
sureof90ppmandincreasingadultconcentrations (90:0,
90:83, and 90:250 ppm), and for female rats without
perinatal exposure (0:0, 0:83, and 0:250 ppm). The inci-
dences of mononuclear cell leukemia in males receiving
90:83 ppm and males and females receiving 90:250 ppm
werestatisticallysignificantrelative totherespective 0:0
ppm groups. Low incidences of renal tubule cell ade-
nomasoccurred inmostdosegroups ofmalerats,butnot
in the highest dose group or the controls.
Studies in B6C3F1 Mice: In a preliminary study to
determine the perinatal dietary concentrations for the
2-year studies, adult female C57BL/6N mice were fed 0,
33, 100, 330, or 1,000 ppm ethylene thiourea in the feed
beginning 2 weeks prior to breeding and continuing
throughout gestation and lactation and up to 9 weeks
postweaning. Because ofreduced survival ofmousepups
atpostnatal day28 andlowerfinalmeanbodyweights in
weanlings receiving perinatal exposure of 1,000 ppm,
dietary concentrations of 0, 33, 110, and 330 ppm were
selected for the perinatal exposure levels in the 2-year
studies. Groups of 10 male and 10 female mice, 8 to 9
weeks of age, were fed diets containing 0, 125, 250, 500,
1,000, or 2,000 ppm ethylene thiourea for 13 weeks to
determine the adult dietary concentrations. Moderately
severe diffuse follicular cell hyperplasia in the thyroid
gland and centrilobular cytomegalyoftheliveroccurred
in mice receiving 2,000 ppm. Because the severity ofthe
thyroid lesion (and degree of hypothyroidism) at this
concentrationwasconsideredpotentiallylifethreatening
in 2-year studies, dietary concentrations of 0, 100, 330,
and 1,000 ppm ethylene thiourea were selected for adult
exposure during the 2-year studies.
Inthe2-yearstudies, perinatal and adultexposures to
ethylene thiourea were applied separately and together
to groups ofmale or female mice as shown in the follow-
ing table.
Theprincipal toxiceffects ofethylenethiourea inmice
occurred in the thyroid gland, liver, and pituitarygland.
SerumlevelsofT3weresignificantlydecreasedingroups
ofmicereceivingadultconcentrations of1,000ppm; TSH
was significantly increased in mice receiving 330 and
1,000 ppm. The incidences of follicular cell hyperplasia
and neoplasia increased principally in males receiving
1,000 ppm and in females receiving 330 or 1,000 ppm.
Follicularcell carcinomasweresignificantlyincreasedin
mice receiving 1,000 ppm. Incidences of centrilobular
hepatocellular cytomegaly (males and females),
hepatocellular adenoma (females), hepatocellular car-
cinoma (males and females), and adenoma or carcinoma
combined (males and females) also were significantly
increased in mice receiving F1 concentrations of 330 or
1,000 ppm. In the pituitary gland, incidences of focal
hyperplasia (males) or adenoma (males and females) of
theparsdistalisweresignificantlyincreasedingroupsof
mice receiving 1,000 ppm ethylene thiourea.
Perinatal exposure to concentrations of 330 ppm had
no effect on the incidences of nonneoplastic lesions or
neoplasms in mice. For groups of mice receiving com-
bined perinatal and adult exposure, females receiving
FoYF1 concentrations of 330:330 ppm had significantly
increased incidences offollicular cell adenomarelative to
those receiving adult-only exposure to 330 ppm. Simi-
larly, male mice receiving FoYF1 concentrations of
330:330 ppm had signiflcantly increased incidences of
follicular cell hyperplasia. Thus, in mice, perinatal expo-
sure slightly enhanced the proliferative effects on the
thyroid gland ofadult exposure. Therewere no effects of
perinatal exposure in mice at sites other than in the
thyroid gland.
Conclusions: 2-Year Adult-Only Exposure:Under the
conditions ofthese 2-year adult-only dietary exposures,
there was clear evidence of carcinogenic activity of
ethylene thiourea in male and female F344/N rats, as
shown by increased incidences of thyroid follicular cell
neoplasms. There was clear evidence ofcarcinogenic
activity ofethylenethioureainmale andfemale B6C3F1
mice as shownbyincreased incidences ofthyroid follicu-
lar cell neoplasms, hepatocellular neoplasms, and ade-
nomas ofthe pars distalis ofthe pituitary gland.
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Nonneoplastic lesions associated with the administra-
tion of ethylene thiourea included follicular cell hyper-
plasia in rats and mice and follicular cell cytoplasmic
vacuolation,centrilobularhepatocellularcytomegaly,and
focal hyperplasia of the pars distalis of the pituitary
gland in mice. Other effects associated with the admin-
istration ofethylene thiourea included decreased serum
levels ofT4 and/or T3 in rats and increased serum levels
ofTSH in rats and mice.
Perinatal-Only Exposure:Perinatal exposure alone
had no effect on the incidences of neoplasms in rats or
mice after 2 years. Animals may have been able to
tolerate higher perinatal exposure concentrations.
Combined Perinatal and 2-YearAdultExposures: Com-
bined perinatal and 2-year adult dietary exposure to eth-
ylene thiourea confirmed the findings ofthe 2-year adult-
only exposures for the incidences of neoplasms in the
thyroid gland ofrats and mice and the liver and pituitary
gland ofmice. Inmale andfemalerats, combinedperinatal
and adult exposure to 90:250 ppm was associated with
marginal increases, relative to the untreated (0:0 ppm)
controls,inZymbal'sglandneoplasmsandmononuclearcell
leukemia, which mayhavebeenrelated to chemical admin-
istration. In rats receiving adult exposure to 250 ppm
ethylenethiourea,perinatalexposureto90ppmwasassoci-
ated with a slightly enhanced incidence of thyroid neo-
plasms compared to adult-only exposure. However,
increasing perinatal exposure from 0 to 90 ppm had no
effect on incidences ofthyroid neoplasms in rats receiving
adult exposure to 83 ppm. Increasing perinatal exposure
from 0 to 330 ppm was associated with a marginally
increased incidence of thyroid neoplasms in female mice
receiving adult exposure to 330 ppm, but there were no
enhancing effects ofperinatal exposure in mice receiving
adult exposure to 1,000 ppm.
Synonyms: 2-Imidazolidinethione; Imidazoline-2-thiol;
2-mercaptoimidazoline; N,N'-ethylenethiourea; 1,3-
ethylenethiourea; 2-imadazoline-2-thiol
Report Date: March 1992
TR-389 Toxicology and Carcinogeneis
Studies ofSodium Azide (CAS: 26628-22-8)
in F344 Rats (Gavage Studies)
Sodium azide is a white crystalline solid used in the
manufacture ofthe explosive lead azide. It is the princi-
palchemicalusedtogeneratenitrogengasin automobile
safetyairbags and airplaneescapechutesandisabroad-
spectrum biocide used in both research and agriculture.
Toxicologyandcarcinogenicitystudieswereconducted
by administering sodium azide (greater than 99% pure)
in distilledwaterbygavagetogroups ofmale andfemale
F344/N rats once daily, 5 days per week for 14 days, 13
weeks, or 2 years. Genetic toxicology studies were con-
ducted in Salmnnella typhimurium and Chinese ham-
ster ovary cells.
14-DayStudies: Ratsreceived 0,5,10,20,40, or80mg/
kgsodiumazide.Allmaleandfemaleratsreceiving40or
80 mg/kg and two offive female rats receiving 20mg/kg
diedduringthefirstweekofthestudies.Clinicalfindings
of toxicity included lethargy and inactivity. No grossly
observable lesions were present in any of the dose
groups.
13-Week Studies: Rats received 0, 1.25, 2.5, 5, 10, or20
mg/kg sodium azide. Seven of9 males and all 10 females
receiving 20 mg/kg died before the end of the studies.
Finalmeanbodyweightsoftreatedratswerewithin10%
ofthose ofthe controls. Compound-related clinical find-
ings of toxicity in the 20 mg/kg dose groups included
lethargy and labored breathing. Histopathologic lesions
induced by sodium azide were limited to the brain
(necrosis of the cerebrum and thalamus) and lung
(congestion, hemorrhage, and edema), and were ob-
served in rats receiving 20 mg/kg that died during the
studies.
BodyWeights, Feed Consumption, and Survivalinthe
2-Year Studies: Because compound-related deaths were
observedinthegroupsreceiving20mg/kginthe13-week
studies,lowerdoselevelswereusedinthe2-yearstudies.
Two-year studies were conducted by administering 0, 5,
or 10 mg/kg sodium azide to groups of 60 male and 60
female rats. Dose-related depression in mean body
weightwas observed throughoutthe studyperiod. Mean
feed consumption values in low- and high-dose groups
were lower than control values. Survival of high-dose
rats of each sex was significantly (P<0.05) lower than
controls (males-control, 24/60; low-dose, 27/60; high-
dose, 9/60; females-37/60; 43/60; 21159). The reduced
survival was attributed to brain necrosis and car-
diovascular collapse induced by sodium azide.
Neoplastic and Nonneoplastic Effects in the 2-Year
Studies: There were no compound-related increases in
incidences ofneoplasms in rats. Significantly decreased
incidences were observed for certain neoplasms, includ-
ing mononuclear cell leukemia in male rats (control,
33/60; low-dose, 28/60; high-dose, 14/60), adrenal gland
pheochromocytoma in male rats (26/55; 16/56; 6/54),
mammary gland fibroadenoma in female rats (20/60;
11160;8/59), andpituitarygland neoplasmsinfemale rats
(37/60; 28/60; 17/59). These decreases reflected to some
extent, but could notbe attributed solely to, the reduced
survivalofthehigh-dosegroups. Compound-relatednon-
neoplastic brain lesions (necrosis of the cerebrum and
thalamus) were observed at significantly (P<0.001)
increased incidences in high-dose male and female rats.
The increased incidence oflung congestion observed in
this dose group was considered due to cardiovascular
collapse secondary to brain necrosis.
Genetic Toxicology: Sodium azide was mutagenic in
Salmonella typhimurium strains TA100 and TA1535,
with or without exogenous metabolic activation (S9); it
was not mutagenic in strain TA1537 or TA98. In
cytogenetic tests with Chinese hamster ovary cells,
sodiumazideinducedsisterchromatidexchanges,butnot
chromosomal aberrations, in the presence and the
absence ofS9.
266ABSTRACTSFROMLONG-TERM CANCER STUDIES, 1976-1992
Conclusions: Under the conditions of these 2-year
gavage studies, there was no evidence ofcarcinogenic
activity of sodium azide in male or female F344/N rats
administered 5 or 10 mg/kg.
Sodiumazideinducednecrosisinthecerebrumandthe
thalamus ofthe brain in both male and female rats.
Synonyms: Azide, Azium, Smite
Report Date: September 1991
TR-390 Toxicology and Carcinogenesis
Studies of3,3'-Dimethylbenzidine
Dihydrochloride (CAS No. 612-82-8) in
F344/N Rats (DrinkingWater Studies)
3,3'-Dimethylbenzidine dihydrochloride is one of five
chemicals being evaluated in 2-year carcinogenicity and
toxicity studies as part of the NTP's Benzidine Dye
Initiative. This Initiativewasdesigned toevaluaterepre-
sentative benzidine congeners, benzidine congener-
derived dyes, and benzidine-derived dyes. 3,3'-
Dimethylbenzidine dihydrochloride was nominated for
study because ofthe potential for human exposure dur-
ing production ofbisazobiphenyl dyes and because ben-
zidine, astructurallyrelated chemical, isaknownhuman
carcinogen.
Toxicology and carcinogenesis studieswere conducted
byadministering3,3'-dimethylbenzidinedihydrochloride
(approximately 99%pure) in drinkingwaterto groups of
F344/N rats ofeach sex for 14 days, 13 weeks, or 9 or 14
months. The 14-month exposures were planned as 24-
month exposures but were terminated early because of
rapidly declining animal survival, due primarily to neo-
plasia. These studies were performed only in rats
because similar studies were beingperformed in mice at
the National Center for Toxicological Research (NCTR).
Hematologic and serum chemical analyses and thyroid
hormone determinations were conducted in conjunction
withthe13-weekand9-month studies. Genetictoxicology
studies were conducted in Salrnanella typhimurium,
Chinese hamster ovary (CHO) cells, and Drosophila
mrelanogaster.
14-Day Studies: Rats were exposed to 3,3'-dimethyl-
benzidine dihydrochloride in drinking water at doses
ranging from 600 to 7,500 ppm. All five males and one
female in the 7,500 ppm group and 1/5males in the 5,000
ppm group died. Final mean body weights were
decreased inmalesreceiving1,250ppmormoreandinall
exposedfemales, andfinalmeanbodyweightsofanimals
receiving 2,500 ppm or more were lower than initial
weights. Water consumption decreased with increasing
chemical concentration. Compound-related effects
observed in rats receiving 5,000 ppm or more included
minimal to slight hepatocellular necrosis, accumulation
of brown pigment (presumably bile) in individual
hepatocytes, increased severity of nephropathy relative
to controls, and severe lymphocytic atrophy of the
thymus. Treatedanimals alsoshowedanincreased sever-
ity of atrophy of the bone marrow relative to controls,
varying degrees oflymphocytic atrophyofthe mandibu-
lar and mesenteric lymph nodes and spleen, increased
vacuolization and necrosis ofcells ofthe adrenal cortex,
focal acinar cell degeneration in the pancreas, and, in
males,increasedimmature spermformsinthetestis and
epididymis.
13-Week Studies: 3,3'-Dimethylbenzidine dihydro-
chloride was administered in drinkingwater at doses of
300, 500, 1,000, 2,000, and 4,000 ppm. All rats receiving
4,000ppmand4/10malesand1/10femalesreceiving2,000
ppm died before the end of the studies. Depressions in
final mean bodyweight relative to controls ranged from
12% to 48% for males and from 9% to 42% for females.
Water consumption decreased with increasing dose. At
compound concentrations of 300 to 2,000 ppm, mean
water consumption was 29% to 83% of control values.
Compound-related effects included an increase in the
severityofnephropathyrelativeto controls; hepatocellu-
lar necrosis and accumulation of brown pigment (pre-
sumably bile) in sinusoidal lining cells; lymphocytic
atrophyofthe thymus, spleen, and mandibular and mes-
enteric lymph nodes; atrophy ofthe bone marrow in the
higher-dose groups; degeneration of pancreatic acinar
cells; and, in males, immature sperm forms in the testis
and epididymis.
Decreases in serum triiodothyronine (T3) values were
observed in exposed females, and decreases in mean
thyroxin (T4) concentrations in exposed males and
females; nosignificantchangeswereobservedinthyroid
stimulating hormone (TSH) levels in exposed rats.
Based on the decreased survival, reductions in water
consumption and body weight gain, and chemical-
induced hepatocellular and renal lesions observed in the
13-week studies, the doses selected for the 9- and 14-
month drinking water studies of3,3'-dimethylbenzidine
dihydrochloride were0,30,70,and150ppm.Seventyrats
ofeach sexwere used in the control group, 45 in the low-
dose group, 75 inthemid-dose group, and 70 in the high-
dose group.
9-Month Studies: Ten rats of each sex in the control
and 150ppm dose groups were evaluated after 9 months.
Chemical-related effects observed in exposed animals
included alveolar/bronchiolar carcinoma in one male,
basal cell carcinoma ofthe skin in one male, a squamous
cell carcinoma ofthe oral cavity in one female, preputial
glandcarcinomaintwomales,clitoralglandcarcinomain
three females, adenocarcinoma ofthe small intestine in
two males, Zymbal's gland carcinoma in two males and
three females, hepatocellular carcinoma in two males,
and adenomatous polyps of the large intestine in three
males. Other effects seen in dosed rats included focal
cellular alteration in the liver, lymphoid atrophy in the
spleen, andincreased severityofnephropathyrelative to
controls.Anincreasein serumT3valueswasobservedin
exposedmales,andadecreaseinmeanT4concentrations
in exposed males and females. TSH concentrations were
increased in exposed male and female rats.
Body Weights and Survival in the 14-Month Studies:
The average amount of 3,3'-dimethylbenzidine
267NTP/NIEHS
dihydrochloride consumed per day was approximately
1.8, 4.0, or 11.2, mg/kg for low-, mid-, or high-dose male
ratsand3.0,6.9, or12.9mg/kgforlow-,mid-, orhigh-dose
female rats. The mean body weight of high-dose males
wasabout85%ofthecontrolvaluebyweek28.Bytheend
ofthe study, mean bodyweights oflow-, mid-, and high-
dosemaleswere97%, 92%,and70%ofthecontrolvalues,
respectively. Mean body weights ofhigh- and mid-dose
females were about 85% ofthe controlvalues atweek 32
and week 44, respectively. At the end ofthe study, mean
body weights ofexposed females were about 94%, 81%,
and 74% of the control values for low-, mid-, and high-
dosegroups,respectively. Becauseofextensiveneoplasia,
many exposed males and females were dying or were
sacrificed moribund in the first year, and all high-dose
males died by week 55. The studies were terminated at
weeks 60 to 61, at which time the group survivals were
male: control,60/60,lowdose,41/45;middose,50/75;high
dose, 0/60; female: 59/60; 39/45; 32/75; 10/60.
Nonneoplastic Effects in the 14-Month Studies:
Increases in nonneoplastic lesions in dosed ratsincluded
cystic degeneration and foci of cellular alteration in the
liver; exacerbation ofnephropathy; and focal or multifo-
cal hyperplasia of the Zymbal's gland, preputial and
clitoral glands, and alveolar epithelium.
Neoplastic Effects in the 14-Month Studies: Neo-
plasmswereobservedinexposedratsatmanysites: skin,
Zymbal's gland, preputial and clitoral glands, liver, oral
cavity, small and large intestine, mammary gland, lung,
brain, and mesothelium. The incidence ofthese neoplas-
tic effects in male and female rats is summarized in the
tableattheendofthissection(seepage8oftheTechnical
Report).
Genetic Toxicology: 3,3'-Dimethylbenzidine dihydro-
chloride was mutagenic in Salmonella typhimurium
strain TA98 with exogenous metabolic activation; it was
not mutagenic in strains TA100, TA1535, or TA97
with or without activation. 3,3'-Dimethylbenzidine
dihydrochloride induced sister-chromatid exchanges
(CHO) and chromosomal aberrations in CHO cells inthe
absence ofexogenous metabolic activation; these effects
were not evident in test with S9 activation. Sex-linked
recessive lethal mutations were induced in germ cells of
adultmaleDrosophila melanogaster administered 3,3'-
dimethylbenzidine dihydrochloride in feed or by injec-
tion. No reciprocal translocations occurred in D.
melanogaster germ cells following exposure to 3,3'-
dimethylbenzidine dihydrochloride.
Conclusions: Under the conditions of these 14-month
drinkingwater studies, therewasclearevidence ofcarci-
nogenicactivity of3,3'-dimethylbenzidinedihydrochloride
formaleF344/Nrats, asindicatedbybenignandmalignant
neoplasms of the skin, Zymbal's gland, preputial gland,
liver, oral cavity, small andlargeintestine, lung, andmeso-
thelium. Increased incidences of neoplasms of the brain
may have been related to chemical administration. There
was clear evidence ofcarcinogenic activity for female
F344/N rats, as indicated by benign and malignant neo-
plasmsoftheskin,Zymbal'sgland,clitoralgland,liver,oral
cavity, small and large intestine, mammary gland, and
lung. Increased incidences of neoplasms ofthe brain and
mononuclearcellleukemiamayhavebeenrelatedtochemi-
cal administration.
Synonyms: o-tolidine dihydrochloride; 3,3'-dimethylbi-
phenyl-4,4'-diamine dihydrochloride; 3,3'-dimethylbi-
phenyl-4,4'-biphenyldiamine dihydrochloride; 4,4'-
diamino-3,3'-dimethylbiphenyl dihydrochloride
Report Date: June 1991
TR-391 Toxicology and Carcinogenesis
Studies oflfis(2-chloroethyl) Phosphate
(CAS No. 115-96-8) in F344/N Rats and
B6C3F1 Mice (Gavage Studies)
Tris(2-chloroethyl) phosphate (TRCP), a flame-
retardant plasticizer used in plastics, polymeric foams,
and synthetic fibers, was studied as part ofthe National
Toxicology Program's class study oftrisalkyl phosphate
flame retardants. Toxicology and carcinogenesis studies
were conducted by administering TRCP (approximately
98%pure) in corn oilbygavage to groups ofF344/N rats
and B6C3F1 mice ofeach sex for 16 days, 16 weeks, or 2
years. Genetic toxicology studies wereperformed in Sal-
monella typhimurium and Chinese hamster ovary
(CHO) cells.
16-Day Studies: There were no chemical-related
deaths, differences in final mean body weight, or histo-
pathological lesions in rats receiving 22 to 350 mg/kg
TRCP or in mice receiving 44 to 700 mg/kgTRCP for 12
doses over 16 days. Serum cholinesterase activity in
female rats receiving 175 or 350 mg/kg TRCP was
reduced slightly (80% of control levels), but enzyme
activityindosedmaleratsandinmicewassimilartothat
in controls.
16-WeekStudies: Ratsreceived22to350mg/kgTRCP
for 16 weeks (female) or 18 weeks (male). Several male
andfemalerats inthe175 or350mg/kgdose groups died
from chemical toxicity. Final mean body weights of
female rats receiving 350 mg/kgwere 20% greater than
thoseofcontrols; finalmeanbodyweights oftheremain-
inggroupsofdosedfemaleratsanddosedmaleratswere
similar. Chemical-related neuronal necrosis occurred in
the hippocampus and thalamus offemale rats and, to a
lesserextent, ofmalerats. Serumcholinesterase activity
wasreducedinfemalesreceiving175or350mg/kgTRCP.
There were no chemical-related deaths, differences in
final mean bodyweight, or differences in cholinesterase
activity in mice receiving 44 to 700 mg/kg TRCP for 16
weeks. Tubule epithelial cells with enlarged nuclei
(cytomegaly and karyomegaly) were observed in the
kidneys ofhigh-dose (700 mg/kg) male and female mice.
2-Year Studies: The 2-year studies in rats were con-
ducted by administering 0, 44, or 88 mg/kg TRCP to
groups of60males andfemales,5daysperweekforupto
104weeks; 9 or10rats ofeach dosegroupwereevaluated
at 66 weeks. The survival ofhigh-dose male and female
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rats was reduced relative to that ofcontrols. Final mean
body weights of surviving rats were similar to those of
controls. Theprincipal chemical-related effects occurred
in the kidney and brain ofdosed rats. Focal hyperplasia
oftherenaltubuleepitheliumandrenaltubuleadenomas
weremarkedlyincreasedinmaleratsreceiving88mg/kg
TRCPand, to alesserextent,infemalerats (renaltubule
hyperplasia, male rats: 0/50; 2/50; 24/50; female rats:
0/50; 3/50; 16/50; renal tubule adenoma, male rats: 1150;
5/50; 24/50; female rats: 0/50; 2/50; 5/50). Renal tubule
carcinomas occurred in one control and one high-dose
male rat. Degenerative lesions consisting ofgliosis, min-
eralization, hemorrhage, and/or hemosiderin accumula-
tion occurred in the cerebrum and brain stem of more
than 50% offemale ratsreceiving44 or88mg/kgTRCP;
similar lesions were seen in only a few dosed males.
Slightly increased incidences ofthyroid gland follicular
cell neoplasms (male rats: 5/50; 14/50; 13/50; female rats:
14/50; 16/50; 20/50) occurred in dosedmales andfemales,
butitisuncertainwhetherthesewererelatedtochemical
administration.
The 2-year studies in mice were conducted by admin-
istering0,175, or350mg/kgTRCPtogroupsof60males
and females, 5 days perweek forup to 104weeks; 8 to 10
mice of each sex per dose group were evaluated at 66
weeks. There were no significant differences in survival
between dosed and control groups ofeither sex, andfinal
mean body weights of mice were similar among all
groups. The principal chemical-related effects occurred
in the kidney, in which nuclear enlargement
(karyomegaly) of tubule epithelial cells was present in
approximately 80% of high-dose mice. In the original
diagnosis, renal tubule adenomas were seen in one con-
trolmale, onehigh-dosemale, and onelow-dosefemale.A
carcinoma was also seen in one high-dose male. In a
subsequent examination ofstep sections ofall the mouse
kidneys, adenomas were found in one low-dose male and
two high-dose males. The incidences of renal tubule
neoplasms in the original and step sections combined
were1V50,1150,and4/50formales. Femalemicereceiving
TRCP demonstrated amarginallyincreasedincidence of
neoplasms (primarily adenomas) ofthe harderian gland
(3/50; 8/50; 7/50); in addition, three harderian gland
neoplasms occurred in high-dose female mice evaluated
after 66 weeks.
Genetic Toxicology: TRCP was not mutagenic in Sal-
monella typhimurium strains TA100, TA1535, TA1537,
or TA98 with or without exogenous metabolic activation
(S9), andittestednegativefortheinductionofchromoso-
mal aberrations in Chinese hamster ovary (CHO) cells.
TRCPproduced anequivocal responseinthepresenceof
S9fortheinduction ofsisterchromatidexchanges (SCE)
in CHO cells.
Conclusions: Under the conditions of these 2-year
gavage studies, there was clear evidence of carcino-
genic activity for male and female F344/N rats receiv-
ingtris(2-chloroethyl) phosphate as shown byincreased
incidences of renal tubule adenomas. Thyroid follicular
cell neoplasms and mononuclear cell leukemia in male
and female rats may have been related to chemical
administration. There was equivocal evidence of car-
cinogenic activity formale B6C3F1 mice as shownbya
marginally increased incidence ofrenal tubule cell neo-
plasms. There was equivocal evidence ofcarcinogenic
activity for female B6C3F1 mice as shown by a mar-
ginallyincreasedincidenceofharderianglandadenomas.
Renal tubule cell hyperplasia in male and female rats
and gliosis, hemorrhage, pigmentation (hemosiderin
accumulation), andmineralization inthebrains offemale
rats were associated with the administration of tris(2-
chloroethyl) phosphate. Karyomegaly of renal tubule
epithelialcellsinmaleandfemalemicewasalsochemical
related.
Synonyms: 2-chloroethanol phosphate (3:1); tris(p-
chloroethyl) phosphate
Trade Names: Fyrol CEF; Disfiamoll TCA; NIAXflame
retardant
Report Date: May 1991
TR-392 lTxicology and Carcinogenesis
Studies ofChlorinated Water (CAS Nos.
7782-50-5 and 7681-52-9) and
Chloraminated Water (CAS No. 10599-90-3)
(Deionized and Charcoal-Filtered) in F344/
N Rats and B6C3F1 Mice (Drinking Water
Studies)
Chlorine and chloramine are used as disinfectants in
water supplies to prevent the spread of waterborne
diseases.TheU.S.EnvironmentalProtectionAgencyand
the U.S. Congress, through the Safe Drinking Water
ActsandAmendments, initiatedstudies todeterminethe
mosteffective wayto disinfectwatersupplies and, atthe
same time, minimize any potential long-term health
effects associated with direct chemical exposure or indi-
rect chemical exposure through the formation of
byproducts. As part ofthis evaluation, 2-year studies of
chlorinated orchloraminated deionized charcoal-filtered
drinking water were conducted in F344/N rats and
B6C3F1 mice to determine the potential toxicity and
carcinogenicity associated with prolonged exposure and
eliminate possible confounding effects of byproducts of
chlorination.
Chlorinated Water Studies: Water containing 0, 70,
140, or 275 ppm chlorine (based on available atomic
chlorine) was provided to groups of 70 F344/N rats or
B6C3F1 mice ofeach sex for up to 2 years. Groups of10
rats or mice ofeach sex were predesignated for evalua-
tion at14 or15weeks and66weeks. Survival at2years of
rats and mice receiving chlorinated waterwas similar to
that of the controls. Mean body weights of dosed male
rats, high-dose femalerats, and dosedmicewere slightly
lower than those of their respective control groups.
Therewas a dose-related decrease inwater consumption
by rats and mice. Water consumption by high-dose rats
duringthesecondyearofthestudieswas21%lowerthan
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controls for males and 23% lower than controls for
females; water consumption by high-dose mice was 31%
lower than controls for males and 26% lower than con-
trols for females.
The incidence of mononuclear cell leukemia in mid-
dose, but not high-dose, female rats was significantly
higherthanthatincontrols (control,8/50;low-dose, 7/50;
mid-dose, 19/51; high-dose, 16/50). The proportion of
female rats that died of leukemia before the end of the
study and the mean time for observation of animals
dyingwith leukemiawere similar among all dose groups
andcontrols.Althoughthemarginalincreaseinleukemia
incidence in the mid- and high-dose female rats sug-
gested a possible association with the administration of
chlorinated water, the incidence of leukemia was not
clearly dose related. There was no indication ofreduced
latency of leukemia, and the incidence of leukemia in
concurrentcontrolswas lessthanthemeanforhistorical
controls; furthermore, therewas no supportingevidence
ofan effect in male rats. Thus, the marginal increase in
leukemiaincidence infemale ratswas considered equivo-
cal evidence of carcinogenic activity. There were no
neoplasms or nonneoplastic lesions in male rats or in
male orfemalemicethatwereclearlyassociatedwiththe
consumption ofchlorinated water.
Chloraminated Water Studies: Water containing 50,
100, or200ppm chloraminewasprovided to groups of70
F344/NratsorB6C3F1 miceofeachsexforupto2years.
The same control groups were used for the chlorinated
waterand chloraminatedwaterstudies. Groups of9or10
rats ormice ofeach sexwere evaluated at 14 or15weeks
and 66 weeks.
Survivalat2yearsofratsandmicereceivingchlorami-
nated water was similar to that of the controls. Mean
body weights of high-dose rats and dosed mice were
lower than those of their respective control groups.
Therewas adose-related decreaseinwaterconsumption
by rats and mice. Water consumption during the second
yearofthestudiesbyhigh-doseratswas34%lowerthan
controls for males and 31% lower than controls for
females; water consumption by high-dose mice was 42%
lower than controls for males and 40% lower than con-
trols for females.
Mononuclear cellleukemiaoccurredwith amarginally
increasedincidenceinthemid-andhigh-dosefemalerats
receiving chloraminated water (control, 8/50; low dose,
11/50; mid dose, 15/50; andhigh dose, 16/50). Asinfemale
ratsreceivingchlorinatedwater,theproportion offemale
ratsthatdiedofleukemiabeforetheendofthestudyand
the mean time for observation of animals dying with
leukemia were similar among all dose groups and con-
trols. The marginal increase in leukemia incidence in
females receiving chloraminated water was considered
equivocal evidence ofcarcinogenic activity for the same
reasonsgivenforfemaleratsreceivingchlorinatedwater.
There were no neoplasms or nonneoplastic lesions in
male rats or in male or female mice that were clearly
associated with the consumption of chloraminated
water.
Conclusions: Undertheconditionsofthese2-yeardrink-
ingwater studies, therewasno evidence ofcarcinogenic
activityofchlorinatedwaterinmaleF344/Nratsreceiving
70, 140, or 275 ppm. There was equivocal evidence of
carcinogenicactivityofchlorinatedwaterinfemaleF344/
Nratsbasedonanincreaseintheincidenceofmononuclear
cell leukemia. There was no evidence of carcinogenic
activity of chlorinated water in male or female B6C3Fj
mice receiving 70,140, or275 ppm.
Under the conditions of these 2-year drinking water
studies,therewasnoevidence ofcarcinogenic activity
ofchloraminatedwaterinmaleF344/Nratsreceiving50,
100, or 200 ppm. There was equivocal evidence ofcar-
cinogenic activity of chloraminated water in female
F344/N rats based on an increase in the incidence of
mononuclear cell leukemia. There was no evidence of
carcinogenicactivity ofchloraminatedwaterinmaleor
female B6C3F1 mice receiving 50, 100, or 200 ppm.
Report Date: March 1992
TR-393 lbxicology and Carcinogenesis
Studies ofSodium Fluoride (CAS No.
7681-49-4) in F344/N Rats and B6C3F1 Mice
(DrinkingWaterStudies)
Sodium fluoride is a white, crystalline, water-soluble
powder used in municipal water fluoridation systems, in
various dental products, and in a variety of industrial
applications. Toxicology and carcinogenesis studieswere
conducted with F344/N rats and B6C3F1 mice of each
sex by incorporating sodium fluoride into the drinking
waterinstudieslasting14days,6months,and2years. In
addition, genetictoxicologystudieswereperformedwith
Salmonella typhimurium, with mouse L5178Y cells,
and with Chinese hamster ovary cells.
14-Day Studies: Rats and mice received sodium fluo-
ride in drinking water at concentrations as high as 800
ppm. (Concentrations are expressed as sodium fluoride;
fluoride ion is 45% ofthe sodium salt byweight.) In the
high-dose groups, 5/5 male and 5/5 female rats and 2/5
male mice died; one female ratwas given 400 ppm in the
drinkingwateralsodiedbeforetheendofthestudies. No
gross lesions were attributed to sodium fluoride admin-
istration.
6-Month Studies: Rats received concentrations of
sodium fluoride in drinking water as high as 300 ppm,
and mice as high as 600 ppm. No rats died during the
studies; however, among the mice, 4/9 high-dose males,
9/11 high-dose females, and 1/8 males in the 300 ppm
group died before the end of the studies. Weight gains
were less than those of controls for rats receiving 300
ppm and mice receiving 200 to 600 ppm.
The teeth ofrats and mice receiving the higher doses
of sodium fluoride were chalky white and chipped or
showedunusualwearpatterns. Mice andmale ratsgiven
thehigherconcentrationshadmicroscopicfocaldegener-
ation ofthe enamel organ. Rats receiving100 or300ppm
sodium fluoride had minimal hyperplasia ofthe gastric
270ABSTRACTSFROMLONG-TERMCANCERSTUDIES, 1976-1992
mucosaofthe stomach, andonehigh-dose ratofeachsex
had an ulcer. Acute nephrosis and/or lesions in the liver
and myocardium were observed in mice that died early,
andminimal alterations inbonegrowth/remodelingwere
observed in the long bones of mice receiving sodium
fluoride at concentrations of50 to 600 ppm.
The sodium fluoride concentrations selected for the
2-year studies in both rats and mice were 0, 25, 100, and
175 ppm in the drinking water. These concentrations
were selectedbased onthe decreasedweightgainofrats
at 300 ppm and of mice at 200 ppm and above, on the
incidence of gastric lesions in rats at 300 ppm in the
6-month studies, and on the absence of significant toxic
effects at sodium fluoride concentrations as high as 100
ppm in an earlier 2-year study.
Body Weights and Survival in the 2-Year Studies:
Mean body weights ofdosed and control groups ofrats
and mice were similar throughout the 2-year studies.
Survival of rats and mice was not affected by sodium
fluoride administration. Survival rates after 2 years
were: male rats-control, 42/80; 25 ppm, 25/51; 100 ppm,
23/50; 175 ppm, 42/80; female rats-59/80; 31150; 34/50;
54/81; male mice-58/79; 39/50; 37/51; 65/80; female
mice-53/80; 38/52; 34/50; 52/80.
Neoplastic and Nonneoplastic Effects in the 2-Year
Studies: Theteethofratsandmicehas adose-dependent
whitish discoloration, and male rats had an increased
incidence of tooth deformities and attrition leading on
occasion to malocclusion. The teeth of male and, to a
lesser degree, female rats had areas of microscopic
dentine dysplasia and degeneration ofameloblasts. Den-
tine dysplasia occurred inboth dosed and control groups
ofmale and female mice; the incidence ofthis lesion was
significantly greater in high-dose than in control male
mice. Osteosclerosis of long bones was increased in
female rats given drinking water containing 175 ppm
sodium fluoride. No other significant nonneoplastic
lesions in rats or mice appeared related to sodium fluo-
ride administration.
Osteosarcomasofbonewereobservedin1/50malerats
inthe100ppmgroup andin3/80maleratsinthe175ppm
group. None were seen in the control or 25 ppm dose
groups. One other175ppmmale rathad an extraskeletal
osteosarcoma arising in the subcutaneous tissue.
Osteosarcomas occurinhistorical controlmalerats atan
incidence of0.5% (range 0-6%). The historical incidence
is not directly comparable with the incidences observed
in this study because examination of bone was more
comprehensive in the sodium fluoride studies than in
previous NTP studies of other chemicals, and the diet
used in previous studies was not controlled for fluoride
content. In the current study, although the pairwise
comparison ofthe incidence in the 175 ppm groupversus
that in the controls was not statistically significant,
osteosarcomas occurred with a statistically significant
dose-response trend, leading to the conclusion that a
weak association may exist between the occurrence of
these neoplasms and the administration ofsodium fluo-
ride. No other neoplastic lesions in rats or mice were
considered possibly related to chemical administration.
Genetic Toxicology: Sodium fluoride was negative for
gene mutation induction in Salmonella typhimurium
strains TA100, TA1535, TA1537, andTA98with andwith-
out S9. In two laboratories, sodium fluoride was tested
for induction of trifluorothymidine resistance in mouse
L5178Y lymphoma cells; results were positive both with
andwithoutS9.Sodiumfluoridewastestedforcytogene-
tic effects in Chinese hamster ovary (CHO) cells in two
laboratories. In the firstlaboratory, the sister chromatid
exchange (SCE) test was negative with and without S9,
and the chromosomal aberration (Abs) testwas positive
in the absence of S9; in the second laboratory, the SCE
testwaspositivewithandwithoutS9,butnoinduction of
Abs was observed. The laboratorythatreported a nega-
tiveresult forAbstested atdosesbelowthatshowntobe
positive at the other laboratory. Similarly, the positive
SCE result was obtained at a higher dose and longer
harvest time than used by the laboratory reporting the
negative SCE response.
Conclusions: Under the conditions of these 2-year
dosed water studies, there was equivocal evidence of
carcinogenic activity ofsodium fluoride in male F344/
N rats, based on the occurrence of a small number of
osteosarcomas indosed animals. "Equivocal evidence"is
a categoryforuncertain findings defined as studies that
are interpreted as showing a marginal increase of neo-
plasms that may be related to chemical administration.
Therewasnoevidenceofcarcinogenicactivity infemale
F344/Nratsreceivingsodiumfluoride atconcentrations of
25,100, or175 ppm (11, 45, or 79 ppm fluoride) in drinking
waterfor2years. Therewasno evidence ofcarcinogenic
activity ofsodiumfluorideinmaleorfemalemicereceiving
sodium fluoride at concentrations of25,100, or175 ppm in
drinkingwater for 2 years.
Dosed rats had lesions typical offluorosis ofthe teeth
and female rats receiving drinkingwater containing 175
ppmsodiumfluoridehadincreased osteosclerosis oflong
bones.
Report Date: December 1990
TR-394 Toxicology and Carcinogenesis
Studies ofAcetaminophen (CAS No.
103-90-2) in F344 Rats and B6C3F1 Mice
(Feed Studies)
ThisTechnical Reportwasnotafinalpublicationatthe
time this "Compendium" was prepared.
TR-395 Toxicology and Carcinogenesis
Studies ofProbenecid (CAS No. 57-66-9) in
F344/N Rats and B6C3F1 (Gavage Studies)
Probenecid is awhite crystalline solid commonlyused
as auricosuric agentinthetreatmentofgout. Becauseof
itsinhibitoryeffects onrenaltubuletransportprocesses,
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probenecid is also used as a therapeutic adjunct to
enhance blood levels ofpenicillin and its action. Toxicol-
ogy and carcinogenicity studies were conducted by
administering probenecid (>99% pure) in corn oil by
gavage to groups of F344/N rats and B6C3F1 mice of
each sex once daily, 5 days per week in 14-day, 13-week,
and 2-year studies. Genetic toxicology studies were con-
ducted in Salmonella typhimurium and Chinese ham-
ster ovary cells.
14-Day Studies: Doses used in the 14-day studies for
both rats and mice were 0, 200, 400, 800,1,600, or 3,200
mg/kg. Ofthe animals receiving3,200mg/kg, allrats, all
female mice, and two of five male mice died during the
studies. No deaths occurred among the other dose
groups. Therewas asignificantreduction inbodyweight
gaininmaleandfemaleratsreceiving1,600mg/kgandin
female rats receiving 800 mg/kg. No gross lesions were
attributed toprobenecid administrationinrats ormiceof
eithersex.
13-Week Studies: Doses used in the 13-week studies
were 0, 50,100, 200,400, or800mg/kgforrats and 0, 100,
200, 400, 800, or 1,600 mg/kg for mice. No rats died
duringthe13-weekstudies. Inmice,5of10malesand3of
10 females receiving 1,600 mg/kg and 1 of 10 males
receiving 800 mg/kg died during the study. Significant
reductions in body weight gain occurred in male rats
administered 800 mg/kg, male mice administered 1,600
mg/kg, andfemalemiceadministered800or1,600mg/kg.
Alldose groups ofmalerats and allgroups offemalerats
receiving 100 mg/kg or more showed significant
increases in absolute and/or relative liver weights com-
pared to control groups. This change was also seen in
mice receiving 200 mg/kg and greater, except female
mice in the 400 mg/kg group. No compound-related
lesions occurred in rats or mice ofeither sex.
Based oncompound-related deaths and suppression of
body weight gains observed at higher doses in the 13-
week studies, doses of 0, 100, and 400 mg/kg were used
forthe2-year studies in rats and mice. These doseswere
administered once daily, 5 days a week for up to 103
weekstogroupsof50males or50females ofeach species.
Body Weight and Survival in the 2-Year Studies: The
mean body weight ofhigh-dose female rats was 10% to
20% lower than that ofcontrols throughout the studies.
Mean body weights for all other dosed rats and for all
dosed mice were similar to those ofcontrols throughout
the 2-year studies.
Survivalofhigh-dosemaleratsandhigh-dose andlow-
dose male mice was significantly lower than that of
controls. Survival rates after 2 years were: male rats-
control,37/50;100mg/kg,34/50;400mg/kg,22/50; female
rats-24/50;35/50;19/50;malemice -38/50;23/50;24/50;
female mice -32/49; 32/49; 32/50.
Neoplasms and Nonneoplastic Lesions in the 2-Year
Studies: Nochemical-relatedhistopathologictoxiceffects
or increased incidence of tumors attributable to pro-
benecid were observed in male or female rats receiving
probenecid by corn oil gavage for up to 2 years. Mam-
mary gland fibroadenomas and combined thyroid C-cell
adenomas or carcinomas exhibited significant negative
trends infemale rats. These decreased tumorrateswere
associated with lower body weights. The incidence of
adrenal medullary pheochromocytomas was signifi-
cantly decreased in high-dose male rats. No compound-
relatedincreaseinnonneoplasticlesionswas observedin
rats ofeither sex.
No compound-related neoplastic effectswereobserved
in male mice. In high-dose female mice, there were
significant increases in the incidences of hepatocellular
adenomas (3/48; 2/49; 14/49), but there was no corres-
ponding increase in carcinomas (2/48; 2/49; 3/49).
Treatment-related increased incidences of ovarian
abscesses in female mice were causally related to Kleb-
siella species infection rather than directly related to
chemical administration.
Genetic Toxicology: Probenecid was not mutagenic in
Salmonella typhimurium strain TA100, TA1535,
TA1537, or TA98with orwithout metabolic activation. In
cytogenetic tests with Chinese hamster ovary cells, pro-
benecid induced sister chromatid exchanges in the
absence, but not in the presence of S9 activation. No
induction ofchromosomal aberrationswas observedwith
or without S9.
Conclusions: Under the conditions of these 2-year
gavage studies, there was no evidence ofcarcinogenic
activity of probenecid for male or female F344/N rats
receiving 100 or 400 mg/kg in corn oil. There was no
evidence of carcinogenic activity of probenecid for
male B6C3F1 mice given 100 or 400mg/kgprobenecid in
corn oil. There was some evidence of carcinogenic
activity ofprobenecid forfemale B6C3F1 micebased on
an increased incidence ofhepatocellular adenomas.
Synonyms: 4-[(Dipropylamino)sulfonyl]benzoic acid;
p-(dipropylsulfamoyl)benzoic acid; p-(dipropylsul-
famyl)benzoic acid
Trade Names: Benacen; Benemid; Benemide; Benn; Pro-
balan; Probecid; Proben; Probenid; Robenecid; Uricocid
Report Date: September 1991
TR-396 Toxicology and Carcinogenesis
Studies ofMonochloroacetic Acid (CAS No.
79-11-8) in F344/N Rats and B6C3F1 Mice
(Gavage Studies)
Monochloroacetic acid, acolorless crystallinematerial,
is used as a postemergence contact herbicide and as an
intermediate in the synthesis of other organic com-
pounds.Toxicologyandcarcinogenicitystudieswere con-
ducted by administering monochloroacetic acid (99%
pure) in deionized water by gavage to groups ofF344/N
rats and B6C3F1 mice ofeach sex once daily, 5 days per
week for16 days, 13weeks, or2 years. Genetic toxicology
studies were conducted in Salmonella typhimurium,
mouse lymphoma L5178Y cells, Chinese hamster ovary
cells, and Drosophila melanogaster.
16-DayStudies: Groupsoffiveratsofeach sexreceived
0, 7.5,15,30,60, or120mgmonochloroacetic acid/kgbody
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weight. Doses administered to mice were 0, 15, 30, 60,
120, or 240 mg/kg to groups offive males and 0, 30, 60,
120, 240, or 480 mg/kg to groups offive females. One of
five male rats given 120 mg/kg died during the studies.
Clear nasal discharge, lacrimation, or both, were
observed in all groups ofmale and female rats receiving
monochloroacetic acid. No compound-related gross
lesions were observed in rats. All male mice given 240
mg/kg and all females given 240 or 480 mg/kg died
during the studies. Hypoactivity, piloerection, ataxia,
and lacrimation were observed in mice given 240 or 480
mg/kg. No compound-related gross lesions were
observed in mice at necropsy.
13-WeekStudies: Groupsof20ratsofeachsexreceived
0,30,60,90,120, or150mg/kgmonochloroacetic acid, and
groups of20 mice ofeach sex received doses of0, 25, 50,
100,150, or200mg/kg. Three tofiveanimalsineachdose
group were killed at weeks 4 and 8 for the evaluation of
hematology parameters. Compound-related deaths
occurred in rats in the three highest dose groups (all
males given 120 or150mg/kg, 9/10males given 90mg/kg,
and all females given 90 to 150mg/kg) and in mice given
200 mg/kg (all males and2/10females). Final meanbody
weights of surviving rats and mice receiving mono-
chloroaceticacidweresimilartothoseofcontrols. Inrats,
dose-related increases in blood urea nitrogen, alanine
aminotransferase, and aspartate aminotransferase lev-
els were observed, and relative liver and kidneyweights
were elevated. Therewere no compound-related changes
in the various hematologic or clinical pathology param-
eters in mice. A dose-related increase in the incidence
and severity of cardiomyopathy was observed in male
and female rats receiving monochloroacetic acid, and
hepatocellularcytoplasmicvacuolizationwas observed in
the high-dose mice that died during the studies.
2-YearStudies: Basedonthemortalityandcompound-
related histopathologic lesions observed in the 13-week
studies, doses selected for the 2-year studies of mono-
chloroacetic acidwere 0,15, or30mg/kg, administered to
groups of 70 rats of each sex, and 0, 50, or 100 mg/kg,
administered to groups of 60 mice of each sex. Interim
evaluations were conducted on 10 rats per dose group
after 6 months oftreatment with monochloroacetic acid
and on seven rats per dose group after 15 months of
treatment.
BodyWeightandSurvivalinthe2-YearStudies: Mean
bodyweights oflow- and high-dose female and low-dose
male rats receiving monochloroacetic acid were within
10% ofthoseofcontrolsthroughoutthe studies; however,
afterweek30, the mean bodyweights ofhigh-dose male
rats were 4% to 8% less than those ofcontrols. In mice,
the mean body weights of dosed males were similar to
controls,butthoseoflow-andhigh-dosefemaleswere6%
to 10% less than controlvalues afterweek52. Survival of
high-dose male and dosed female rats and high-dose
male mice was significantly lower than that of controls
(male rats: control, 27/53; low-dose, 21/53; high-dose,
16/53; female rats: 37/53; 19/53; 26/53; male mice: 46/60;
39/60; 21/60; female mice: 42/60; 40/60; 44/60).
Neoplasms and Nonneoplastic Lesions in the 2-Year
Studies: There was no compound-related increase in the
incidence of neoplasms or nonneoplastic lesions in rats
givenmonochloroacetic acid for2years. Theincidence of
uterine stromal polyps in low- and high-dose female rats
was slightly higher than that in controls (2/60; 7/57;
10/60). However, the incidence in the controls was
unusually low, and those in the dosed groups were well
withintherangeforNTPhistorical controls (mean: 21%,
range: 10%-38%). Further, because the only malignant
stromal neoplasm occurred in a control animal, the
polyps were not considered to be related to the admin-
istration of monochloroacetic acid. Similarly, there was
no monochloroacetic acid-related increase in the inci-
dence of neoplasms in male or female mice, and malig-
nant lymphoma occurred with a significant negative
trend in dosed femalemice. Increases in theincidence of
inflammation ofthe mucosaofthe nasal passages, respi-
ratoryepithelialmetaplasiaoftheolfactoryepitheliumof
thenose, andfocal squamouscellhyperplasiaofthefore-
stomach occurred in dosed male and female mice.
Genetic Toxicology: Monochloroacetic acid was not
mutagenic in Salmanella typhimurium strains TA100,
TA1535, TA1537, or TA98, with or without exogenous
metabolic activation (S9). It induced trifluorothymidine
resistance in L5178Y cells in the absence of S9 and
induced sister chromatid exchanges without S9 in Chi-
nese hamster ovary cells. Monochloroacetic acid did not
induce asignificantincrease inchromosomalaberrations
in Chinese hamster ovary cells, with or without S9.
Monochloroacetic acidadministeredinfeedwasnegative
forthe induction ofsex-linked recessive lethal mutations
in germ cells of male Drosophila melanogaster; how-
ever, when it was administered by injection, the results
were equivocal.
Conclusions: Under the conditions of these 2-year
gavage studies, there was no evidence of carcinogenic
activity formonochloroacetic acid inmale orfemale F344/
N rats given 15 or 30 mg/kg. There was no evidence of
carcinogenicactivityformonochloroacetic acidinmaleor
female B6C3F1 mice given 50 or100mg/kg.
Monochloroacetic acid administration was associated
with inflammatory lesions of the nasal mucosa, meta-
plasia of the olfactory epithelium, and squamous cell
hyperplasia ofthe forestomach in male and female mice.
Synonyms: Chloroacetic acid, a-chloroacetic acid, chlo-
roethanoic acid
Report Date: January 1992
TR-397 Toxicology and Carcinogenesis
Studies ofC.I. Direct Blue 15 (CAS No.
2429-74-5) in F344 Rats (Drinking Water
Studies)
ThisTechnicalReportwas notafinalpublication atthe
time this "Compendium" was prepared.
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TR-398 Tobxicology and Carcinogenesis
Studies ofPolybrominated Biphenyl
Mixture (Firemaster FF-1) (CAS No.
67774-32-7) in F344 Rats and B6C3F1 Mice
(Feed Studies)
ThisTechnical Report was not afinalpublication atthe
time this "Compendium" was prepared.
Note: Polybrominated Biphenyl Mixture (Firemaster
FF-1) was previously tested in F344 rats and B6C3Fj
mice administered in feed (See TR-244, reported
1983).
TR-399 Toxicology and Carcinogenesis
Studies ofTitanocene Dichloride (CAS No.
1271-19-8) in F344/N Rats (Gavage Studies)
Titanocene dichloride is an organometallic compound
composed of two cyclopentadienyl rings, titanium, and
chloride. It is used as a cocatalyst in polymerization
reactions. Toxicology and carcinogenesis studies were
conducted by administering titanocene dichloride
(greaterthan98%pure)in cornoilby gavageto groupsof
F344/N rats for 14 days, 13 weeks, and 2 years. Genetic
toxicology studies were conducted in Salmonella
typhimurium and in Chinese hamster ovary cells.
14-Day and 13-Week Studies: In the 14-day studies,
titanocene dichloride was administered at doses of0, 65,
125,250, 500, or1,000mg/kg. All high-dose rats and four
ofthe five male and two ofthe five female rats given 500
mg/kg died during the studies. A dose-related decrease
in bodyweight gain was seen in rats given 125, 250, 500,
and1,000mg/kg. Lesionsrelated to chemicaladministra-
tion included hepatocellular necrosis, tubule necrosis in
the kidney, erosions andulcers ofthe glandular stomach,
and hyperplasia ofthe forestomach epithelium.
The 13-week studies were conducted byadministering
titanocene dichloride atdoses of0,8,16,31,62, or125mg/
kg. Onefemale ratinthe125mg/kgdose group diedfrom
chemical toxicity during the fourth week of the studies.
Bodyweightgain waslowerinratsgiven62 or125mg/kg
than in control groups. Treatment-associated histo-
pathologiclesions were seeninthe stomachs ofhigh-dose
males and all groups of females given titanocene
dichloride. These lesions included hyperplasia and meta-
plasia of the glandular stomach and hyperplasia and
hyperkeratosis ofthe forestomach.
Body Weight and Survival in the 2-Year Studies: The
doses selected forthe2-year studies in rats (0,25, and 50
mg/kg) were based on the potentially life-threatening
nature of the glandular stomach lesions and the
decreasedbodyweightgaincompared to controls seenin
the 62 and 125 mg/kg dose groups in the 13-week
studies.
The final mean body weights of high-dose males and
females were 91% and 89% ofcontrols, respectively. The
2-year survival rates for males in the control, low-, and
high-dose groups were 41160, 30/60, and 24/60; survival
rates for female rats were 37/60, 30/61, and 31/60.
Nonneoplastic and Neoplastic Effects in the 2-Year
Studies: The principal toxic effects associated with the
administration of titanocene dichloride for 2 years
occurredinthestomach.Thelesionsinthestomachwere
seen at the 15-month interim evaluations and were simi-
larto,butlessseverethan,thoseobserved at2years.The
lesions included focal erosions of the glandular mucosa
with an associated inflammatory response, hyperplasia
andmetaplasiaoftheepitheliumofthefundicglands,and
fibrosis of the lamina propria and submucosa. Fore-
somach lesions included focal acanthosis (hyperplasia)
and hyperkeratosis of the stratified squamous epi-
thelium. Squamous cell papillomas of the forestomach
wereseeninfourlow-dosemales, onehigh-dosemale,one
low-dose female, and two high-dose females; none were
observed in controls. A squamous cell carcinoma of the
forestomach occurred in one low-dose male and a
benign basosquamous tumor occurred in one high-dose
male.
Accumulations of macrophages with blue-gray pig-
ment believed to contain titanium were present in many
organs ofdosed ratsincludingthegastrointestinal tract,
liver, lung, and lymph nodes. A dose-related increase in
the incidence of inflammation of the nasal mucosa and
lung also occurred and was attributed to reflux and/or
regurgitationandaspirationofgavagesolutionduetothe
severe stomach lesions.
Genetic Toxicology: Titanocene dichloride was muta-
genic in Salmonella typhimurium strain TA100 in the
absenceofexogenousmetabolicactivation(S9);itwas not
mutagenic in TA100 with S9, nor was it mutagenic in
TA1535, TA1537, or TA98with orwithout S9. Titanocene
dichloride did not induce sister chromatid exchanges or
chromosomal aberrations in Chinese hamster ovary
cells, with or without S9.
Conclusions: Under the conditions of these 2-year
gavage studies, there was equivocal evidence of car-
cinogenic activity of titanocene dichloride in male
F344/N rats based on a marginal increase in the inci-
dence of forestomach squamous cell papillomas,
squamous cell carcinoma, and basosquamous tumor
benign. There was equivocal evidence ofcarcinogenic
activity of titanocene dichloride in female F344/N rats
based on a marginal increase in the incidence of fore-
stomach squamous cell papillomas.
Nonneoplastic lesions associated with the administra-
tion of titanocene dichloride for up to 2 years included
erosions and inflammation ofthe gastric mucosa, hyper-
plasiaandmetaplasiaofthefundicglandswithfibrosisof
the lamina propria in the glandular stomach, and
acanthosis (hyperplasia) and hyperkeratosis ofthe fore-
stomach epithelium.
Synonyms: Titanium ferrocene; biscyclopentadienylti-
tanium dichloride; dichlorodi-Tr-cyclopentadienylti-
tanium;dichlorobis('r5-2,4-cyclopentadien-1-yl)titanium;
dicyclopentadienyltitanium dichloride; dichlorodicyclo-
pentadienyltitanium; dichlorotitanocene; dicyclopentadi-
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enyldichlorotitanium; dichlorobis(Qr-cyclopentadienyl)-
titanium; bis(n5-cyclopentadienyl)titanium dichloride;
dichlorobis(n5-cyclopentadienyl)titanium; dichlorobis-
cyclopentadienyl titanium; dichlorobis(1,3-cyclopenta-
diene)titanium; bis(cyclopentadienyl)dichlorotitanium
Report Date: September 1991
TR-400 Toxicology and Carcinogenesis
Studies of2,3-Dibromo-1-Propanol (CAS
No. 96-13-9) in F344 Rats and B6C3F1 Mice
(Dermal Studies)
ThisTechnical Reportwas notafinalpublication atthe
time this "Compendium" was prepared.
TR-401 Toxicology and Carcinogenesis
Studies of2,4-Dirminophenol
Dihydrochloride (CAS No. 137-09-7) in F344
Rats and B6C3F1 Mice (Gavage Studies
ThisTechnical Reportwasnotafinalpublication atthe
time this "Compendium" was prepared.
TR-402 lTxicology and Carcinogenesis
Studies ofFuran (CAS No. 110-00-9) in
F344 Rats and B6C3F1 Mice (Gavage
Studies)
ThisTechnical Reportwas notafinalpublication atthe
time this "Compendium" was prepared.
TR-403 Toxicology and Carcinogenesis
Studies ofResorcinol (CAS No. 108-46-3) in
F344 Rats and B6C3F1 Mice (Gavage
Studies)
ThisTechnical Reportwasnotafinalpublication atthe
time this "Compendium" was prepared.
TR-404 Toxicology and Carcinogenesis
Studies ofDiphenylhydantoin (Phenytoin)
(CAS No. 57-41-0) in F344 Rats and B6C3F
Mice (Feed Studies)
ThisTechnical Reportwasnotafinalpublication atthe
time this "Compendium" was prepared.
TR-405 Toxicology and Carcinogenesis
Studies ofC.I. Acid Red 114 (CAS No.
6459-94-5) in F344/N Rats (Drinking Water
Studies)
C.I. Acid Red 114 is one offive chemicals being evalu-
ated in 2-year carcinogenicity and toxicity studies as
part ofthe NTP's Benzidine Dye Initiative. This Initia-
tive was designed to evaluate representative benzidine
congeners, benzidine congener-derived dyes, and
benzidine-derived dyes. C.I.Acid Red 114was nominated
for study because of the potential for human exposure
during production of bisazobiphenyl dyes and because
benzidine, a structurally related chemical, is a known
human carcinogen.
Toxicologyand carcinogenesis studieswere conducted
by administering desalted, industrial grade C.I. Acid
Red 114 in drinking water to groups of F344/N rats of
each sexfor13 days, 13weeks, 9 or15months, or2 years.
These studieswereperformed onlyin rats because stud-
ies ofbenzidine congeners werebeingperformed inmice
at the National Center for Toxicological Research
(NCTR). Genetic toxicology studies were conducted in
Salmonella typhimurium, Chinese hamster ovary
cells, andDrosophilamelanogaster.
13-DayStudies: RatswereexposedtoC.I.AcidRed114
in drinkingwater at doses of0, 10,000, 20,000, or 30,000
ppm.Allcontrolanddosedrats survived exceptonemale
rat in the 20,000 ppm dose group. Final mean body
weightsinthethreedosedgroupswere94%,83%,or77%
ofcontrolsformalesand92%,88%, or80%ofcontrolsfor
females. Water consumption declined with increased
dose. Clinicalfindingsincludedred stainedfur, ears, and
tail in all test animals. On gross necropsy, organs and
tissues were also stained red.
13-Week Studies: C.I. Acid Red 114 was administered
indrinkingwateratdosesof0,600, 1,200,2,500, 5,000, or
10,000 ppm. All control and dosed animals survived until
the end ofthe study. Final meanbodyweights inthefive
dosed groups were 97%, 89%, 87%, 87%, or 85% of
controls for males and 97%, 94%, 94%, 92%, or 89% of
controls for females. Water consumption was decreased
in dosed animals. As was seen in the 13-day studies,
major organs and tissues from treated animals were
stained red. Kidney toxicity characterized by regenera-
tion and karyomegaly of tubule epithelial cells with
chronic inflammation was observed in female rats at
dosesof1,200ppm orabove.Treatment-relatedincreases
in relative liverweights and elevated liver enzyme levels
were seen in males and females, centrilobular pallor in
the liver was seen in all male dose groups. Because of
these body weight differences, decreases in water con-
sumption, and organ toxicity, the doses chosen for the
2-year studies were 70,150, and 300 ppm for males and
150, 300, and 600 for females.
2-Year Studies: Male rats received doses of0, 70,150,
or300ppm ofC.I.Acid Red 114, andfemale rats received
0, 150, 300, or 600 ppm. Seventy animals were in the
control and high-dose groups, 45 in the low-dose groups,
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and 75 in the mid-dose groups. Ten animals were evalu-
ated from the control and high-dose groups at 9 months,
andtenanimalsfromalldosegroupswereevaluatedat15
months. The average amountofcompound consumed per
daywas4,8, or20mg/kgformalesand 9,20, or70mg/kg
forfemales.
Survival and BodyWeights: Survival at 105weeks for
male rats receiving 0, 70, 150, or 300 ppm was 24/50,
15/35, 26/65, and 1/50; forfemales receiving0, 150, or300
ppm, survival was 36/50,13/35, and 6/64. All female rats
receiving 600 ppm died by week 89. The decreased
survival in treated groups was due primarily to the
development of chemical-related neoplasms. Of the sur-
viving animals, the final mean body weights for males
receiving70or150ppmwere 94% and90% ofcontrol and
for females receiving 150 or 300 ppm, 99% and 84% of
control. These weight differences began in the second
year of the studies and were attributed in part to the
development ofneoplasms in the dosed groups.
Histopathologic Effectsinthe2-YearStudies:At9and
15 months, a few neoplasms were seen in the liver, lung,
clitoral gland, skin, Zymbal's gland, oral cavity epi-
thelium, and smallandlargeintestine, andthenumberof
neoplasms at these sites increased as the studies pro-
gressed. At 2 years, there was a clear carcinogenic
response in the skin, Zymbal's gland, and liver ofmale
and female rats, and in the clitoral gland, oral cavity
epithelium, small and large intestine, and lung in female
rats. TIeatment-related increases were also seen in the
incidence in neoplasms of the oral cavity epithelium,
adrenalgland, andlung ofmale rats, andinmononuclear
cell leukemia and in neoplasms of the mammary gland
and adrenal gland in female rats. The incidence ofthese
neoplasms was generally lower, but was significant and
considered to be marginally related to chemical treat-
ment. The same neoplastic effects have been previously
observed in some or all of the NTP studies with
dimethoxybenzidine, dimethylbenzidine, or C.I. Direct
Blue 15.
Genetic Toxicology: In a standard preincubation pro-
tocol, C.I. Acid Red 114 was mutagenic in Salmanella
typhimurium strain TA98 in the presence of induced
hamsterliverS9, and anequivocal responsewas noted in
strain TA100 with hamster liver S9. However, no signifi-
cant mutagenic activity was noted in strains TA1535 or
TA1537 with or without S9 activation. In a modified S.
typhimurium gene mutation test which employed
reductive metabolism followed by oxidative metabolism
with S9 liver enzymes, C.I. Acid Red 114 was strongly
mutagenic in strain TA1538. C.I. Acid Red 114 did not
induce sisterchromatidexchanges orchromosomal aber-
rations inChinesehamsterovarycellswithorwithoutS9
activation; reductive metabolism was not used in these
cytogenetic tests. No increase in sex-linked recessive
lethal mutations was observed in germ cells of male
Drosophila melanogaster administered C.I. Acid Red
114 by feeding or injection.
Conclusions: Under the conditions of these 2-year
drinking water studies, there was clear evidence of
carcinogenic activity of C.I. Acid Red 114 for male
F344/N rats, as indicated by benign and malignant neo-
plasms ofthe skin, Zymbal's gland, and liver. Increased
incidences of neoplasms of the oral cavity epithelium,
adrenal gland, and lungmayhave been related to chemi-
caladministration.Therewasclearevidenceofcarcino-
genic activity for female F344/N rats, as indicated by
benign and malignant neoplasms of the skin, Zymbal's
gland, clitoral gland, liver, oral cavity epithelium, small
and large intestines, and lung. Increased incidences of
mononuclear cell leukemia, mammary gland adenocar-
cinoma, and adrenal gland pheochromocytomas may
have been related to chemical administration.
Synonyms: 1,3-Naphthalenedisulfonic acid, 8-((3,3'-
dimethyl-4'-((4-(((4-methylphenyl)sulfonyl) oxy)phenyl)
azo) (1,1'-biphenyl)-4-yl)azo)-7-hydroxy, disodium salt,
Acid Leather Red BG, Acid Red 114,Amacid Milling Red
PRS, Benzyl Fast Red BG, Benzyl Red BR, Cerven
Kysela, C.I. 23635, Erionyl Red RS, Folan Red B,
Kayanol Milling Red RS, Leather Fast Red B, Levanol
Red GG, Midlon Red PRS, Milling Red B, Milling Red
BB, Milling Red SWB, NCI C61096, Polar Red RS,
Sandolan Red N-RS, Sella Fast Red RS, Sulphonol Fast
Red R, Supranol Fast Red GG, Supranol Red PBX-CF,
Supranol Red R, Telon Fast Red GG, Tertracid Milling
Red B, Vondamol Fast Red RS
Report Date: December 1991
TR-406 Toxicology and Carcinogenesis
Studies of y-Butyrolactone (CAS No.
96-48-0) in F344/N Rats and B6C3F1 Mice
(GavageStudies)
y-Butyrolactone is an intermediate in the synthesis of
polymers used as film formers in hair sprays, blood
plasmaextenders, andclarifyingagentsinbeerandwine.
Toxicologyandcarcinogenesis studieswereconductedby
administering y-butyrolactone (greater than 97% pure)
in corn oil by gavage to groups of F344/N rats and
B6C3F1 mice ofeach sex, 5 days perweekfor 16 days, 13
weeks, and 2 years. Genetic toxicology studies were
conducted in Salmanella typhimurium, Drosophila
rnelanogaster, and Chinese hamster ovary cells.
16-DayStudies:Groupsoffiveratsofeachsexreceived
dosesof0,75,150,300,600,or1,200mgofy-butyrolacton-
e per kg ofbodyweight and groups offive mice ofeach
sexreceived doses of0, 87, 175, 350, 700, or 1,400 mg/kg.
All male and female rats given 1,200mg/kgand one male
rat given 600 mg/kg died within 3 days. The mean body
weight gain offemale rats given 600 mg/kg was signifi-
cantlylowerthanthatofthe controls. Meanbodyweight
gains ofthe other female dose groups and all male dose
groups were similar to those of the controls. All of the
male and four female mice receiving 1,400 mg/kg died
during the studies. Mean body weight gains of dosed
miceweregenerallysimilartothose ofthecontrols. Rats
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receiving 600 or 1,200 mg/kg and mice receiving 350 mg/
kg or more became inactive or recumbent with irregular
respiration following dosing.
13-WeekStudies: Groupsof10ratsofeachsexreceived
doses of0, 56, 112,225, 450, or 900mgofy-butyrolactone
per kg ofbodyweight and groups of10 mice ofeach sex
received doses of0, 65, 131, 262, 525, or1,050 mg/kg. One
female and allmalerats given 900mg/kgdied duringthe
studies. The final mean body weight and mean body
weight gain of male rats receiving 450 mg/kg were
significantly lower than those ofthe controls; final mean
body weights and body weight gains of all female rat
dose groups were similar to those ofthe controls. There
was an increased incidence offocal inflammation ofthe
nasal mucosa in rats administered y-butyrolactone.
Three male mice and one female receiving 1,050 mg/kg
died from y-butyrolactone toxicity during the studies.
The mean bodyweight gain and final mean bodyweight
of high-dose male mice were lower than those of the
controls; the mean body weight gains and final mean
bodyweights ofdosed female micewere similar to those
ofthecontrols. Nolesionsrelatedtotheadministrationof
y-butyrolactone occurred in mice ofeither sex.
2-Year Studies: The doses administered to groups of
50 animals per sex were 0, 112, and 225 mg of
y-butyrolactone per kg ofbody weight for male rats; 0,
225, and 450 mg/kg for female rats; and 0, 262, and 525
mg/kg for male and female mice.
BodyWeight and Survival in the 2-Year Studies: The
mean body weights of male rats administered
y-butyrolactone were similar to those of the controls
throughout the study. The mean body weight of high-
dose females was lower than that of the controls after
week 5 and was 10% to 20% lower than that of the
controls throughout the second year. The survival of
high-dose male rats was slightly higher than that ofthe
controls (control, 24/50; low-dose, 27/50, high-dose,
32/50) due primarilyto alowerincidence ofmononuclear
cell leukemia in the high-dose group (16/50, 15/50, 9/50).
The survival ofdosed females was similar to that ofthe
controls (28/50, 27/50, 28/50).
Themeanbodyweightsofdosedmalemicewerelower
than those ofthe controls throughout the study, but the
differences in mean bodyweights decreased when male
micewerehousedindividuallyatweek67.Thefinalmean
bodyweightsofdosedmalemicewere6%lowerthanthat
ofthe controls. Meanbodyweights ofdosed female mice
werealsolowerthanthoseofthecontrolsthroughoutthe
study, andthefinalmeanbodyweightswerefrom14%to
17% lowerthanthatofthecontrols. The survival inhigh-
dose male mice was significantly lower than that ofthe
controls (35/50, 30/50, 12/50) due to bite wounds and
fighting in high-dose males recovering fromthe sedative
effects of y-butyrolactone. The survival offemale dosed
mice was similar to that of the controls (38/50, 34/50,
38/50).
Neoplasms and Nonneoplastic Lesions in the 2-Year
Studies: No increased incidences of neoplasms or non-
neoplastic lesionsinmaleratswererelated tothe admin-
istration of y-butyrolactone for 2 years. In female rats,
negative trends were observed in the incidences ofcysts
(42/50, 35/50, 23/50) andfibroadenomas ofthemammary
gland (22/50, 14/50, 6/50) and in cysts of the pituitary
pars distalis (25/49, 13/37, 11148). These decreases were
considered to be related to y-butyrolactone administra-
tion.
Increasedincidences ofproliferativelesions,primarily
hyperplasia, oftheadrenalmedullainlow-dosemalemice
were associated with y-butyrolactone administration
(pheochromocytoma, benign or malignant: 2/48, 6/50,
1/50; hyperplasia: 2/48, 9/50, 4/50). The incidence of
hepatocellular neoplasms in both dose groups of male
mice was lower than the incidence in the controls
(hepatocellular adenoma or carcinoma: 24/50, 8/50,
9/50).
Genetic Toxicology: y-Butyrolactone was not muta-
genic, with or without exogenous metabolic activation
(S9), in Salmonella typhimurium strains TA98, TA100,
TA1535, and TA1537, nor did it induce sex-linked reces-
sive lethal mutations in germ cells of male Drosophila
melanogasterwhen administered infeed orbyinjection.
Positive results were obtained, however, in cytogenetic
tests with Chinese hamster ovary cells; y-butyrolactone
induced sister chromatid exchanges and chromosomal
aberrations in trials conducted in the presence of S9
activation.
Conclusions: Under the conditions of these 2-year
gavage studies, there was no evidence ofcarcinogenic
activity ofy-butyrolactoneinmaleF344/Nratsgiven112
or 225 mg/kg or in female F344/N rats given 225 or 450
mg/kg in corn oil. There was equivocal evidence of
carcinogenic activity of y-butyrolactone in male
B6C3F1 mice based on marginally increased incidences
ofadrenal medullapheochromocytomas and hyperplasia
inthelow-dosegroup.Thesensitivityofthestudyinmale
mice to detect a carcinogenic effect was reduced by the
low survival of the high-dose group associated with
fighting. There was no evidence of carcinogenic
activity ofy-butyrolactone infemaleB6C3F1 micegiven
262 or 525 mg/kg in corn oil.
A decreased incidence ofhepatocellular neoplasms in
dosed male mice and decreased incidences ofmammary
gland fibroadenomas and cysts and pituitary cysts in
female rats were associated with the administration of
-y-butyrolactone.
Synonyms: Dihydro-2(3H)-furanone (8CI) (9CI), 1,2-
butanolide, butyrolactone, 1,4-butanolide, 4-butyrolac-
tone, 4-hydroxybutanoic acid lactone, y-hydroxybutyric
acidcyclicester, y-hydroxybutyricacidlactone, y-lactone
4-hydroxy-butanoic acid, butyric acid lactone, butyryl
lactone, 4-hydroxybutyric acid lactone, tetrahydro-2-
furanone, 4-butanolide, 4-deoxytetronic acid,
,v-hvf1rnYvhu]t.vrals.9.t.ann
Report Date: March 1992
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TR-407 Toxicology and Carcinogenesis
Studies ofC.I. Pigment Red 3 (CAS No.
2425-85-6) in F344/N Rats and B6C3F
Mice (FeedStudies)
C.I.PigmentRed3, ayellowishredsolid,iswidelyused
for coloring paints, inks, plastics, and rubber, and in
textile printing. It is used in a wide range of consumer
items such as wallpaper, typewriter ribbons, carbon
paper, and art materials. Toxicology and carcinogenicity
studieswereconductedbyfeedinggroupsofF344/Nrats
and B6C3F1 mice ofeach sex diets containing C.I. Pig-
mentRed3(97%pure)for2weeks,13weeks,and2years.
GenetictoxicologystudieswereconductedinSalnmonella
typhimurium and cultured Chinese hamster ovary
cells.
2-Week Studies: Groups of five rats and five mice of
each sex were given feed containing 0, 6,000, 12,500,
25,000, 50,000, or 100,000 ppm C.I. Pigment Red 3 for 2
weeks. No chemical-related deaths occurred in rats or
mice. Final mean bodyweights ofexposed rats and male
micewere lowerthancontrols; femalemicethatreceived
6,000 and 50,000 ppm had significantly increased final
meanbodyweights comparedtothatofthecontrols. The
feed consumption oftreated rats and mice was slightly
greater than that of the controls, suggesting that C.I.
Pigment Red 3 had no adverse effects on the feed pal-
atability. Dose-related decreases in erythrocyte counts
and hematocrit values and an increase in reticulocyte
counts were observed in rats. Changes in these param-
eters were observed in mice, but there were no clear,
dose-related trends.
13-Week Studies: Groups of ten rats and ten mice of
each sex were given feed containing 0, 3,000, 6,000,
12,500, 25,000, or 50,000 ppm C.I. Pigment Red 3 for 13
weeks. No chemical-related deathswere observed inrats
or mice. The final mean bodyweights ofexposed female
rats were significantly lower than that of the controls;
the final mean body weights of exposed male rats and
exposedmiceweresimilartocontrols.Thereweresignifi-
cant increases in relative liver and kidney weights of
exposedmale rats. Increases intherelativeliverweights
in mice did not occurwith a dose-related trend and thus
theywere notconsidered related tochemical administra-
tion. SitesforthetoxicityofC.I. Pigment Red3werethe
bone marrow, kidney, liver, and spleen in rats. Lesions
observed in rats included bone marrow hyperplasia,
congestion and hematopoietic cell proliferation of the
spleen, and iron-positive pigmentation of the spleen,
kidney, and liver. Sites for the toxicity of C.I. Pigment
Red 3 in mice were the liver, kidney, and spleen in males
andtheliverandspleeninfemales. Lesions noted among
mice in the spleen were hematopoietic cell proliferation
and iron-positive pigmentation. In the liver, there was
hematopoietic cell proliferation in male and female mice.
Cytomegaly occurred in the renal tubulee epithelium of
the male mouse kidney.
2-Year Studies: Doses selected for the 2-year feed
studieswere0, 6,000,12,500, and25,000 ppmforrats and
0, 12,500, 25,000, and 50,000 ppm for mice. The dose
selection for rats was based on body weight changes
observed for females that received 50,000 ppm; the dose
selection for mice was based on the lack ofbodyweight
depression or death at the doses tested during the 13-
week studies. Concentrations higherthan 50,000 ppm in
the feed were notused because higher levels might have
adverselyaffectedthenutritionalvalueofthedietduring
the 2-year studies.
Body Weight, Feed Consumption, Clinical Findings,
and Survival in the 2-Year Studies: Final mean body
weights for male rats that received 25,000 ppm, female
rats that received 12,500 and 25,000 ppm, and male and
female mice that received 50,000 ppm were more than
10% lower than those ofthe controls. Feed consumption
of exposed rats and mice was similar to that of the
controls. No clinical findings indicative of toxicity were
observed in rats or mice. The survival oflow-dose male
rats was greater than that ofthe controls (0 ppm, 28/50;
6,000 ppm, 40/50; 12,500 ppm, 28/50; 25,000 ppm, 20/50).
Survival ofexposed female rats and exposed male mice
was similar to the controls; the survival of high-dose
female mice was significantly decreased compared to
that of the controls (39/50, 37/50, 31150, 25/50). The
reduced survivalinthis dose groupmayhavebeen dueto
the increased incidence ofovarian abscesses.
Neoplasms and Nonneoplastic Lesions in the 2-Year
Studies: Benign adrenal pheochromocytomas were sig-
nificantlyincreased in the 12,500 and 25,000 ppm groups
ofmaleratscomparedtothecontrols(22/50,29/50,35/50,
34/50). However, malignant neoplasms were not
increased in incidence (6/50, 7/50, 10/50, 4/50). The inci-
dence of adrenal pheochromocytomas in dosed groups
exceeded the range for NTP historical controls for feed
studies (22%-48%), and the increased incidence of this
neoplasm was attributed to C.I. Pigment Red 3 admin-
istration.
Squamous cell papillomas ofthe skin occurred with a
positivetrendinmale rats (0/50,4/50,2/50,6/50), and the
incidence in the high-dose group was significantly
greater than that ofthe controls. Apoorly differentiated
squamous cell carcinoma (diagnosed as carcinoma) was
observedin acontrolmale.The historical controlrate for
squamous cell papillomas in NTP feed studies is low
(16/800 or2%, range 0%-4%), andthe higherincidenceof
this tumor in male rats may have been caused by the
administration ofC.I. Pigment Red 3.
Hepatocellular adenomas occurred with a positive
trend in female rats, with a significantly greater inci-
dence in the high-dose group than in the control group
(0/50, 0/50, 1/50,10/50). This neoplasm has occurred in
only one historical control group in NTP feed studies
(3/800, range 0%-6%), and the increase in hepatocellular
adenomas in female rats was attributed to chemical
administration.
Chemical-relatednonneoplasticlesionsobservedinthe
livers of male and female rats included eosinophilic or
mixed type foci of cellular alteration. Foci were often
accompanied by angiectasis and cystic degeneration in
males and by granulomas and cholesterol pigmentation
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infemales. Chronicnephropathyoccurredwithincreased
severity in exposed male and female rats. The lesions
were more severe inmales thanin females. Otherlesions
considered secondary to renal disease included para-
thyroid gland hyperplasia, fibrous osteodystrophyofthe
bone, and mineralization of various organs (stomach,
intestine, heart, and blood vessels). The increased inci-
dence ofhyperplasia ofthetransitional epithelium ofthe
renal papilla observed in treated rats was considered to
be part ofthe chronic nephropathy.
Zymbal's gland carcinomaincidencesweremarginally
increasedinthemid-andhigh-dosemalerats (0/50,0/50,
2/50, 3/50). The incidence in the high-dose group was
outside the NTP historical control range (0%-4%), and
the Zymbal's gland carcinomas mayhavebeenrelated to
C.I. Pigment Red 3 administration.
Mononuclear cell leukemias, mammary gland fibro-
adenomas, and preputial gland/clitoral gland adenomas
occurred atlowerincidences in exposed male and female
rats. The decrease in mononuclear cell leukemia was
attributed tothedirecteffectofC.I. Pigment Red3 orits
metabolites on the mechanism responsible for inducing
leukemias in agingrats,while the decreasedincidence of
mammary gland fibroadenomas might be attributed to
decreased bodyweights in female rats. The cause ofthe
decreased incidences of preputial and clitoral gland
tumors is unknown.
Tubule adenomas of the renal cortex occurred at a
significantly higher incidence in high-dose male mice
than in controls (0 ppm, 0/50; 12,500 ppm, 0/50; 25,000
ppm, 0/50; 50,000 ppm, 6/50). Because this tumor
occurred only in exposed males and was outside the
range for NTP historical controls in feed studies
(0%-2%), renal cortical tubule adenomas in male mice
were considered to be related to the administration of
C.I. Pigment Red 3.
Follicular cell adenoma ofthe thyroid gland occurred
with a positive trend in male mice (0/50, 0/49,1/50, 5/50).
The incidence in the high-dose group was significantly
greater than that in the controls. This chemical-related
effectissupportedbytheincreasedincidence offollicular
cell hyperplasia. Because the incidence of this tumor
exceeded the range ofthe historical controls from NTP
feed studies (0%-4%), the increase offollicular cell ade-
nomawas attributed to chemical administration. Female
mice receiving C.I. Pigment Red 3 had a significant
increase in follicular cell hyperplasia but showed no
increase in tumor incidence at this site.
Focal renal tubule hyperplasia and cystic hyperplasia
occurred in exposed male mice but not in the controls.
Cytomegaly (karyomegaly) of the renal tubule epi-
theliumwas seeninalltreatedmalemice.Theseverityof
the accompanying chronic nephropathywasincreased in
both male and female mice.
GeneticToxicology: C.I.Pigment Red3wasmutagenic
inSalmonella typhimurium strains TA100 andTA98in
the presence of exogenous metabolic activation (S9); no
increases in gene mutation were observed in strains
TA1535 and TA1537, with or without S9. C.I. Pigment
Red 3 did not induce sister chromatid exchanges or
chromosomal aberrations inChinesehamsterovarycells
in either the presence or the absence ofS9.
Conclusions: Undertheconditions ofthese2-yearfeed
studies, there was some evidence of carcinogenic
activity of C.I. Pigment Red 3 in male F344/N rats as
exhibited by increased incidences of benign phe-
ochromocytomas of the adrenal gland. The marginal
increase in theincidences ofsquamous cell papillomas of
the skin and Zymbal's gland carcinomas may have been
related to C.I. Pigment Red 3 administration. Therewas
some evidence ofcarcinogenic activity ofC.I. Pigment
Red3infemaleF344/Nratsasindicatedbytheincreased
incidence of hepatocellular adenomas. There was some
evidenceofcarcinogenic activity ofC.I.PigmentRed3
in male B6C3F1 mice as exhibited by the increased
incidences of tubule adenomas of the renal cortex and
follicular cell adenomas ofthe thyroid gland. There was
no evidence of carcinogenic activity of C.I. Pigment
Red 3 in female B6C3F1 mice that received 12,500,
25,000, or 50,000 ppm.
The incidences ofmononuclear cell leukemia and pre-
putial gland tumors in male rats and mononuclear cell
leukemia, mammary gland fibroadenoma, and clitoral
gland tumors in female rats were lower in the exposed
groups. The incidences of liver foci were markedly
increased in exposed male and female rats. The severity
ofchronicnephropathywasincreased inmalerats and to
a lesser extent in female rats given C.I. Pigment Red 3.
Anincrease inthe severityofnephropathywas observed
in male and female mice; cytomegaly (karyomegaly) of
renal tubule epithelium was observed in male mice. Thy-
roid follicular cell hyperplasia occurred with an
increased incidence in male and female mice receiving
C.I. Pigment Red 3.
Synonyms: 2-Naphthalenol, 1-((4-methyl-2-nitrophenyl)-
azo)-; CalcotoneToluidine RedYP; FastRedA; Pigment
ScarletR; Recolite Fast Red RBL; Sengale Light Red B
Report Date: March 1992
TR-408 Toxicology and Carcinogenesis
Studies ofMercuric Chloride (CAS No.
7487-94-7) in F344 Rats and B6C3F1 Mice
(Gavage Studies
ThisTechnical Reportwas notafinalpublication atthe
time this "Compendium" was prepared.
TR-409 Toxicology and Carcinogenesis
Studies ofQuercetin (CAS No. 117-39-5) in
F344 Rats (Feed Studies)
ThisTechnicalReportwas notafinalpublication atthe
time this "Compendium" was prepared.
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TR-410 Toxicology and Carcinogenesis
Studies ofNaphthalene (CAS No. 91-20-3)
in B6C3F1 Mice (Inhalation Studies)
Naphthalene, awhite, crystalline powder, is used as a
moth repellent and in the manufacture of phthalic and
anthranilic acids, naphthylamines, and synthetic resins.
The2-yearstudieswereconductedbyexposinggroupsof
male and female B6C3F1 mice to naphthalene (>99%
pure) vapor for 6 hours daily, 5 days per week, for 104
weeks. Genetic toxicology studies were conducted in
Salmonella typhimurium and Chinese hamster ovary
cells.
2-Year Studies: Groups ofmale and female mice were
exposedtoatmospheres containing0(75micepergroup),
10 (75 mice per group), or 30 ppm (150 mice per group)
naphthalene. Micefrom each groupwereincluded for14-
day hematology evaluations (male: 0 ppm, 5 animals; 10
ppm, 4; 30 ppm, 10; female: 0 ppm, 4; 10 ppm, 5; 30 ppm,
10). Mean body weights of exposed mice were slightly
lower than those of controls throughout the studies.
Survival ofmale control mice was significantly less than
thatofexposed mice; thelowersurvivalwastheresult of
wound trauma and secondaryinfections related to fight-
ing amongthe group-housed mice (0ppm, 26/70, 37%; 10
ppm, 52/69, 75%; 30 ppm, 118/133, 89%). Survival of
exposed female mice was similar to that of controls
(59/69, 86%; 57/65, 88%; 102/135, 76%).
Neoplastic and Nonneoplastic Effects in the 2-Year
Studies: No increase in tumor incidence related to
naphthalene administration was observed in male mice.
In females, the incidence of pulmonary alveolar/
bronchiolar adenomas was significantly greater in the
high-dose groupthan in the controls (5/69, 7%; 2/65,3%;
28/135,21%).Oneotherhigh-dosefemalehadanalveolar/
bronchiolar carcinoma. The combined incidence ofalveo-
lar/ bronchiolar adenomas and carcinomas in the high-
dosefemales was above thoseforcontrol femaleB6C3Fj
mice from NTP feed, water, and inhalation studies
(9111,166, 7.8%, range 0%-16%). These lung tumors were
attributed to naphthalene exposure.
Nonneoplastic lesions attributed to naphthalene
exposure were observed in the nose and lungs ofmice of
both sexes. In the nose, naphthalene exposure was asso-
ciated with an increase in the incidence and severity of
chronic inflammation, metaplasia of the olfactory epi-
thelium, and hyperplasia of respiratory epithelium.
Chronic inflammation in the lung was associated with
chemical exposure.
Genetic Toxicology: Naphthalene was negative for the
induction of gene mutations in Salmonella
typhimurium strainsTA100,TA1535,TA1537, andTA98
with and without exogenous metabolic activation (S9). In
cytogenetic tests with Chinese hamster ovary cells,
naphthalene induced sister chromatid exchanges with
and without S9 activation. Exposure to naphthalene
induced a significant increase in chromosomal aberra-
tions in Chinese hamster ovary cells in the presence of
S9.
Conclusions: Under the conditions of these 2-year
inhalation studies, there was no evidence of car-
cinogenic activity ofnaphthalene in male B6C3F1 mice
exposed to 10 or 30 ppm. There was same evidence of
carcinogenic activity ofnaphthalene in femaleB6C3Fj
mice, based on increased incidences ofpulmonary alveo-
lar/bronchiolar adenomas.
In both male and female mice, naphthalene caused
increased incidences and severity of chronic inflamma-
tion, metaplasia of the olfactory epithelium, and hyper-
plasia of the respiratory epithelium in the nose and
chronic inflammation in the lungs.
Synonyms: Naphthalin, Naphthene, Tar Camphor
Report Date: April 1992
TR-411 Toxicology and Carcinogenesis
Studies ofC.I. Pigment Red 23 (CAS No.
6471-49-4) in F344 Rats and B6C3F1 Mice
(Feed Studies)
This Technical Report was not a final publication at the
time this Compendium was prepared.
TR-412 Tbxicology and Carcinogenesis
Studies of4,4'-Diamino-2,2'-
Stilbenedisulfonic Acid Disodium Salt
(CAS No. 7336-20-1) in F344 Rats and
B6C3F1 Mice (Feed Studies)
ThisTechnical Reportwasnotafinalpublicationatthe
time this Compendium was prepared.
TR-413 Toxicology and Carcinogenesis
Studies ofEthylene Glycol (CAS No.
107-21-1) in B6C3F1 Mice (Feed Studies)
ThisTechnical Reportwas notafinalpublication atthe
time this Compendium was prepared.
TR-414 Toxicology and Carcinogenesis
Studies ofPentachloroanisole (CAS No.
1825-21-4) in F344 Rats and B6C3F1 Mice
(Feed Studies)
ThisTechnicalReportwasnotafinalpublication atthe
time this Compendium was prepared.
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TR-415 Toxicology and Carcinogenesis
Studies ofPolysorbate 80 (CAS No.
9005-65-6) in F344/N Rats and B6C3F
Mice (FeedStudies)
Polysorbate 80 is a nonionic surfactant used widely as
an additive in foods, pharmaceutical preparations, and
cosmetics as an emulsifier, dispersant, or stabilizer. Tox-
icity and carcinogenicity studies were conducted by
administering polysorbate 80 (which met all compendial
specifications) in feed to groups of F344/N rats and
B6C3F1 mice of each sex for 14 days, 13 weeks, and 2
years. Genetic toxicology studies were conducted in Sal-
monella typhimurium.
14-Day Studies: Groups of five rats and five mice of
each sex received diets containing 0, 3,000, 6,000,12,500,
25,000, or 50,000 ppm polysorbate 80. All animals sur-
vived to the end of the studies. The mean body weight
change ofmale ratsthatreceived 50,000ppmwas signifi-
cantly lower than that of the controls. The mean body
weightchanges inallothergroups ofdosedratsandinall
groups ofdosed micewere similarto those ofthe respec-
tive controls. No clinical findings or changes in absolute
or relative organ weights in rats or mice were related to
polysorbate 80 administration.
13-Week Studies: Groups of10rats and10mice ofeach
sex received diets containing 0, 3,100, 6,200, 12,500,
25,000, or 50,000 ppm polysorbate 80. All animals sur-
vived to the end of the studies. The final mean body
weights of dosed rats and mice were similar to those of
the controls. No clinical findings, changes in absolute or
relative organweights, or gross ormicroscopic lesions in
rats or mice were related to polysorbate 80 administra-
tion.
2-Year Studies: Doses for the 2-year studies were
selected based onthe lack ofobserved compound-related
effects at the dose levels used in the 13-week studies.
Groups of60 rats and 60 mice ofeach sex received diets
containing 0,25,000, or50,000ppmpolysorbate 80forup
to 103 weeks.
15-Month Interim Evaluations: Interim evaluations
were performed on 7 to 10 rats and mice from each dose
group at15months. Therewere no significantchanges in
absolute or relative organ weights. Incidences of hyper-
plasia and inflammation of the forestomach were
increased in female mice that received 50,000 ppm. No
other chemical-related lesions occurred in rats or male
mice evaluated at 15 months.
Body Weights, Clinical Findings, and Survival in the
2-Year Studies: The mean body weights in male and
female rats and male mice administered polysorbate 80
were similar to those of the controls throughout the
studies. The final mean body weight of female mice
receiving 50,000 ppm was 11% lower than that of the
controls. No clinical findings were associated with
administration ofpolysorbate 80. The survival of dosed
male rats was lower than that of the controls (0 ppm,
29/50;25,000ppm,18/50; 50,000ppm,18/50); the survival
of dosed female rats and male and female mice was
similar to that of the respective controls (female rats:
23/50,25/50,25/50; malemice: 33/49,34/50,32/50; female
mice: 30/50, 28/50, 26/50).
Neoplasms and Nonneoplastic Lesions in the 2-Year
Studies: The incidence of adrenal medulla phe-
ochromocytoma was marginally increased in high-dose
male rats (21150, 19/50, 29/50). The incidence of hyper-
plasia ofthe adrenal medulla was increased in low-dose
male rats but not in high-dose male rats (11V50, 22/50,
12/50).
No chemical-related increases in the incidences of
neoplasms occurred in male or female mice. The inci-
dences ofsquamous hyperplasia andinflammation ofthe
forestomach were significantly increased in high-dose
male and female mice; forestomach ulcers were signifi-
cantly increased in high-dose females.
Genetic Toxicology: Polysorbate 80was notmutagenic
in Salmonella typhirnurium strains TA100, TA1535,
TA1537, and TA98 with or without exogenous metabolic
activation (S9).
Conclusions: Underthe conditions ofthese2-yearfeed
studies, there was equivocal evidence ofcarcinogenic
activity forpolysorbate 80inmaleF344/Nratsbased on
an increased incidence of pheochromocytomas of the
adrenal medulla. There was no evidence of car-
cinogenic activity for polysorbate 80 in female F344/N
rats or in male or female B6C3F1 mice given 25,000 or
50,000ppm.
Administration ofpolysorbate 80 was associated with
inflammation and squamous hyperplasia of the fore-
stomach in male and female mice, and with ulcers ofthe
forestomach in female mice.
Synonyms: Glycol; sorbitan mono-9-octadecenoate
poly(oxy-1,2-ethanediyl) derivatives; polyoxyethylene
(20) sorbitan mono-oleate; sorethytan (20) mono-oleate;
polyethylene oxide sorbitan mono-oleate
Trade names: Alkamuls PSMO-20; Armotan PMO-20;
Capmul POE-0; Drewmulse POE-SMO; Emsorb 2722;
Glycosperse 0-20; Glycosperse 020 Veg; Glycosperse
020X; Hetsorb 020; Industrol 020S; Laxan ESO;
Liposorb 0-20; Lonzest SMO-20; Montanox 80; Nikkol
TO-10;
Protasorb 0-20; Sorbitan mono-oleate polyoxyethylene;
Sorlate; Tween 80; Monitan; Olothorb; Sorbimacrogol
Oleate 300; T-Maz 80
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